2012AB LOINC Source Information

Attribute Name	Description	Count (MRSAT.RRF)
COMMON_ORDER_RANK	Ranking of approximately 300 common orders performed by laboratories in USA	67447
COMMON_SI_TEST_RANK	Corresponding SI terms for 2000 common tests performed by laboratories in USA	67447
COMMON_TEST_RANK	Numeric ranking of approximately 2,000 common tests performed by hospitals	67447
LCL	LOINC Class - arbitrary classification of terms in LOINC designed to assist LOINC development and to group related observations together (e.g. ABXBACT = Antibiotic susceptibility)	67447
LCN	LOINC Classtype - 1 = Laboratory class; 2 = Clinical class	67447
LCS	LOINC status - valid values are "ACTIVE," "TRIAL," "DISCOURAGED," "DEPRECATED." For "DEPRECATED" concepts, the term that should now be used may appear in the LMP element.	67447
LOINC_COMPONENT	LOINC component	67447
LRN2	Related names 2	67447
LOINC_TIME_ASPECT	LOINC time aspect	67446
LOINC_SYSTEM	LOINC system	67427
LOINC_PROPERTY	LOINC property	67423
LOINC_SCALE_TYP	LOINC scale type	67421
LLR	LOINC Date Last Changed YYYYMMDD - date the LOINC term was last changed	67216
LCT	LOINC Change Type Code - type of change made to a LOINC term.	66862
LOR	LOINC ORDER_OBS field. Defines term as order only, observation only, or both. Values are: BOTH OBSERVATION ORDER. A fourth category, Subset, is used for terms that are subsets of a panel but do not represent a package that is known to be orderable.	53970
LUR	Units required when used as OBX segment - a Y/N field that indicates that units are required when this LOINC is included as an OBX segment in a HIPAA attachment	53604
LCA	LOINC ACSSYM field - LOINC chemical name synonyms, alternative names and chemical formulae from the Chemical Abstract Society	52399
LOINC_METHOD_TYP	LOINC method type	30961
EXAMPLE_UCUM_UNITS	The Unified Code for Units of Measure (UCUM)	22339
EXAMPLE_UNITS	Example units	21061
HL7_V2_DATATYPE	HL7 V2 Datatype	18843
LSU	Submitted Units	14380
HL7_V3_DATATYPE	HL7 V3 Datatype	13730
LQS	Survey Question Source	6284
SOS	Scope Statement	5033
LEA	LOINC Example Answers - for some tests and measurements, LOINC has supplied examples of valid answers. These values differ from those in the ANSWERLIST field because that details possible values for nominal scale terms.	4921
LQT	Survey Question Text	4534
LMM	Molecular weights - contains the molecular weights of many chemical moieties when they are provided.	1881
STATUS_REASON	Classification of the reason for concept status in LOINC	1741
LMP	LOINC Map to Code of the term that has superseded a term with a LCS value of DEPRECATED.	1487
LCD	LOINC CDISC common tests	833
MTH_LSU	MTH Submitted Units	618
STATUS_TEXT	Explanation of concept status in narrative text in LOINC	560
CHANGE_REASON_PUBLIC	Detailed explanation about special changes to the term over time.	557
LNC	LOINC NAACCR_ID - LOINC terms mapped to North American Association of Central Cancer Registries Identification	449
MTH_COPYRIGHT	MTH Copyright	399
LFO	LOINC Formula - regression equation details for many OB.US calculated terms.	352
LSP	LOINC Species code	267
CONSUMER_NAME	An experimental (beta) consumer friendly name	195
CURATED_RANGE_AND_UNITS	Curated Range and Units	191
DOCUMENT_SECTION	Classification of whether this LOINC code can be used a full document, a section of a document, or both.	144
LNE	LOINC CODE_TABLE	79
MTH_LEA	MTH LOINC Example Answers - for some tests and measurements, LOINC has supplied examples of valid answers. These values differ from those in the ANSWERLIST field because that details possible values for nominal scale terms.	62
MTH_SOS	Metathesaurus version of SOS	49
HL7_FIELD_SUBFIELD_ID	A value which indicates the content should be delivered in the named field/subfield of the HL7 message. When NULL, the data should be sent in an OBX segment with this LOINC code stored in OBX-3 and with the value in the OBX-5	34
LCB	LOINC Chemical base name from the Chemical Abstract Society	31
MTH_LQT	MTH Survey Question Text	28
MTH_LRN2	MTH Related names 2	24
MTH_LFO	MTH LOINC Formula - regression equation details for many OB.US calculated terms.	7
MTH_SOS	Metathesaurus version of SOS	6
COPYRIGHT	Copyright	2
FROMRSAB	Root source abbreviation for the "from" identifiers of a map set	1
FROMVSAB	Versioned source abbreviation for the "from" identifiers of a map set	1
MAPSETRSAB	Root source abbreviation for a map set	1
MAPSETTYPE	Indicates the nature of a map set. Its value is map set specific. It can be used to indicate the inclusion of one to one, one to many and choices of maps.	1
MAPSETVERSION	Version of the map set	1
MAPSETVSAB	Versioned source abbreviation for a map set	1
MTH_MAPFROMCOMPLEXITY	Indicates the complexity of "from" expressions used in a map set	1
MTH_MAPFROMEXHAUSTIVE	Indicates whether or not the "from" source of a map set is completely mapped	1
MTH_MAPSETCOMPLEXITY	Indicates the overall complexity of a map set	1
MTH_MAPTOCOMPLEXITY	Indicates the complexity of "to" expressions in a map set	1
MTH_MAPTOEXHAUSTIVE	Indicates whether or not the "to" source is completely mapped	1
TORSAB	Root source abbreviation for the "to" identifiers of a map set	1
TOVSAB	Versioned source abbreviation for the "to" identifiers of a map set	1

COMMON_ORDER_RANK

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	STR
C0550725	A18098485	L2424318	S7461613	AUI	10991-8	COMMON_ORDER_RANK	Metronidazole:MCnc:Pt:Ser/Plas:Qn
C0550151	A18138011	L1465913	S7379376	AUI	12930-4	COMMON_ORDER_RANK	Thyroxine^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0551635	A20870355	L10329426	S12910347	AUI	11508-9	COMMON_ORDER_RANK	Progress note:Find:Pt:{Setting}:Doc:Physical therapy
C0486231	A18098795	L2403272	S7395244	AUI	1160-1	COMMON_ORDER_RANK	little e Ab:ACnc:Pt:Ser/Plas^BPU:Ord
C0550845	A18330997	L1031237	S7450295	AUI	12732-4	COMMON_ORDER_RANK	Interleukin 12:ACnc:Pt:Ser/Plas:Qn
C0796765	A18099996	L1472968	S7349572	AUI	13574-9	COMMON_ORDER_RANK	Norfluoxetine:ACnc:Pt:Ser/Plas:Ord
C0796816	A18370296	L1495094	S7461143	AUI	13625-9	COMMON_ORDER_RANK	Methoxsalen:MCnc:Pt:Ser/Plas:Qn
C0482486	A18370570	L1836859	S7418573	AUI	1402-7	COMMON_ORDER_RANK	Cortisol^1H post 250 ug corticotropin IV rapid:MCnc:Pt:Ser/Plas:Qn
C0798777	A18255384	L1467420	S7407882	AUI	15610-9	COMMON_ORDER_RANK	Cat epithelium Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0485329	A18333445	L1468217	S7427200	AUI	16795-7	COMMON_ORDER_RANK	Echovirus Ab:ACnc:Pt:Ser:Qn
C0800744	A18217957	L3157160	S7374238	AUI	17630-5	COMMON_ORDER_RANK	Streptococcus pneumoniae 3 Ab^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn
C1148462	A18218114	L6694346	S7799354	AUI	17942-4	COMMON_ORDER_RANK	Bacteria identified^^^2:Prid:Pt:Line:Nom:Intravascular line culture
C0801086	A18256797	L1730903	S7426318	AUI	18037-2	COMMON_ORDER_RANK	E wave.max:Vel:Pt:Mitral valve:Qn:US.doppler
C0801226	A18256854	L1487320	S7385075	AUI	18177-6	COMMON_ORDER_RANK	Vendor serial number:ID:Pt:Cardiac echo imaging device:Qn
C0801928	A18334553	L6404209	S7452409	AUI	18935-7	COMMON_ORDER_RANK	Kanamycin:Susc:Pt:Isolate:OrdQn
C0882232	A18257634	L1839514	S7444878	AUI	19742-6	COMMON_ORDER_RANK	Hexahydrophthalic anhydride Ab.IgE:ACnc:Pt:Ser:Qn
C0802630	A18219076	L1491351	S7378438	AUI	19815-0	COMMON_ORDER_RANK	Therapeutic results:Desc:Stdy:Endoscopy procedure:Nar
C0802748	A18257766	L1485063	S10619466	AUI	19933-1	COMMON_ORDER_RANK	Gas flow.constant^baseline setting:VRat:Pt:Ventilator:Qn
C0803879	A18104201	L4851401	S7372192	AUI	21084-9	COMMON_ORDER_RANK	Aspergillus flavus Ab:ACnc:Pt:CSF:Ord:Immune diffusion

COMMON_SI_TEST_RANK

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0549677	A18252369	L6405498	S7376190	AUI	11578-2	COMMON_SI_TEST_RANK	0	Sulfisoxazole:Susc:Pt:Isolate:OrdQn:Gradient strip
C0549750	A18330029	L2269428	S7358068	AUI	10955-3	COMMON_SI_TEST_RANK	0	Pinus palustris Ab.IgE:ACnc:Pt:Ser:Qn
C0549801	A18098573	L6410454	S7429253	AUI	11131-0	COMMON_SI_TEST_RANK	0	Erythroblasts early/100 cells:NFr:Pt:Bone mar:Qn
C0551560	A18175936	L1037304	S7417899	AUI	11487-6	COMMON_SI_TEST_RANK	0	Consultation request.total:Find:Pt:^Patient:Nar
C0552193	A18214737	L1493064	S7375321	AUI	12079-0	COMMON_SI_TEST_RANK	0	Study observation:Find:Pt:Heart.interventricular septum^fetus:Nom:US
C0552240	A18291164	L1493107	S7375377	AUI	12128-5	COMMON_SI_TEST_RANK	0	Study observation:Find:Pt:Yolk sac^fetus:Nar:US
C0550282	A18176306	L6406762	S7420230	AUI	12192-1	COMMON_SI_TEST_RANK	0	Creatinine^2H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn
C0550393	A18177054	L1032820	S7447799	AUI	13312-4	COMMON_SI_TEST_RANK	0	IgA Ab.IgG:ACnc:Pt:Ser/Plas:Qn
C1764785	A18292828	L6417149	S7428215	AUI	13353-8	COMMON_SI_TEST_RANK	0	Eosinophils/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0550404	A18331438	L6427953	S7451455	AUI	13402-3	COMMON_SI_TEST_RANK	0	Isoleucine:MCnc:Pt:Amnio fld:Qn
C0796881	A18138401	L6409161	S7384670	AUI	13690-3	COMMON_SI_TEST_RANK	0	Vanillylmandelate/Creatinine:MCrto:Pt:Urine:Qn
C0797152	A18293236	L1851114	S7461460	AUI	13964-2	COMMON_SI_TEST_RANK	657	Methylmalonate:SCnc:Pt:Ser/Plas:Qn
C0797745	A18332053	L1836793	S10021877	AUI	14569-8	COMMON_SI_TEST_RANK	850	17-Hydroxyprogesterone:SCnc:Pt:Ser/Plas:Qn
C2718219	A18294385	L2268272	S7363545	AUI	15884-0	COMMON_SI_TEST_RANK	0	Quercus alba Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799609	A18140050	L2413071	S7398455	AUI	16458-2	COMMON_SI_TEST_RANK	0	Bethanechol:MCnc:Pt:Ser/Plas:Qn
C0799745	A18371997	L1467349	S7412503	AUI	16598-5	COMMON_SI_TEST_RANK	0	Chlamydia trachomatis C Ab.IgG:ACnc:Pt:Ser:Qn
C0799767	A18217356	L6403210	S7414790	AUI	16620-7	COMMON_SI_TEST_RANK	0	Clarithromycin+Ethambutol:Susc:Pt:Isolate:OrdQn:MIC
C0801325	A18102753	L6701230	S7805517	AUI	18279-0	COMMON_SI_TEST_RANK	0	Hemoglobin F:ACnc:Pt:Stool:Ord:Apt-Downey
C0363888	A18295339	L6404072	S7446678	AUI	1754-1	COMMON_SI_TEST_RANK	0	Albumin:MCnc:Pt:Urine:Qn

COMMON_TEST_RANK

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	STR
C0485208	A18368659	L6426860	S7412909	AUI	10652-6	COMMON_TEST_RANK	Chlamydophila pneumoniae DNA:ACnc:Pt:Sputum/Bronchial:Ord:Probe.amp
C0797850	A18293579	L6427034	S7418439	AUI	14676-1	COMMON_TEST_RANK	Cortisol.free:SRat:24H:Urine:Qn
C0796927	A18215646	L6423984	S7429874	AUI	13736-4	COMMON_TEST_RANK	Estradiol/Creatinine:MCrto:24H:Urine:Qn
C0549858	A18254123	L6422651	S7383324	AUI	13355-3	COMMON_TEST_RANK	Unspecified cells/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0796837	A18292980	L6428259	S7460920	AUI	13646-5	COMMON_TEST_RANK	Methaqualone:MCnt:Pt:Hair:Qn
C0798426	A18332475	L2268218	S7423557	AUI	15255-3	COMMON_TEST_RANK	(Actinidia chinensis+Cucumis melo+Musa spp+Prunus dulcis+Vitis vinifera) Ab.IgE:ACnc:Pt:Ser:Ord:Multidisk
C0797672	A18331137	L6405780	S7391293	AUI	14496-4	COMMON_TEST_RANK	Virus identified:Prid:Pt:Sputum:Nom:IF
C0797792	A18332070	L6415327	S7362242	AUI	14617-5	COMMON_TEST_RANK	Appearance:Aper:Pt:Pericard fld:Nom
C0798074	A18100144	L1473060	S7364277	AUI	14901-3	COMMON_TEST_RANK	Ranitidine:ACnc:Pt:Ser/Plas:Ord
C0363777	A18294694	L6409259	S7393174	AUI	1646-9	COMMON_TEST_RANK	Xylose^post dose PO:MRat:5H:Urine:Qn
C0799717	A18178957	L1467451	S7411197	AUI	16570-4	COMMON_TEST_RANK	Centromere Ab:ACnc:Pt:Ser:Ord:IF
C2718100	A18256330	L1491371	S7461175	AUI	17268-4	COMMON_TEST_RANK	Methsuximide+Desmethylmethsuximide:MCnc:Pt:Ser/Plas:Qn
C0804665	A18181900	L1484333	S7376400	AUI	21877-6	COMMON_TEST_RANK	Surgery procedure for regional nodes at facility.YYY:Prid:Pt:Cancer.XXX:Nom
C0804730	A18104700	L1487014	S7349183	AUI	21942-8	COMMON_TEST_RANK	Non cancer directed surgery summary:Type:Pt:Cancer.XXX:Nom
C0879800	A18336417	L1724158	S7419423	AUI	22218-2	COMMON_TEST_RANK	Coxsackievirus A4 Ab:Titr:Pt:Ser:Qn
C0880006	A18104975	L1725019	S7364115	AUI	22458-4	COMMON_TEST_RANK	Rabies virus Ab:ACnc:Pt:Tiss:Qn
C0364390	A18220547	L6410489	S7430015	AUI	2255-8	COMMON_TEST_RANK	Estrogen:MCnc:Pt:Urine:Qn
C0880138	A18220572	L1724719	S7392484	AUI	22610-0	COMMON_TEST_RANK	Western equine encephalitis virus Ab:ACnc:Pt:CSF:Ord
C0880220	A18375435	L1731496	S7457967	AUI	22713-2	COMMON_TEST_RANK	Lysine:SCnc:Pt:XXX:Qn

LCL

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0549680	A18291488	L1839522	S7367283	AUI	10930-6	LCL	ALLERGY	Artemia salina Ab.IgE:ACnc:Pt:Ser:Qn
C0364753	A18330150	L6428247	S7460578	AUI	11139-3	LCL	CHEM	Metanephrine:MCnc:Pt:Urine:Qn
C0551854	A18137343	L8868779	S11022132	AUI	11735-8	LCL	OB.US	Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&BPD&FL.Hadlock 1985
C0552155	A18214722	L1487941	S7375278	AUI	12043-6	LCL	OB.US	Study observation:Find:Pt:Cerebrum^fetus:Nar:US
C0550360	A18176537	L6697385	S7804956	AUI	12608-6	LCL	CHEM	Glucose^2H specimen:MCnc:Pt:Dial fld prt:Qn
C0551283	A18331263	L1839904	S7425464	AUI	13107-8	LCL	SERO	Disialylganglioside GD1a Ab:ACnc:Pt:Ser:OrdQn
C0551293	A18292713	L1839484	S7432312	AUI	13173-0	LCL	SERO	Fibronectin aggregate Ab.IgA:ACnc:Pt:Ser:Qn
C0797795	A18293552	L6418711	S7362273	AUI	14620-9	LCL	SPEC	Appearance:Aper:Pt:Plr fld:Nom
C0798243	A18332362	L6410612	S7435035	AUI	15071-4	LCL	CHEM	Galactose:SRat:24H:Urine:Qn
C0799594	A18177867	L1467218	S7397510	AUI	16442-6	LCL	SERO	Benzene ring Ab.IgM:ACnc:Pt:Ser:Qn
C0363795	A18179013	L0460875	S10018585	AUI	1661-8	LCL	CHEM	11-Ketoandrosterone:MCnc:Pt:Ser:Qn
C0802182	A18103198	L6419604	S7397615	AUI	19285-6	LCL	DRUG/TOX	Benzodiazepines screen method:Prid:Pt:Urine:Nom:*
C0801505	A18295831	L8574522	S10638972	AUI	18463-0	LCL	CHEM	Oleoylcarnitine (C18:1):MCnc:Pt:Ser/Plas:Qn
C0801516	A18141165	L6408440	S11755728	AUI	18475-4	LCL	CHEM	Phenylalanine/Creatinine:SCrto:Pt:Urine:Qn
C0801760	A18141271	L5314098	S7375563	AUI	18746-8	LCL	ATTACH.CLINRPT	Study report:Find:Pt:Lower GI tract:Doc:Colonoscopy
C0801877	A18256437	L6416563	S7408421	AUI	18884-7	LCL	ABXBACT	Cefoperazone:Susc:Pt:Isolate:OrdQn
C0802606	A18335018	L1491270	S7449550	AUI	19791-3	LCL	ENDO.GI	Insertion depth:Len:Stdy:Gastrointestine.upper:Qn:EGD
C0804306	A18181658	L1839223	S7368777	AUI	21512-9	LCL	MICRO	Salmonella paratyphi A H Ab:Titr:Pt:Ser:Qn:IF
C0364435	A18375616	L0692072	S7447927	AUI	2298-8	LCL	CHEM	Aldolase:CCnc:Pt:Ser:Qn

LCN

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0488903	A18175195	L1494280	S7449616	AUI	10274-9	LCN	2	Institution inventory number:ID:Pt:Urine tube:Nom
C0484501	A18098166	L0847086	S7384829	AUI	10428-1	LCN	1	Varicella zoster virus immune globulin given:Vol:Pt:^Patient:Qn
C0549733	A18330169	L2269338	S7370246	AUI	11186-4	LCN	1	Setaria italica Ab.IgE:ACnc:Pt:Ser:Qn
C0796807	A18292964	L6408225	S7349009	AUI	13616-8	LCN	1	Nitrite:MCnc:Pt:Water:Qn
C0796894	A18177210	L6420901	S7440201	AUI	13703-4	LCN	1	Adipate/Creatinine:MCrto:Pt:Urine:Qn
C0797187	A18293256	L1472151	S7380609	AUI	13999-8	LCN	1	Transferrin.carbohydrate deficient:ACnc:Pt:Ser/Plas:Qn
C0797650	A18370792	L6698335	S7801477	AUI	14473-3	LCN	1	Chlamydia trachomatis Ag:ACnc:Pt:Penis:Ord:EIA
C0798066	A18139107	L6401785	S7361730	AUI	14892-4	LCN	1	Propranolol:SCnc:Pt:Urine:Qn
C0798396	A18293907	L2268388	S7426254	AUI	15225-6	LCN	1	(Foeniculum vulgare seed+Ocimum basilicum+Pimpinella anisum+Zingiber officinale) Ab.IgE:ACnc:Pt:Ser:Ord:Multidisk
C0798649	A18216648	L1725045	S7455307	AUI	15480-7	LCN	1	Leptospira interrogans serovar Icterohaemorrhagiae Ab:Titr:Pt:Ser:Qn:Aggl
C0799890	A18140199	L2424511	S7349768	AUI	16746-0	LCN	1	Nortrimipramine:MCnc:Pt:Ser/Plas:Qn
C0804038	A18101699	L1491663	S7424934	AUI	16366-7	LCN	1	Diethylpropion:MCnc:Pt:Ser/Plas:Qn
C0801618	A18257067	L1465695	S7368097	AUI	18577-7	LCN	2	ST amplitude.J point+80 ms:Elpot:Pt:Lead V4:Qn:EKG
C0800517	A18294351	L2424582	S7352854	AUI	17397-1	LCN	1	Oxytriphylline:MCnc:Pt:Ser/Plas:Qn
C0800559	A20858964	L1473198	S13458601	AUI	17440-9	LCN	1	Phenothiazines:ACnc:Pt:Ser/Plas:Qn
C0801943	A18295191	L6428348	S7463371	AUI	18950-6	LCN	1	Moxalactam:Susc:Pt:Isolate:OrdQn
C0802342	A18373621	L6407083	S7430413	AUI	19460-5	LCN	1	Ethylamphetamine cutoff:MCnc:Pt:Urine:Qn:Screen
C0879665	A18141775	L2268464	S7368143	AUI	19744-2	LCN	1	Artocarpus heterophyllus Ab.IgE:ACnc:Pt:Ser:Qn
C0804175	A18297404	L4850114	S7361306	AUI	21381-9	LCN	1	Prolactin^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn

LCS

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0488459	A18252156	L1484626	S7368232	AUI	10120-4	LCS	ACTIVE	ST wave displacement.mid.lead AVR:Elpot:Pt:Heart:Qn:EKG
C0485045	A18252528	L6418697	S7361816	AUI	10583-3	LCS	ACTIVE	Prostaglandin F1 alpha:SCnc:Pt:Semen:Qn
C0551668	A18214407	L1493183	S7357485	AUI	11429-8	LCS	ACTIVE	Physical findings:Find:Pt:Forearm:Nom:Observed
C0551672	A18369083	L1493195	S7357499	AUI	11431-4	LCS	ACTIVE	Physical findings:Find:Pt:Genitalia:Nom:Observed
C0550960	A18099787	L1032583	S7419418	AUI	13234-0	LCS	ACTIVE	Coxsackievirus A4 Ab:ACnc:Pt:CSF:Qn
C0797713	A18332038	L1841218	S7459456	AUI	14537-5	LCS	ACTIVE	Measles virus Ag:ACnc:Pt:Eye:Ord:IF
C0798504	A18178221	L1484002	S7362886	AUI	15335-3	LCS	ACTIVE	Pulsativity.index:VelRto:Pt:Penile cavernosal artery:Qn:US.calculated
C0799987	A18216897	L6403673	S7430394	AUI	16849-2	LCS	ACTIVE	Ethyl benzene:MCnc:Pt:Urine:Qn
C0801786	A18102970	L4854600	S7376374	AUI	18772-4	LCS	ACTIVE	Surgeon.resident name:Pn:Pt:Surgical procedure:Nom
C0801926	A18257219	L6421126	S7448060	AUI	18933-2	LCS	DEPRECATED	Imipenem+Cilastatin:Susc:Pt:Isolate:OrdQn
C0802470	A18373152	L6418161	S7463162	AUI	19600-6	LCS	ACTIVE	Morphine cutoff:MCnc:Pt:Urine:Qn:Confirm
C0364144	A18373297	L1463451	S7405648	AUI	2012-3	LCS	ACTIVE	Cancer Ag 27-29:ACnc:Pt:Ser/Plas:Ord
C0802944	A18257195	L1484963	S7391731	AUI	20129-3	LCS	ACTIVE	Volume:Vol:Pt:Breathing bag:Qn:Gas dilution.rebreathing
C0804048	A18374610	L1467619	S7427366	AUI	21254-8	LCS	ACTIVE	Egg yolk Ab.IgG.RAST class:ACnc:Pt:Ser:Ord
C0881212	A18221300	L1731018	S7429467	AUI	23859-2	LCS	ACTIVE	Erythrocytes:NCnc:Pt:XXX:Qn:Microscopy.light
C0881662	A18260317	L1724536	S7402832	AUI	24397-2	LCS	ACTIVE	Brucella sp Ab.IgM:ACnc:Pt:Ser:Ord
C0881817	A18144486	L1729941	S7389395	AUI	24579-5	LCS	ACTIVE	Views survey:Find:Pt:Bones.long:Nar:XR
C0882536	A18376644	L5391937	S7390705	AUI	24764-3	LCS	ACTIVE	Views^W contrast intraarticular:Find:Pt:Hip:Nar:XR.fluor
C0941368	A18183726	L1846139	S7378271	AUI	25173-6	LCS	ACTIVE	Thallium:SCnc:Pt:Bld:Qn

LOINC_COMPONENT

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0485988	A18368753	L1493892	S7365641	AUI	10827-4	LOINC_COMPONENT	Reticulum.microscopic observation	Reticulum.microscopic observation:Prid:Pt:Tiss:Nom:Gomori stain
C0485635	A18098346	L6692690	S7794786	AUI	10712-8	LOINC_COMPONENT	Pneumocystis sp identified	Pneumocystis sp identified:Prid:Pt:Lung tiss:Nom
C0484868	A18175381	L1471255	S7432213	AUI	10523-9	LOINC_COMPONENT	Fibrinogen Ag	Fibrinogen Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0550655	A18330047	L2424501	S7349707	AUI	10983-5	LOINC_COMPONENT	Norparamethadione	Norparamethadione:MCnc:Pt:Ser/Plas:Qn
C0552249	A18099100	L9076254	S11343931	AUI	12135-0	LOINC_COMPONENT	Systolic flow/Diastolic flow	Systolic flow/Diastolic flow:VelRto:Pt:Cerebral artery middle^fetus:Qn:US.doppler
C0551223	A18176635	L1033629	S7427863	AUI	12737-3	LOINC_COMPONENT	Endothelin	Endothelin:ACnc:Pt:Ser/Plas:Qn
C0363554	A18215940	L1838454	S7418666	AUI	1419-1	LOINC_COMPONENT	Cortisol^30M post dose insulin IV	Cortisol^30M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn
C0799337	A18178781	L6404422	S7458590	AUI	16172-9	LOINC_COMPONENT	Magnesium	Magnesium:MCnt:Pt:Hair:Qn
C0803753	A18372560	L1490808	S7368932	AUI	17563-8	LOINC_COMPONENT	Salmonella sp identified	Salmonella sp identified:Prid:Pt:XXX:Nom:Organism specific culture
C0799593	A18370986	L1467217	S7397508	AUI	16441-8	LOINC_COMPONENT	Benzene ring Ab.IgG	Benzene ring Ab.IgG:ACnc:Pt:Ser:Qn
C0803463	A18181091	L1495728	S7382719	AUI	20660-7	LOINC_COMPONENT	Tyrosine	Tyrosine:SCnc:Pt:Ser/Plas:Qn
C0804025	A18297223	L2268704	S7405754	AUI	21231-6	LOINC_COMPONENT	Cancer pagurus Ab.IgG.RAST class	Cancer pagurus Ab.IgG.RAST class:ACnc:Pt:Ser:Ord
C0364482	A18375813	L0554370	S7436776	AUI	2342-4	LOINC_COMPONENT	Glucose	Glucose:MCnc:Pt:CSF:Qn
C0879761	A18182082	L1725359	S7412836	AUI	22170-5	LOINC_COMPONENT	Chlamydophila pneumoniae Ab.IgA	Chlamydophila pneumoniae Ab.IgA:Titr:Pt:Ser:Qn
C0880650	A18298438	L1726270	S7455435	AUI	23203-3	LOINC_COMPONENT	Leptospira sp Ag	Leptospira sp Ag:ACnc:Pt:Tiss:Ord:IF
C0880720	A18181389	L1724695	S7346277	AUI	23285-0	LOINC_COMPONENT	Mycoplasma mycoides subspecies mycoides small colony Ab	Mycoplasma mycoides subspecies mycoides small colony Ab:ACnc:Pt:Ser:Ord
C0880819	A18182727	L4851735	S7366704	AUI	23406-2	LOINC_COMPONENT	Rift valley fever virus Ag	Rift valley fever virus Ag:ACnc:Pt:Ser:Ord:Immune diffusion
C0882557	A18376753	L1731154	S7342753	AUI	24980-5	LOINC_COMPONENT	Multisection	Multisection:Find:Pt:Spine.thoracic:Nar:MRI
C0881351	A18376145	L6408855	S7373767	AUI	24020-0	LOINC_COMPONENT	Streptococcus agalactiae Ag	Streptococcus agalactiae Ag:ACnc:Pt:Urine:Ord

LRN2

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0551581	A18330264	L1493326	S7445669	AUI	11341-5	LRN2	; Occupation Hx; Finding; Findings; Point in time; Random; Nominal; H/O	History of occupation:Find:Pt:^Patient:Nom:Reported
C0552039	A18253253	L8881080	S11031900	AUI	11922-2	LRN2	; GA; Point in time; Random; Fetal; Quantitative; QNT; Quant; Quan; from FL.Hohler82; 82; FL chart; from FL.Hohler82; Femur Length; US.est; predicted; Ultrasound; ULS; Sonogram; Sonography; Sonograph; Echography; Est; estimation; Gest; Gestation; Prenatal; OBSTERICAL.ULTRASOUND; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from FL.Hohler 1982
C0550802	A18253487	L6405573	S7378715	AUI	12370-3	LRN2	Pentothal; Mass concentration; Level; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Drugs; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY	Thiopental:MCnc:Pt:Urine:Qn
C0550287	A18214972	L6406754	S7420055	AUI	12586-4	LRN2	; Creat; Crea; CR; mRate; Mass rate; 4 hours; 240 minutes; 4.0Hr; 4HR; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Chemistry; UCr	Creatinine:MRat:4H:Urine:Qn
C0550128	A18215228	L1463727	S7379187	AUI	12939-5	LRN2	; TSH; Thyrotropic hormone; Thyroid stimulating hormone; 2h p chal; Arbitrary concentration; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; PST; After; 2 hours; 120 minutes; 120 min; 120min; CHEMISTRY.CHALLENGE TESTING; CHEMISTRY.CHALLENGE TESTING	Thyrotropin^2H post XXX challenge:ACnc:Pt:Ser/Plas:Qn
C0551467	A18176853	L1495551	S7355856	AUI	13019-5	LRN2	Identity or presence; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Nominal; Drugs; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY	Pesticides:Prid:Pt:Ser/Plas:Nom
C0798267	A18255095	L6405548	S7377956	AUI	15095-3	LRN2	; Testost; Testo; Testos; sRate; Substance rate; 1 day; 24 hours; 24HR; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Chemistry	Testosterone:SRat:24H:Urine:Qn
C0798085	A18370455	L1460764	S7371246	AUI	14912-0	LRN2	Basket cells; WBC; White blood cell; Leuc; Leuk; Leukocyte; Lkcs; White blood cells; WBCs; Cell; Cellularity; 100WBC; Number fraction; Percent; Point in time; Random; Blood; WB; Whole blood; Quantitative; QNT; Quant; Quan; Manl; HEMATOLOGY/CELL COUNTS; HEMATOLOGY/CELL COUNTS	Smudge cells/100 leukocytes:NFr:Pt:Bld:Qn:Manual count
C0799503	A18255876	L6421279	S7454290	AUI	16340-2	LRN2	; A-AIB; 2-aminoisobutyric acid; alpha aminoisobutyric acid; 2-aminoisobutyrate; 2-methylalanine; AIB; Mass concentration; Level; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Alfa; Chemistry	Alpha aminoisobutyrate:MCnc:Pt:Urine:Qn
C0799823	A18256035	L1467339	S7419135	AUI	16677-7	LRN2	Immune globulin G; Immunoglobulin G; Q fev; C burnetii; Qfever; Coxiella burnettii; Q fever; Arbitrary concentration; Point in time; Random; Serum; SR; Quantitative; QNT; Quant; Quan; ABS; Antibodies; Autoantibody; Antibody; Autoantibodies; Antby; Aby; Anti; Microbiology	Coxiella burnetii Ab.IgG:ACnc:Pt:Ser:Qn
C0800357	A18178994	L6414576	S7457944	AUI	17230-4	LRN2	Lys; 2,6-diaminohexanoic acid; Arbitrary concentration; Point in time; Random; Ur; UR; Urn; UA; Ql; Ordinal; QL; Qualitative; Qual; Screen; Chemistry	Lysine:ACnc:Pt:Urine:Ord
C0800922	A18218067	L6409503	S7398132	AUI	17815-2	LRN2	; B-Globulin; Protein beta globulin; Prot; PR; GLB; Globulins; Glob; Glob%; Globul; B-Globulin; TP; Mass fraction; Percent; ?Tm; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Elph; Elp; Elect; Electrophrs; Electrophhrs; Electr; Elec; Ep; Electro; Tot; Totl; B; Chemistry; PEUR; UPEP	Beta globulin/Protein.total:MFr:XXX:Urine:Qn:Electrophoresis
C0801307	A18295234	L1488227	S7413619	AUI	18261-8	LRN2	; LDLc; LDL-C; Low density lipoprotein cholesterols; Low density lipoprotein cholesterol; Chol; Choles; Cholest; Lipid; Cholesterol total; Cholesterols; Mass concentration; Level; Point in time; Random; SerPl.Ultracent; SerPl.Ultracent; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; Chemistry	Cholesterol.in LDL:MCnc:Pt:Ser/Plas.ultracentrifugate:Qn
C0803052	A18257888	L1463690	S7424662	AUI	20237-4	LRN2	Maximum; Maximal; Largest; Peak; Dias.max; Dias; Diastoli; Diast; Volume; Point in time; Random; LV; Hrt ventr; Ventricular; Cardiac; Quantitative; QNT; Quant; Quan; US.2D.Mod Simp; MOD-SIMP; Method of disks; Method of discs; US.2D.Mod Simp; 2D US; Ultrasound; ULS; Sonogram; Sonography; Sonograph; Echography; Calc; Calculation; Cardiology; LVEDV	Diastole.max:Vol:Pt:Heart.ventricle.left:Qn:US.2D.modified Simpson.calculated
C0802119	A18103120	L1473648	S7361861	AUI	19203-9	LRN2	; PSA Free; fPSA; P-30 antigen; seminin; Kallikrein 3; Substance concentration; Level; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; Antigen; Antigens; Spec; FR; Non-protein bound; Chemistry	Prostate specific Ag.free:SCnc:Pt:Ser/Plas:Qn
C0802374	A18257521	L6414255	S7447271	AUI	19492-8	LRN2	; OH-Alpraz; Hydroxyalpraz; Mass concentration; Level; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Cfm; CNFR; CNFRM; Conf; Confirmation; GCMS; Confirmatory; CtO; Drugs; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY	Hydroxyalprazolam cutoff:MCnc:Pt:Urine:Qn:Confirm
C0802462	A18296389	L6416606	S10027723	AUI	19591-7	LRN2	; 6MAM; 6 MAM; 6-acetylmorphine; Acetylmorphine; 6 mono acetyl morphine; Heroin metabolite; Arbitrary concentration; Point in time; Random; Ur; UR; Urn; UA; Ql; Ordinal; QL; Qualitative; Qual; Scn; Scr; Scrn; Drugs; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY	6-Monoacetylmorphine:ACnc:Pt:Urine:Ord:Screen
C0804181	A18335905	L6407961	S7461426	AUI	21387-6	LRN2	Xylene metabolite; Methylhippuric acid; Mass concentration; Level; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Drugs; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY	Methylhippurate:MCnc:Pt:Urine:Qn
C0803303	A18103794	L1468811	S7803575	AUI	20491-7	LRN2	Immune globulin M; Immunoglobulin M; VCA; Viral capsid; EBV VCA; Mono; Mononucleosis; Dilution factor; Titer; Titre; Ttr; Titered; Point in time; Random; Serum; SR; Quantitative; QNT; Quant; Quan; ABS; Antibodies; Autoantibody; Antibody; Autoantibodies; Antby; Aby; Anti; Epstn; Cap; Microbiology	Epstein Barr virus capsid Ab.IgM:Titr:Pt:Ser:Qn

LOINC_TIME_ASPECT

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0488763	A18252212	L0775466	S7352403	AUI	10243-4	LOINC_TIME_ASPECT	Pt	Oxygen content:SCnc:Pt:Vena cava.inferior:Qn
C0550869	A18291469	L4851410	S7374363	AUI	10894-4	LOINC_TIME_ASPECT	Pt	Aspergillus niger Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0484504	A18252428	L1471031	S7392034	AUI	10431-5	LOINC_TIME_ASPECT	Pt	B-cell Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0485939	A18252614	L1485896	S7462222	AUI	10775-5	LOINC_TIME_ASPECT	Pt	Microscopic observation:Prid:Pt:Tiss:Nom:Bleach stain
C0550747	A18214146	L1037525	S7350374	AUI	10997-5	LOINC_TIME_ASPECT	Pt	O-desmethylencainide:MCnc:Pt:Ser/Plas:Qn
C0549834	A20855316	L10816764	S13456947	AUI	11115-3	LOINC_TIME_ASPECT	Pt	Neutrophils/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0551721	A18291821	L4853958	S7375590	AUI	11529-5	LOINC_TIME_ASPECT	Pt	Study report:Find:Pt:^Patient:Doc:Surgical pathology
C0550865	A18331305	L1032620	S7372213	AUI	13193-8	LOINC_TIME_ASPECT	Pt	Aspergillus flavus Ab:ACnc:Pt:CSF:Qn
C0796931	A18138434	L6410510	S7430484	AUI	13741-4	LOINC_TIME_ASPECT	Pt	Ethylmalonate/Creatinine:MCrto:Pt:Urine:Qn
C0796863	A18253803	L6402714	S10024776	AUI	13672-1	LOINC_TIME_ASPECT	Pt	2-Hydroxyglutarate/Creatinine:MCrto:Pt:Urine:Qn
C0797439	A18215977	L9454748	S11748722	AUI	14254-7	LOINC_TIME_ASPECT	Pt	Ganglioside GQ1b Ab.IgG:Titr:Pt:Ser:Qn
C0797738	A18293521	L6408116	S7346037	AUI	14562-3	LOINC_TIME_ASPECT	Pt	Mycobacterium tuberculosis DNA:ACnc:Pt:Semen:Ord:Probe.amp.tar
C0798455	A18332531	L2268198	S7358710	AUI	15285-0	LOINC_TIME_ASPECT	Pt	Platanus acerifolia Ab.IgE:ACnc:Pt:Ser:Qn
C0799504	A18217205	L1471396	S7454213	AUI	16341-0	LOINC_TIME_ASPECT	Pt	Alpha aminoisobutyrate:ACnc:Pt:Plas:Ord
C0799171	A18139801	L2268454	S7367446	AUI	16003-6	LOINC_TIME_ASPECT	Pt	Artemisia tridentata Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799287	A18255751	L1840585	S7417145	AUI	16122-4	LOINC_TIME_ASPECT	Pt	Colorado tick fever virus Ab.IgM:Titr:Pt:Ser:Qn
C0799762	A18217354	L1036827	S7413695	AUI	16615-7	LOINC_TIME_ASPECT	Pt	Cholesterol.total/Cholesterol.in LDL:MCrto:Pt:Ser/Plas:Qn
C0799955	A18179126	L1472583	S7427682	AUI	16813-8	LOINC_TIME_ASPECT	Pt	Emetine:ACnc:Pt:Ser/Plas:Qn
C0800665	A18333908	L1468542	S7367112	AUI	17550-5	LOINC_TIME_ASPECT	Pt	Rubella virus Ab:ACnc:Pt:Ser:Qn:LA

LOINC_SYSTEM

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0489408	A18290871	L1492172	S7367661	AUI	10079-2	LOINC_SYSTEM	Heart	S' wave duration.lead V4:Time:Pt:Heart:Qn:EKG
C0488499	A18136361	L0831398	S7445646	AUI	10159-2	LOINC_SYSTEM	^Patient	History of industrial exposure:Find:Pt:^Patient:Nar:Reported
C0362190	A18136363	L6409811	S7408418	AUI	101-6	LOINC_SYSTEM	Isolate	Cefoperazone:Susc:Pt:Isolate:OrdQn:Agar diffusion
C0552266	A18291905	L1491686	S7378660	AUI	12153-3	LOINC_SYSTEM	Heart.interventricular septum^fetus	Thickness.systolic:Len:Pt:Heart.interventricular septum^fetus:Qn:US.measured.real time two dimension
C0550798	A18214901	L6408958	S7377823	AUI	12419-8	LOINC_SYSTEM	Urine	Terfenadine:MCnc:Pt:Urine:Qn
C0797134	A18100257	L1472311	S7417642	AUI	13946-9	LOINC_SYSTEM	RBC	Complement+Immunoglobulin:ACnc:Pt:RBC:Ord
C0797384	A18177562	L1468746	S7412459	AUI	14199-4	LOINC_SYSTEM	Ser	Chlamydia trachomatis B Ab.IgA:Titr:Pt:Ser:Qn:IF
C0797924	A18177793	L6417409	S7436850	AUI	14750-4	LOINC_SYSTEM	Synv fld	Glucose:SCnc:Pt:Synv fld:Qn
C0799096	A18139764	L2269010	S7369300	AUI	15929-3	LOINC_SYSTEM	Ser	Schinus molle Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799561	A18101718	L6408741	S7369408	AUI	16408-7	LOINC_SYSTEM	Urine	Ascorbate:MCnc:Pt:Urine:Qn
C0799961	A18333460	L1468287	S7428015	AUI	16819-5	LOINC_SYSTEM	Ser	Entamoeba histolytica Ab:ACnc:Pt:Ser:Qn:IF
C0363877	A18217860	L1838762	S7444620	AUI	1743-4	LOINC_SYSTEM	Ser/Plas	Alanine aminotransferase:CCnc:Pt:Ser/Plas:Qn:With P-5'-P
C0801948	A18257229	L6418335	S7349034	AUI	18955-5	LOINC_SYSTEM	Isolate	Nitrofurantoin:Susc:Pt:Isolate:OrdQn
C0802569	A18334955	L6422606	S7381085	AUI	19714-5	LOINC_SYSTEM	Urine	Triazolam:ACnc:Pt:Urine:Ord:Screen
C0803930	A18180943	L2268874	S7420841	AUI	21136-7	LOINC_SYSTEM	Ser	Cucumis melo spp Ab.IgG.RAST class:ACnc:Pt:Ser:Ord
C0803970	A18374333	L1472162	S7411431	AUI	21176-3	LOINC_SYSTEM	CSF	Cerebroventricular lining cells:ACnc:Pt:CSF:Ord:Microscopy.light
C0881162	A18259962	L1724320	S7343254	AUI	23800-6	LOINC_SYSTEM	Ser	(Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) Ab.IgE:ACnc:Pt:Ser:Ord:Multidisk
C0879985	A18182212	L1725569	S7347619	AUI	22430-3	LOINC_SYSTEM	Ser	Neisseria gonorrhoeae Ab:Titr:Pt:Ser:Qn
C0880067	A18259248	L1724733	S7368998	AUI	22530-0	LOINC_SYSTEM	Ser	Salmonella typhi little d Ab:ACnc:Pt:Ser:Ord

LOINC_PROPERTY

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0549753	A18291500	L2269261	S7358050	AUI	10957-9	LOINC_PROPERTY	ACnc	Pinus elliottii Ab.IgE:ACnc:Pt:Ser:Qn
C0550976	A18369140	L1461755	S7426982	AUI	11594-9	LOINC_PROPERTY	ACnc	Echovirus 16 Ab:ACnc:Pt:Ser:Qn
C0551738	A18330359	L1473330	S7435852	AUI	11620-2	LOINC_PROPERTY	Find	Activity:Find:Pt:Respiratory system^fetus:Nar:US
C0796855	A18215147	L1468721	S7346613	AUI	13664-8	LOINC_PROPERTY	Titr	Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM:Titr:Pt:Ser:Qn
C0796860	A18369860	L6419614	S10024740	AUI	13669-7	LOINC_PROPERTY	MCrto	2-Hydroxy-3-Methylvalerate/Creatinine:MCrto:Pt:Urine:Qn
C0797179	A18215849	L6422061	S7360315	AUI	13991-5	LOINC_PROPERTY	MFr	Prealbumin/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis
C0797621	A18138855	L6416750	S7413713	AUI	14444-4	LOINC_PROPERTY	MCnc	Cholesterol:MCnc:Pt:Urine:Qn
C0797876	A18293595	L1491815	S7425525	AUI	14702-5	LOINC_PROPERTY	SCnc	Disopyramide:SCnc:Pt:Ser/Plas:Qn
C0799563	A18294663	L6425698	S7370474	AUI	16410-3	LOINC_PROPERTY	ACnc	Asparagine:ACnc:Pt:Urine:Ord
C0363818	A18255561	L6413034	S10026379	AUI	1684-0	LOINC_PROPERTY	MCnc	3-Methoxy-4-Hydroxyphenylglycol:MCnc:Pt:Urine:Qn
C0800191	A18256249	L1462261	S7454377	AUI	17062-1	LOINC_PROPERTY	Titr	Legionella pneumophila 2 Ab:Titr:Pt:Ser:Qn
C1145733	A18334070	L6419559	S7396327	AUI	17896-2	LOINC_PROPERTY	Prid	Bacteria identified^^^5:Prid:Pt:Sputum:Nom:Aerobic culture
C0801441	A18373054	L6693986	S7794821	AUI	18399-6	LOINC_PROPERTY	Titr	Polio virus 3 Ab:Titr:Pt:CSF:Qn:Comp fix
C0801577	A18102896	L1492486	S7363512	AUI	18536-3	LOINC_PROPERTY	Time	QT interval:Time:Pt:Lead II:Qn:EKG
C0803727	A18374423	L1495295	S7352200	AUI	20928-8	LOINC_PROPERTY	MCnt	Oxalate:MCnt:Pt:Plant:Qn
C0804331	A18374766	L2269107	S7372900	AUI	21537-6	LOINC_PROPERTY	ACnc	Spinacia oleracea Ab.IgG.RAST class:ACnc:Pt:Ser:Ord
C0804451	A18220093	L2271727	S7404620	AUI	21661-4	LOINC_PROPERTY	Prid	CYP2D6 gene mutation analysis del:Prid:Pt:Bld/Tiss:Nom:Molgen
C0804525	A18181835	L1476240	S7367969	AUI	21735-6	LOINC_PROPERTY	Prid	SNCA gene mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
C0879726	A18182065	L6416329	S7401191	AUI	22129-1	LOINC_PROPERTY	ACnc	Borrelia burgdorferi Ab.IgG:ACnc:Pt:Synv fld:Ord

LOINC_SCALE_TYP

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0551124	A18213749	L1033080	S7368426	AUI	10906-6	LOINC_SCALE_TYP	Qn	Saint Louis encephalitis virus Ab.IgG:Titr:Pt:Ser:Qn:IF
C0551009	A18291713	L2271056	S7443647	AUI	11259-9	LOINC_SCALE_TYP	Ord	Hepatitis C virus RNA:ACnc:Pt:Ser/Plas:Ord:Probe.amp.tar
C0551622	A18175892	L1037881	S7455836	AUI	11379-5	LOINC_SCALE_TYP	Qn	Level of education:Time:Pt:^Patient:Qn:Reported
C0551802	A18175411	L9082417	S11326337	AUI	11683-0	LOINC_SCALE_TYP	Qn	Blood flow.mean:Vel:Pt:Ovarian artery.left:Qn:US.doppler
C0552126	A18292054	L1492199	S7364031	AUI	12009-7	LOINC_SCALE_TYP	Qn	RR duration:Time:Pt:Heart^fetus:Qn:US.measured
C0551388	A18292212	L6416244	S7397627	AUI	12364-6	LOINC_SCALE_TYP	Ord	Benzodiazepines:ACnc:Pt:Gast fld:Ord
C0551269	A18292250	L1495212	S7380000	AUI	12441-2	LOINC_SCALE_TYP	Qn	Tolmetin:MCnc:Pt:Ser/Plas:Qn
C0550015	A18369786	L1461925	S7449981	AUI	12763-9	LOINC_SCALE_TYP	Qn	Insulin^19M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0482436	A18254085	L2403605	S7384146	AUI	1330-0	LOINC_SCALE_TYP	Ord	V Ab:ACnc:Pt:Ser/Plas^donor:Ord
C0797229	A18100319	L1471772	S7413859	AUI	14041-8	LOINC_SCALE_TYP	Qn	Choriogonadotropin.beta subunit:ACnc:Pt:CSF:Qn
C0879938	A18102034	L1725420	S7806846	AUI	17039-9	LOINC_SCALE_TYP	Qn	La Crosse virus Ab.IgM:Titr:Pt:Ser:Qn
C0800449	A18371281	L6425089	S7347821	AUI	17328-6	LOINC_SCALE_TYP	Ord	Neisseria meningitidis B Ag:ACnc:Pt:Urine:Ord:LA
C0801090	A18295618	L1481615	S7427563	AUI	18041-4	LOINC_SCALE_TYP	Qn	Ejection:Time:Pt:Aortic valve:Qn:US.doppler
C0801950	A18103054	L6408264	S7349861	AUI	18957-1	LOINC_SCALE_TYP	OrdQn	Novobiocin:Susc:Pt:Isolate:OrdQn
C0802050	A20851562	L10831004	S13453368	AUI	19113-0	LOINC_SCALE_TYP	Qn	IgE:ACnc:Pt:Ser/Plas:Qn
C0802280	A18141639	L6413358	S7413324	AUI	19389-6	LOINC_SCALE_TYP	Ord	Chlorpheniramine:ACnc:Pt:Urine:Ord:Screen
C0802532	A20858977	L6401636	S13458595	AUI	19672-5	LOINC_SCALE_TYP	Qn	Phenothiazines cutoff:MCnc:Pt:Urine:Qn:Screen
C0364189	A18218733	L6419912	S7407978	AUI	2057-8	LOINC_SCALE_TYP	Qn	Catecholamines:MCnc:Pt:Urine:Qn
C0803750	A18297008	L6405308	S7368935	AUI	20951-0	LOINC_SCALE_TYP	Nom	Salmonella sp serotype:Prid:Pt:Isolate:Nom:Aggl

LLR

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0489362	A18097805	L1492168	S7363884	AUI	10033-9	LLR	19980820	R' wave duration.lead V6:Time:Pt:Heart:Qn:EKG
C0488521	A18290951	L0814299	S7445775	AUI	10171-7	LLR	19961126	History of symptoms & diseases:Find:Pt:Eyes:Nar:Reported
C1959619	A18329718	L2406794	S7395286	AUI	10408-3	LLR	20020403	little i Ag:ACnc:Pt:RBC:Ord
C0549769	A20078175	L10338399	S12911566	AUI	11197-1	LLR	20110929	Sardina pilchardus Ab.IgE:ACnc:Pt:Ser:Qn
C0552281	A18330659	L1485542	S7391862	AUI	12168-1	LLR	19990125	Volume^post void:Vol:Pt:Urinary bladder^fetus:Qn:US.measured
C0552200	A18330630	L1493076	S7375325	AUI	12086-5	LLR	20070312	Study observation:Find:Pt:Heart.valves^fetus:Nom:US
C0550723	A18176402	L6421545	S7461189	AUI	12346-3	LLR	20061026	Methyclothiazide:ACnc:Pt:Urine:Ord
C0549935	A18369673	L1465903	S7418775	AUI	12564-1	LLR	19980824	Cortisol^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549994	A18330935	L1465031	S7437720	AUI	12640-9	LLR	19980824	Glucose^6.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0551485	A18369217	L6405595	S7379727	AUI	12708-4	LLR	20061026	Tin:MCnc:Pt:Urine:Qn
C0800750	A18176916	L2267527	S7374196	AUI	13145-8	LLR	20010824	Streptococcus pneumoniae 26 Ab^1st specimen:ACnc:Pt:Ser:Qn
C0551141	A18254038	L1840155	S7373127	AUI	13242-3	LLR	20010129	Sporothrix schenckii Ab.IgM:ACnc:Pt:Ser:Qn
C0551018	A18370099	L1462187	S7444196	AUI	13252-2	LLR	19980318	Herpes simplex virus 2 Ab.IgM:ACnc:Pt:CSF:Qn
C0797535	A18216010	L1491021	S7462127	AUI	14355-2	LLR	20120622	Microscopic observation:Prid:Pt:Cvx:Nom:KOH preparation
C0797790	A18332068	L6425164	S7349927	AUI	14615-9	LLR	20061026	Nuclear Ab:Titr:Pt:Periton fld:Qn
C0799011	A18371581	L2268349	S7411779	AUI	15844-4	LLR	20011128	Chenopodium ambrosioides Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799756	A18333333	L1471844	S7413340	AUI	16609-0	LLR	20020403	Chlorphentermine:ACnc:Pt:Bld:Qn
C0799293	A18217083	L1467358	S7443607	AUI	16128-1	LLR	19980604	Hepatitis C virus Ab:ACnc:Pt:Ser:Ord
C0799716	A18140096	L1469055	S7408800	AUI	16569-6	LLR	19980604	Ceftriaxone Ab.IgE:MCnc:Pt:Ser:Qn

LCT

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0484627	A18098178	L1470841	S7434303	AUI	10457-0	LCT	MIN	Actin Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0484718	A18368525	L1471060	S7428190	AUI	10478-6	LCT	MIN	Eosinophil major basic protein Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0550461	A18136990	L1036596	S7357206	AUI	11058-5	LCT	ADD	Phosphofructokinase:CCnc:Pt:RBC:Qn
C0551623	A18098696	L1035467	S7459245	AUI	11380-3	LCT	ADD	Marital status and living arrangements:Find:Pt:^Patient:Nar:Reported
C0482418	A18369724	L2403012	S7353066	AUI	1292-2	LCT	DEL	P2 Ab:ACnc:Pt:Ser/Plas^BPU:Ord:Aggl RBC
C0552088	A18330567	L8885516	S11036784	AUI	11971-9	LCT	MAJ	Long axis.mean:Len:Pt:Fibula.diaphysis^fetus:Qn:Estimated from gestational age.Merz 1987
C0550324	A18215502	L6420374	S7421445	AUI	13393-4	LCT	MAJ	Cystathionine:MCnc:Pt:Amnio fld:Qn
C0797923	A18177792	L1493865	S7436849	AUI	14749-6	LCT	ADD	Glucose:SCnc:Pt:Ser/Plas:Qn
C0798923	A18101295	L2268953	S7445890	AUI	15756-0	LCT	NAM	Holcus lanatus Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799713	A18101777	L6423281	S7408213	AUI	16566-2	LCT	MAJ	Cefazolin:MCnc:Pt:Urine:Qn
C0800186	A18102068	L1471350	S7454622	AUI	17057-1	LCT	ADD	Legionella pneumophila Ag:ACnc:Pt:XXX:Ord
C0800239	A18256273	L1722220	S7409199	AUI	17111-6	LCT	MIN	Cells.CD12/100 cells:NFr:Pt:Bld:Qn
C0800377	A18295140	L1495084	S7460280	AUI	17253-6	LCT	MAJ	Mercury:MCnc:Pt:Milk:Qn
C0363974	A18295790	L0501530	S7463581	AUI	1839-0	LCT	MIN	Ammonia:SCnc:Pt:Bld:Qn
C0802615	A18141830	L5814846	S7350163	AUI	19800-2	LCT	MIN	Number of specimens obtained:Num:Stdy:Gastrointestine.upper:Qn:EGD
C0804265	A18219966	L2269306	S7362931	AUI	21471-8	LCT	NAM	Punica granatum Ab.IgE:ACnc:Pt:Ser:Qn
C0802860	A18296250	L1459466	S7354930	AUI	20045-1	LCT	MAJ	Peak inspiratory flow^at 2.0 liter per second on ventilator:Pres:Pt:Respiratory system.airway opening:Qn
C0364191	A18219393	L1726422	S7411404	AUI	2059-4	LCT	MAJ	Cerebroside sulfatase:ACnc:Pt:Ser/Plas:Ord
C0804589	A20862854	L10820595	S13465595	AUI	21800-8	LCT	NAM	t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen

LOR

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0484512	A18175345	L1471126	S7404005	AUI	10439-8	LOR	Both	CD3 Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0485044	A18136732	L7984303	S10024342	AUI	10582-5	LOR	Both	pH:LsCnc:Pt:Cvm:Qn
C0485967	A18214049	L1493536	S7462277	AUI	10803-5	LOR	Observation	Microscopic observation:Prid:Pt:Tiss:Nom:Quinacrine fluorescent stain
C0363415	A18214938	L2418366	S7458720	AUI	1252-6	LOR	Observation	Major crossmatch^post immediate spin:Imp:Pt:Ser/Plas:Nom
C0362219	A18215277	L7983141	S10027116	AUI	130-5	LOR	Observation	Cefsulodin:Titr:Pt:Isolate+Ser:Qn:SBT
C0798047	A18332254	L7975053	S10024334	AUI	14873-4	LOR	Both	pH:LsCnc:Pt:BldCo:Qn
C0797712	A18177705	L6696362	S7807738	AUI	14536-7	LOR	Both	Measles virus Ag:ACnc:Pt:Skin:Ord:IF
C0800120	A18294971	L6696257	S7806141	AUI	16989-6	LOR	Observation	Hydrogen/Expired gas^3.5H post dose glucose:VFr:Pt:Exhl gas:Qn
C0799287	A18255751	L1840585	S7417145	AUI	16122-4	LOR	Both	Colorado tick fever virus Ab.IgM:Titr:Pt:Ser:Qn
C0799405	A18333145	L6421952	S7355353	AUI	16240-4	LOR	Both	Pentobarbital:MCnc:Pt:Urine:Qn:Confirm
C0800094	A18372185	L1485744	S7444817	AUI	16963-1	LOR	Observation	Hexacarboxylporphyrin:MCnc:Pt:Bld:Qn
C0800119	A18256183	L6700029	S7806139	AUI	16988-8	LOR	Observation	Hydrogen/Expired gas^2H post dose glucose:VFr:Pt:Exhl gas:Qn
C0879657	A18257626	L1724639	S7411901	AUI	19734-3	LOR	Both	Chicken droppings Ab.IgE:ACnc:Pt:Ser:Qn
C0802139	A18218692	L2274871	S7423382	AUI	19227-8	LOR	Observation	Deoxyhemoglobin/Hemoglobin.total:MFr:Pt:BldV:Qn
C0812461	A18103133	L1485370	S7398593	AUI	19231-0	LOR	Observation	Bicarbonate^^standard:SCnc:Pt:BldC:Qn
C0803909	A18219796	L2269102	S7384458	AUI	21115-1	LOR	Observation	Vaccinium myrtillus Ab.IgG.RAST class:ACnc:Pt:Ser:Ord
C0804092	A18297369	L1467694	S7435735	AUI	21298-5	LOR	Observation	Gelatin porcine Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0879763	A18259067	L1725363	S7412847	AUI	22172-1	LOR	Both	Chlamydophila pneumoniae Ab.IgG:Titr:Pt:Ser:Qn
C0879982	A18182208	L1725649	S7346332	AUI	22427-9	LOR	Both	Mycoplasma pneumoniae Ab.IgM:Titr:Pt:Ser:Qn

LUR

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0549702	A18252694	L1032772	S7427639	AUI	10927-2	LUR	Y	Elk meat Ab.IgE:ACnc:Pt:Ser:Qn
C0484477	A18329712	L0847085	S7448219	AUI	10402-6	LUR	Y	Immune serum globulin given:Vol:Pt:^Patient:Qn
C0551276	A18368578	L1032987	S7397016	AUI	10862-1	LUR	Y	Basement membrane Ab:Titr:Pt:Ser:Qn
C0550249	A18175593	L1487421	S7407441	AUI	10876-1	LUR	Y	Carnitine esters:MCnc:Pt:Ser/Plas:Qn
C0550674	A18175651	L2419964	S7425969	AUI	10986-8	LUR	Y	Doxycycline:MCnc:Pt:Ser/Plas:Qn
C0550133	A18098508	L1838683	S7379214	AUI	11033-8	LUR	Y	Thyrotropin^45M post dose TRH IV:MCnc:Pt:Ser/Plas:Qn
C0551833	A18098875	L9088031	S11326387	AUI	11714-3	LUR	Y	Blood flow.systolic.max:Vel:Pt:Heart.ventricle.left.outflow tract:Qn:US.doppler
C0551845	A18330431	L9076916	S11326406	AUI	11726-7	LUR	Y	Blood flow.systolic.max:Vel:Pt:{Circulatory system}:Qn:US.doppler
C0550369	A18137773	L6696155	S7804982	AUI	12635-9	LUR	Y	Glucose^6th specimen:MCnc:Pt:Dial fld prt:Qn
C0796802	A18177179	L6409833	S10027666	AUI	13611-9	LUR	Y	6-Beta-Hydroxycortisol:MRat:24H:Urine:Qn
C0550556	A18138168	L6699369	S7797962	AUI	13506-1	LUR	Y	Urea nitrogen renal clearance:VRat:Pt:Urine+Ser/Plas:Qn
C0796712	A18292503	L9456335	S11752409	AUI	13518-6	LUR	Y	Lymphocytes.variant/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0797610	A18293459	L6410877	S7446058	AUI	14432-9	LUR	Y	Albumin/Globulin:MCrto:Pt:Amnio fld:Qn
C0798476	A18293981	L1491314	S7391755	AUI	15306-4	LUR	Y	Volume:Vol:Pt:Testis.left:Qn:US.derived.HWL
C0363862	A18333724	L5809040	S7438107	AUI	1728-5	LUR	Y	Adenosine monophosphate.cyclic/Creatinine:MCrto:Pt:Ser/Plas:Qn
C0799762	A18217354	L1036827	S7413695	AUI	16615-7	LUR	Y	Cholesterol.total/Cholesterol.in LDL:MCrto:Pt:Ser/Plas:Qn
C0800963	A18831189	L2268112	S7442631	AUI	17856-6	LUR	Y	Hemoglobin A1c/Hemoglobin.total:MFr:Pt:Bld:Qn:HPLC
C0481965	A18257154	L6403212	S7414807	AUI	188-3	LUR	Y	Clarithromycin:Susc:Pt:Isolate:Qn:MLC
C0802386	A18831399	L9577709	S12039436	AUI	19505-7	LUR	Y	Methotrimeprazine cutoff:MCnc:Pt:Urine:Qn:Confirm

LCA

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0484922	A18098215	L0813280	S7425332	AUI	10536-1	LCA	DIPRYRIDAMOLE	Dipyridamole:MCnc:Pt:Ser/Plas:Qn
C0485606	A18329805	L6404819	S7350324	AUI	10697-1	LCA	NYSTEX	Nystatin:Susc:Pt:Isolate:OrdQn:MIC
C0550449	A18098437	L6415193	S7356227	AUI	10883-7	LCA	EX LAX	Phenolphthalein:MCnt:Pt:Stool:Qn
C0551439	A18175730	L1038616	S7456070	AUI	11097-3	LCA	APLIDAL	Lindane:MCnc:Pt:Ser/Plas:Qn
C0550459	A18330199	L1037437	S7357161	AUI	11224-3	LCA	2 AMINOETHYL DIHYDROGEN PHOSPHATE	Phosphoethanolamine:MCnc:Pt:CSF:Qn
C0551259	A18137671	L6408633	S7365322	AUI	12414-9	LCA	RAUSERPOL	Resperine:MCnc:Pt:Urine:Qn
C0549943	A18137717	L1463741	S7428541	AUI	12529-4	LCA	EPIRENAMINE	Epinephrine^2H post XXX challenge:MCnc:Pt:Plas:Qn
C0550712	A18369654	L1472855	S7459597	AUI	12532-8	LCA	ANCOLAN	Meclizine:ACnc:Pt:Ser/Plas:Ord
C0549932	A18253588	L1465381	S7418726	AUI	12561-7	LCA	EF CORTELAN	Cortisol^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549950	A18330518	L1464384	S7429916	AUI	12596-3	LCA	BETA ESTRADIOL	Estradiol^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549982	A18369717	L1463771	S7437350	AUI	12652-4	LCA	D GLUCOPYRANOSE	Glucose^2M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549982	A18369717	L1463771	S7437350	AUI	12652-4	LCA	GLU	Glucose^2M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0796755	A18370266	L1472766	S7447727	AUI	13564-0	LCA	HALTRAN	Ibuprofen:ACnc:Pt:Ser/Plas:Ord
C0550540	A18369956	L1465551	S7381676	AUI	12958-5	LCA	L LIOTHYRONINE	Triiodothyronine^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0482478	A18370108	L6403305	S7418454	AUI	1390-4	LCA	EVACORT	Cortisol.free^48H post 40 ug corticotropin IM BID 3 day:MCnc:24H:Urine:Qn
C0798048	A18332255	L1495700	S7356195	AUI	14874-2	LCA	DONPHEN	Phenobarbital:SCnc:Pt:Ser/Plas:Qn
C0550216	A18138255	L6422167	S7364445	AUI	13387-6	LCA	S ARGININE	Arginine:MCnc:Pt:Amnio fld:Qn
C0796835	A18292979	L1459713	S10030812	AUI	13644-0	LCA	TOTAL XYLENES	1,3-Dimethylbenzene:MCnc:Pt:Bld:Qn
C0482493	A18331601	L3157814	S7418624	AUI	1413-4	LCA	ALA CORT	Cortisol^2D post 500 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn

LOINC_METHOD_TYP

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0485752	A18214026	L6699345	S7797681	AUI	10728-4	LOINC_METHOD_TYP	Organism specific culture	Trichomonas sp identified:Prid:Pt:Genital:Nom:Organism specific culture
C0488584	A18136309	L0837980	S7357500	AUI	10198-0	LOINC_METHOD_TYP	Observed	Physical findings:Find:Pt:Genitourinary tract:Nar:Observed
C0549677	A18252369	L6405498	S7376190	AUI	11578-2	LOINC_METHOD_TYP	Gradient strip	Sulfisoxazole:Susc:Pt:Isolate:OrdQn:Gradient strip
C0485695	A18098348	L6425672	S7369399	AUI	10715-1	LOINC_METHOD_TYP	Microscopy.light	Schistosoma sp identified:Prid:Pt:Urine sed:Nom:Microscopy.light
C0485975	A18329946	L1493979	S7462288	AUI	10811-8	LOINC_METHOD_TYP	Silver stain.Grimelius	Microscopic observation:Prid:Pt:Tiss:Nom:Silver stain.Grimelius
C0551589	A18291761	L1493313	S7445700	AUI	11349-8	LOINC_METHOD_TYP	Reported	History of past illness:Find:Pt:^Patient:Nom:Reported
C0798416	A18255167	L2268391	S7411830	AUI	15245-4	LOINC_METHOD_TYP	Multidisk	(Brassica oleracea var capitata+Capsicum annuum+Lycopersicon lycopersicum+Spinacia oleracea) Ab.IgE:ACnc:Pt:Ser:Ord:Multidisk
C0798579	A18294034	L1839944	S7384701	AUI	15410-4	LOINC_METHOD_TYP	EIA	Varicella zoster virus Ab.IgG:ACnc:Pt:Ser:Ord:EIA
C0801057	A18140937	L1487519	S7424557	AUI	18007-5	LOINC_METHOD_TYP	US	Diameter:Len:Pt:Vena cava.superior:Qn:US
C0799738	A18140107	L1467502	S7412043	AUI	16591-0	LOINC_METHOD_TYP	IF	Chlamydia sp Ab.IgG:ACnc:Pt:CSF:Qn:IF
C0800706	A18140688	L1468299	S7371176	AUI	17591-9	LOINC_METHOD_TYP	IF	Smith extractable nuclear Ab:ACnc:Pt:Ser:Ord:IF
C0800923	A18218068	L6412866	S7398126	AUI	17816-0	LOINC_METHOD_TYP	Electrophoresis	Beta globulin/Protein.total:MFr:Pt:Body fld:Qn:Electrophoresis
C0802988	A18335208	L1729184	S7399367	AUI	20173-1	LOINC_METHOD_TYP	US.doppler	Blood flow.diastole.max:Vel:Pt:Aortic valve.regurgitant jet:Qn:US.doppler
C0801849	A18257199	L1849681	S7438571	AUI	18851-6	LOINC_METHOD_TYP	US	Grade:Type:Pt:Placenta^fetus:Nar:US
C0803042	A18103649	L1494083	S7442275	AUI	20227-5	LOINC_METHOD_TYP	US.M-mode	Height:Len:Pt:Region of interest.XXX:Qn:US.M-mode
C0803981	A18335443	L1471493	S7412600	AUI	21187-0	LOINC_METHOD_TYP	Probe.amp.tar	Chlamydia trachomatis DNA:ACnc:Pt:Cnjt:Ord:Probe.amp.tar
C0804407	A18258704	L1481804	S7404343	AUI	21614-3	LOINC_METHOD_TYP	Molgen	CDKN2A gene deletion:Arb:Pt:Bld/Tiss:Ord:Molgen
C0804427	A18142951	L1476201	S7394434	AUI	21636-6	LOINC_METHOD_TYP	Molgen	BRCA1 gene mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
C0804519	A18143023	L1476237	S7353409	AUI	21729-9	LOINC_METHOD_TYP	Molgen	PSAP gene mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen

EXAMPLE_UCUM_UNITS

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0485044	A18136732	L7984303	S10024342	AUI	10582-5	EXAMPLE_UCUM_UNITS	[pH]	pH:LsCnc:Pt:Cvm:Qn
C0549773	A18136336	L1032872	S7370754	AUI	11199-7	EXAMPLE_UCUM_UNITS	k[IU]/L	Silver Ab.IgE:ACnc:Pt:Ser:Qn
C0552053	A18099022	L8884970	S11031931	AUI	11936-2	EXAMPLE_UCUM_UNITS	d	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from HL.Jeanty 1984
C0551194	A18369527	L1033077	S7380259	AUI	12261-4	EXAMPLE_UCUM_UNITS	{titer}	Toxoplasma gondii Ab.IgG:Titr:Pt:Ser:Qn:EIA
C0550329	A18292319	L1463858	S7423016	AUI	12590-6	EXAMPLE_UCUM_UNITS	ng/dL	Dehydroepiandrosterone^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0797852	A20866546	L10809642	S13444415	AUI	14678-7	EXAMPLE_UCUM_UNITS	nmol/L	Cortisol^PM trough specimen:SCnc:Pt:Ser/Plas:Qn
C0797129	A18331744	L6404385	S7457723	AUI	13941-0	EXAMPLE_UCUM_UNITS	%	Lymphocytes/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0797788	A18293548	L6425162	S7349924	AUI	14613-4	EXAMPLE_UCUM_UNITS	{titer}	Nuclear Ab:Titr:Pt:Body fld:Qn
C0363626	A18293720	L1835630	S7436943	AUI	1492-8	EXAMPLE_UCUM_UNITS	mg/dL	Glucose^1.5H post 0.5 g/kg glucose IV:MCnc:Pt:Ser/Plas:Qn
C0363842	A18177877	L6424052	S7432462	AUI	1708-7	EXAMPLE_UCUM_UNITS	U/L	Acetylcholinesterase:CCnc:Pt:Amnio fld:Qn
C0364149	A18335204	L0501533	S7406542	AUI	2017-2	EXAMPLE_UCUM_UNITS	umol/h/mg{protein}	Carbamoyl phosphate synthetase(ammonia):CCnt:Pt:Tiss:Qn
C0802088	A18218666	L1473626	S7406916	AUI	19167-6	EXAMPLE_UCUM_UNITS	umol/L	Carcinoembryonic Ag:SCnc:Pt:Ser/Plas:Qn
C0364094	A18373688	L0525703	S7398554	AUI	1961-2	EXAMPLE_UCUM_UNITS	mmol/L	Bicarbonate:SCnc:Pt:BldC:Qn
C0364101	A18103420	L1726922	S7398737	AUI	1968-7	EXAMPLE_UCUM_UNITS	mg/dL	Bilirubin.glucuronidated+Bilirubin.albumin bound:MCnc:Pt:Ser/Plas:Qn
C0802747	A18141911	L1490163	S10619463	AUI	19932-3	EXAMPLE_UCUM_UNITS	L/min	Gas flow.constant setting:VRat:Pt:Ventilator:Qn
C0802753	A18103552	L1474530	S7435391	AUI	19938-0	EXAMPLE_UCUM_UNITS	L/min	Gas flow.max^post therapy:VRat:Pt:Respiratory system.airway:Qn
C0802756	A18257772	L1491216	S7435404	AUI	19941-4	EXAMPLE_UCUM_UNITS	L/min	Gas flow.oxygen:VRat:Pt:Oxygen delivery system:Qn
C0803559	A18258212	L1488271	S7413993	AUI	20759-7	EXAMPLE_UCUM_UNITS	ug/g	Chromium:MCnt:Pt:Tiss:Qn
C0803959	A18335797	L1487620	S7410455	AUI	21165-6	EXAMPLE_UCUM_UNITS	%	Cells.CD5/Gated cells.total:NFr:Pt:XXX:Qn

EXAMPLE_UNITS

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0550743	A18213580	L6401462	S7349524	AUI	11075-9	EXAMPLE_UNITS	ng/mL	Norfentanyl:MCnc:Pt:Urine:Qn
C0552012	A18176165	L1473973	S7436170	AUI	11895-0	EXAMPLE_UNITS	days	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from BD
C0549913	A18369213	L6426672	S7408016	AUI	12519-5	EXAMPLE_UNITS	pg/mL	Catecholamines^5th specimen post XXX challenge:MCnc:Pt:Urine:Qn
C0796927	A18215646	L6423984	S7429874	AUI	13736-4	EXAMPLE_UNITS	ug/g creatinine	Estradiol/Creatinine:MCrto:24H:Urine:Qn
C0797061	A18100223	L6414826	S10017531	AUI	13872-7	EXAMPLE_UNITS	ug/24 h	11-Deoxycortisol:MRat:24H:Urine:Qn
C0797129	A18331744	L6404385	S7457723	AUI	13941-0	EXAMPLE_UNITS	%	Lymphocytes/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0797913	A18100180	L1835697	S7435568	AUI	14739-7	EXAMPLE_UNITS	pmol/L	Gastrin^2M post 0.2 U/kg secretin:SCnc:Pt:Ser/Plas:Qn
C0798100	A18293718	L1495726	S7381552	AUI	14927-8	EXAMPLE_UNITS	mmol/L	Triglyceride:SCnc:Pt:Ser/Plas:Qn
C0363629	A18371072	L6427567	S7436946	AUI	1495-1	EXAMPLE_UNITS	mg/dL	Glucose^1.5H post 100 g glucose PO:MCnc:Pt:Urine:Qn
C0798662	A18255313	L1463992	S7354056	AUI	15493-0	EXAMPLE_UNITS	titer	Parainfluenza virus 3 Ab:Titr:Pt:Ser:Qn:HAI
C0363720	A18371676	L1835977	S7457140	AUI	1588-3	EXAMPLE_UNITS	ug/uL	Lutropin^1.5H post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn
C0800355	A18294758	L1469118	S7457834	AUI	17228-8	EXAMPLE_UNITS	titer	Lymphocytic choriomeningitis virus Ab:Titr:Pt:CSF:Qn
C0800803	A18295427	L1838449	S7377975	AUI	17691-7	EXAMPLE_UNITS	ng/mL	Testosterone^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0802777	A18373815	L2274841	S7352744	AUI	19962-0	EXAMPLE_UNITS	%	Oxyhemoglobin/Hemoglobin.total^post bronchodilation:MFr:Pt:BldA:Qn:Pulse oximetry
C0802823	A18820156	L9579882	S12040690	AUI	20008-9	EXAMPLE_UNITS	mm Hg	Oxygen^on oxygen.low flow & asleep:PPres:Stdy^max:BldC:Qn:Transcutaneous O2 monitor
C0802131	A18296154	L1485817	S7352382	AUI	19218-7	EXAMPLE_UNITS	mol/L	Oxygen content:SCnc:Pt:BldA:Qn
C0802155	A18296166	L1460781	S7459940	AUI	19252-6	EXAMPLE_UNITS	%	Megakaryocytes/100 leukocytes:NFr:Pt:Bld:Qn
C0802711	A18141890	L1846174	S7406741	AUI	19896-0	EXAMPLE_UNITS	mm Hg	Carbon dioxide^during XXX treatment:PPres:Pt:BldC:Qn
C0803449	A18258089	L1494168	S7445185	AUI	20645-8	EXAMPLE_UNITS	mcmol/dL; mcmol/L; umol/L	Histidine:SCnc:Pt:Ser/Plas:Qn

HL7_V2_DATATYPE

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0550041	A18098411	L1839001	S7450136	AUI	10833-2	HL7_V2_DATATYPE	NM/ST	Insulin^7H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn
C0484734	A18098072	L6407281	S7438496	AUI	10336-6	HL7_V2_DATATYPE	NM/ST	Gonadotropin peptide:MCnc:Pt:Urine:Qn
C0551953	A18369297	L1491510	S7424425	AUI	11836-4	HL7_V2_DATATYPE	NM	Diameter.long:Len:Pt:Kidney.right^fetus:Qn:US.measured
C0550611	A18098478	L6411383	S7462821	AUI	10978-5	HL7_V2_DATATYPE	NM/ST	Amitriptyline+Nortriptyline:MCnc:Pt:Urine:Qn
C0551853	A18253116	L8895298	S11022131	AUI	11734-1	HL7_V2_DATATYPE	NM	Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&BPD&FL.Hadlock 1984
C0552027	A18330543	L8877422	S11031884	AUI	11910-7	HL7_V2_DATATYPE	TM	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from CRL.Hadlock 1992
C0552080	A18176201	L1484663	S7456680	AUI	11963-6	HL7_V2_DATATYPE	NM	Long axis:Len:Pt:Femur.diaphysis^fetus:Qn:US.measured
C0552102	A18214701	L1493142	S7355608	AUI	11986-7	HL7_V2_DATATYPE	NM	Perimeter:Len:Pt:Head^fetus:Qn:US.traced
C0552103	A18137475	L1491307	S7355609	AUI	11987-5	HL7_V2_DATATYPE	NM	Perimeter:Len:Pt:Thorax^fetus:Qn:US.derived
C0802312	A18369627	L6410324	S7424049	AUI	12477-6	HL7_V2_DATATYPE	NM/ST	Dextromethamphetamine:MCnc:Pt:Urine:Qn
C0550500	A18369225	L6696571	S7795173	AUI	12848-8	HL7_V2_DATATYPE	NM/ST	Protein^6th specimen:MCnc:Pt:Dial fld prt:Qn
C0550390	A18099525	L1037432	S7447430	AUI	13374-4	HL7_V2_DATATYPE	NM/ST	Hydroxyproline:MCnc:Pt:CSF:Qn
C0797576	A18254375	L6415866	S7383576	AUI	14397-4	HL7_V2_DATATYPE	NM/ST	Urea nitrogen:MCnc:Pt:Gast fld:Qn
C0798202	A18177978	L6401552	S7353002	AUI	15029-2	HL7_V2_DATATYPE	NM/ST	Androsterone:SCnc:Pt:Ser/Plas:Qn
C0798216	A18177338	L6423648	S7418500	AUI	15043-3	HL7_V2_DATATYPE	NM/ST	Cortisol:SCnc:Pt:Urine:Qn
C0798329	A18139270	L6420115	S7413207	AUI	15158-9	HL7_V2_DATATYPE	NM/ST	Chloride:SCnc:Pt:Stool:Qn
C0799616	A18294690	L6416271	S7398643	AUI	16465-7	HL7_V2_DATATYPE	NM/ST	Bile acid:MCnc:Pt:Urine:Qn
C0800133	A18333557	L2417861	S7447471	AUI	17002-7	HL7_V2_DATATYPE	NM/ST	Hydroxytriazolam:MCnc:Pt:Ser/Plas:Qn:Confirm
C0800605	A18140625	L1838112	S7361147	AUI	17486-2	HL7_V2_DATATYPE	NM/ST	Progesterone^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn

LSU

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0551047	A18136494	L1033123	S7446978	AUI	10903-3	LSU	titer	Hyaluronidase Ab:Titr:Pt:Ser:Qn
C0550399	A18252777	L1036749	S7448376	AUI	11051-0	LSU	mg/dL	Immunoglobulin light chains.lambda:MCnc:Pt:Ser:Qn
C0549880	A18099888	L1722332	S7410739	AUI	13338-9	LSU	%	Cells.CD8+CD57+/100 cells:NFr:Pt:Bld:Qn
C0798525	A18371323	L6410635	S7436554	AUI	15356-9	LSU	mg/24hr	Globulins:MRat:24H:Urine:Qn
C0800166	A18217557	L1469689	S7806864	AUI	17037-3	LSU	titer	La Crosse virus Ab:Titr:Pt:CSF:Qn
C0800191	A18256249	L1462261	S7454377	AUI	17062-1	LSU	titer	Legionella pneumophila 2 Ab:Titr:Pt:Ser:Qn
C0803224	A18335327	L6407041	S7429465	AUI	20409-9	LSU	RBCS/uL	Erythrocytes:NCnc:Pt:Urine:Qn:Test strip
C0803838	A18373480	L6409645	S10025864	AUI	21042-7	LSU	ug/mg creatinine	3-Hydroxydodecanoate/Creatinine:MCrto:Pt:Urine:Qn
C0803952	A18104238	L1487588	S7409573	AUI	21158-1	LSU	%	Cells.CD20/Gated cells.total:NFr:Pt:XXX:Qn
C0879686	A18297231	L1725028	S7441565	AUI	22081-4	LSU	titer	Afipia felis Ab.IgG:Titr:Pt:Ser:Qn
C0880260	A18375480	L1725695	S7358763	AUI	22759-5	LSU	titer	Platelet Ab:Titr:Pt:Ser:Qn
C0879961	A18220473	L1725660	S7455364	AUI	22405-5	LSU	titer	Leptospira interrogans serovar Pomona Ab:Titr:Pt:Ser:Qn
C0882417	A18375971	L1726491	S7429591	AUI	23635-6	LSU	units/kg bw	Erythropoietin given:ACnt:Pt:Dose:Qn
C0941322	A18260719	L6414702	S11752892	AUI	25115-7	LSU	mmol/mole creatinine	Methylmalonate/Creatinine:SCrto:24H:Urine:Qn
C0881312	A18298944	L6693099	S7799758	AUI	23976-4	LSU	titer	Blastomyces dermatitidis Ab:Titr:Pt:CSF:Qn:Comp fix
C0881480	A18260206	L1723477	S7359338	AUI	24174-5	LSU	titer	Polio virus 3 Ab^2nd specimen:Titr:Pt:Ser:Qn:Neut
C0881580	A18337620	L1723044	S7365412	AUI	24298-2	LSU	titer	Respiratory syncytial virus Ab^1st specimen:Titr:Pt:Ser:Qn
C0881650	A18299168	L2403336	S7395232	AUI	24384-0	LSU	IU/mL	little c Ab:ACnc:Pt:Ser/Plas:Qn
C0941351	A18144932	L6413569	S7421517	AUI	25155-3	LSU	per HPF	Cystine crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.HPF

HL7_V3_DATATYPE

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0551950	A18176101	L4852084	S7424408	AUI	11833-1	HL7_V3_DATATYPE	PQ	Diameter.largest pocket.mean:Len:Pt:Am fld space^fetus:Qn:US.measured
C0550610	A18175648	L1034242	S7457166	AUI	10977-7	HL7_V3_DATATYPE	PQ	Alprazolam:MCnc:Pt:Bld:Qn
C0550247	A18252851	L6402956	S7406697	AUI	11211-0	HL7_V3_DATATYPE	PQ	Carbon dioxide:SCnc:Pt:Body fld:Qn
C0550459	A18330199	L1037437	S7357161	AUI	11224-3	HL7_V3_DATATYPE	PQ	Phosphoethanolamine:MCnc:Pt:CSF:Qn
C0551733	A18291855	L1033324	S7427058	AUI	11614-5	HL7_V3_DATATYPE	PQ	Abortions.spontaneous:Num:Pt:^Patient:Qn:Reported
C0551914	A20078182	L3166541	S7424533	AUI	11797-8	HL7_V3_DATATYPE	PQ	Diameter:Len:Pt:Mitral valve:Qn:US.measured
C0552203	A18292097	L1493070	S7375328	AUI	12091-5	HL7_V3_DATATYPE	ED	Study observation:Find:Pt:Heart.ventricle.right.outflow tract^fetus:Nar:US
C0549930	A18330873	L1464841	S7418705	AUI	12559-1	HL7_V3_DATATYPE	PQ	Cortisol^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549997	A18253624	L1465032	S7437752	AUI	12642-5	HL7_V3_DATATYPE	PQ	Glucose^7.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549961	A18253671	L1465542	S7433678	AUI	12669-8	HL7_V3_DATATYPE	PQ	Follitropin^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
C0797080	A18370501	L1495118	S7463291	AUI	13891-7	HL7_V3_DATATYPE	PQ	Motilin:MCnc:Pt:Ser/Plas:Qn
C0363714	A18371568	L6417854	S7453667	AUI	1582-6	HL7_V3_DATATYPE	PQ	Lactose^1H post 50 g lactose PO:MCnc:Pt:Ser/Plas:Qn
C0797601	A18216025	L6402735	S7398817	AUI	14423-8	HL7_V3_DATATYPE	PQ	Bilirubin:MCnc:Pt:Synv fld:Qn
C0797909	A18100633	L4849959	S7435523	AUI	14735-5	HL7_V3_DATATYPE	PQ	Gastrin^10M post 0.2 U/kg secretin:SCnc:Pt:Ser/Plas:Qn
C0797945	A18370400	L1487988	S7437851	AUI	14771-0	HL7_V3_DATATYPE	PQ	Glucose^post CFst:SCnc:Pt:Ser/Plas:Qn
C0798103	A18139119	L1851254	S7381652	AUI	14930-2	HL7_V3_DATATYPE	PQ	Triiodothyronine:SCnc:Pt:Ser/Plas:Qn
C0799596	A18294682	L2413028	S7397689	AUI	16444-2	HL7_V3_DATATYPE	PQ	Benzophenone:MCnc:Pt:Ser/Plas:Qn
C0799984	A18294344	L2420650	S7430329	AUI	16845-0	HL7_V3_DATATYPE	PQ	Ethionamide:MCnc:Pt:Ser/Plas:Qn
C0800362	A18372327	L6424790	S7458630	AUI	17236-1	HL7_V3_DATATYPE	PQ	Magnesium:SCnc:Pt:Stool:Qn

LQS

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0943760	A18185316	L5813000	S7435374	AUI	28110-5	LQS	CLINICAL CARE CLASSIFICATION L26.3	Gas exchange impairment:Find:Pt:Respiratory system:Ord:Observed.CCC
C0945579	A18301157	L5813041	S7448601	AUI	28124-6	LQS	CLINICAL CARE CLASSIFICATION K25.6	Infection unspecified:Find:Pt:Immune system:Ord:Observed.CCC
C0943791	A18223616	L5809756	S7401766	AUI	28145-1	LQS	CLINICAL CARE CLASSIFICATION B03.0	Bowel elimination alteration:Find:Pt:Gastrointestinal system:Ord:Observed.CCC
C0943924	A18146293	L6402002	S7371049	AUI	28299-6	LQS	OMAHA III.26	Skin.behavior:Find:Pt:^Patient:Ord:Observed.OMAHA
C0943960	A18378492	L1845680	S7371082	AUI	28341-6	LQS	OMAHA IV.36	Sleep and rest pattern.behavior:Find:Pt:^Patient:Ord:Observed.OMAHA
C0943977	A18108129	L1850262	S7377566	AUI	28358-0	LQS	OMAHA IV.43	Technical procedure.status:Find:Pt:^Patient:Ord:Observed.OMAHA
C0944027	A18378555	L1847433	S7417240	AUI	28416-6	LQS	OMAHA II.06	Communication with community resources.knowledge:Find:Pt:^Family:Ord:Observed.OMAHA
C0944065	A18185496	L1848780	S7423354	AUI	28460-4	LQS	OMAHA III.22	Dentition.knowledge:Find:Pt:^Family:Ord:Observed.OMAHA
C1830918	A18272549	L8566579	S10636937	AUI	46840-5	LQS	OMAHA I.04	Neighborhood &or workplace safety.behavior:Find:Pt:^Community:Ord:Observed.OMAHA
C1830996	A18195547	L6422065	S7360398	AUI	46918-9	LQS	OMAHA III.48	Pregnancy function.behavior:Find:Pt:^Family:Ord:Observed.OMAHA
C2598390	A18391634	L8582240	S10639722	AUI	52720-0	LQS	CARE I.a01	Other useful information:Find:Pt:^Patient:Nom:CARE
C2734035	A18316297	L9094412	S11334150	AUI	56099-5	LQS	PhenX.020601030000	Hand dominance - coloring:Find:Pt:^Patient:Nom:ALSPAC
C2734070	A18238964	L9081492	S11342018	AUI	56118-3	LQS	PhenX.010101020001	Proxy name:Pn:Pt:Proxy:Nom
C2926078	A18124392	L9454506	S11745768	AUI	58278-3	LQS	PhenX.041201040100	Date of deep vein thrombosis diagnosis:TmStp:Pt:^Patient:Qn
C2925921	A18356080	L9457451	S11747638	AUI	58302-1	LQS	PhenX.040501010000	Ever told by doctor that you had rheumatic heart or heart valve problems:Find:Pt:^Patient:Ord
C2926090	A18240227	L9452954	S11742822	AUI	58329-4	LQS	PhenX.040701040000	Cardiopulmonary resuscitation &or cardioversion performed within 24 hours of death:Find:Pt:^Patient:Ord
C2973107	A18872132	L9581387	S12036227	AUI	61530-2	LQS	PhenX.050501190100	How often did you take saw palmetto:Find:Pt:^Patient:Ord:PhenX
C3169348	A19508149	L10083798	S12608403	AUI	62529-3	LQS	PhenX.060900	PhenX measure - environmental exposures - day care - pre-school attendance:-:Pt:^Patient:-:PhenX
C3169666	A19525917	L10083835	S12608694	AUI	62585-5	LQS	PhenX.080500	PhenX measure - oral health - existence of cleft lip or palate:-:Pt:^Patient:-:PhenX

SOS

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0488608	A18252194	L1849697	S7357491	AUI	10210-3	SOS	Physical findings (of general status) describes general observations and readily observable attributes of the patient, including affect and demeanor, apparent age compared to actual age, gender, ethnicity, nutritional status based on appearance, body build and habitus (e.g., muscular, cachectic, obese), developmental or other deformities, gait and mobility, personal hygiene, evidence of distress, and voice quality and speech.	Physical findings:Find:Pt:General status:Nar:Observed
C0488638	A18097935	L7977471	S10022093	AUI	10222-8	SOS	Surgical operation note (surgical complications) is a record of problems that occurred during surgery. The complications may have been known risks or unanticipated problems.	Surgical operation note surgical complications:Imp:Pt:^Patient:Nar
C0551052	A18291077	L1033044	S7806831	AUI	10904-1	SOS	California encphalitis virus has more than 20 strains- most of which include "strain" in the name, One of these, La Crosse vIrus, has a name that does not signal that it is a strain of California encephalitis.	La Crosse virus Ab.IgG:Titr:Pt:Ser:Qn:IF
C0549741	A18175145	L1032850	S7353762	AUI	10945-4	SOS	not same as chymopapain	Papain Ab.IgE:ACnc:Pt:Ser:Qn
C0551497	A18291689	L6424422	S11324485	AUI	11218-5	SOS	Term used for test for microalbumin using test strip such as Roche Micral (TM) Microalbuminuria Urine Test Strip or Bayer Clinitech (R) Microalbumin Reagent Strip	Albumin:MCnc:Pt:Urine:Qn:Detection limit <= 20 mg/L test strip
C0551783	A18253055	L9079700	S11326307	AUI	11664-0	SOS	Minumum value of the maximum Doppler shift frequency envelope.	Blood flow.diastolic.min:Vel:Pt:Uterine artery.right:Qn:US.doppler
C0551822	A18253072	L9074114	S11326386	AUI	11703-6	SOS	Maximum value of the Doppler shift frequency envelope.	Blood flow.systolic.max:Vel:Pt:Ductus arteriosus^fetus:Qn:US.doppler
C0551944	A18176034	L1490318	S7424389	AUI	11827-3	SOS	Longest hilum-cortex dimension. Measured in the plane that contains the longest rostral caudal diameter and, perpendicular to it, the longest hilum-cortex dimension.	Diameter.hilum-cortex:Len:Pt:Kidney.right^fetus:Qn:US.measured
C0551966	A18176113	L1033260	S7424449	AUI	11849-7	SOS	Mean diameter predicted for estimated gestational age by use regression formula derived from a standard population.	Diameter.mean:Len:Pt:Abdomen^fetus:Qn:Estimated from gestational age
C0552011	A18137431	L1473969	S7436280	AUI	11894-3	SOS	This term pertains only to the FETUS. Method Reference can be supplied by DICOM Supplement 23-Structured Reporting, Relationship Module (C.6.29).	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from area corrected BPC
C0552067	A18329568	L1490572	S7447764	AUI	11949-5	SOS	Used to list and describe the criteria used by the ultrasonographer to identify individual fetuses in a multiple gestation.	Identification criteria:Find:Pt:^Fetus:Nom:US
C0798777	A18255384	L1467420	S7407882	AUI	15610-9	SOS	We reviewed the major allergy testing manufacturers and found that they all use the same allergen code, e1, but use different test descriptions (dander, epithelium, hair)	Cat epithelium Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799120	A18255655	L2268897	S7362458	AUI	15953-3	SOS	This is FOOD allergen	Prunus domestica Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0801048	A18218156	L1481605	S7422830	AUI	17998-6	SOS	MC685; Time from peak AR gradient to zero baseline	Deceleration:Time:Pt:Aortic valve.regurgitant jet:Qn:US.doppler
C0801541	A18179801	L1491013	S7462124	AUI	18500-9	SOS	Thin prep is an automated method of preparing the smear;cells are first treated/lysed to diminish obstructions such as blood, then spread very thinly by the machine.	Microscopic observation:Prid:Pt:Cvx:Nom:Cyto stain.thin prep
C0802823	A18820156	L9579882	S12040690	AUI	20008-9	SOS	Transcutaneous monitors measure saturation	Oxygen^on oxygen.low flow & asleep:PPres:Stdy^max:BldC:Qn:Transcutaneous O2 monitor
C0802826	A18864689	L9586019	S12040695	AUI	20011-3	SOS	Transcutaneous monitors measure saturation	Oxygen^on oxygen.low flow & awake:PPres:Stdy^min:BldC:Qn:Transcutaneous O2 monitor
C0804441	A18336091	L1476204	S7403800	AUI	21650-7	SOS	Some mutations predictive of HIV1 resistance	CCR5 gene mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
C0804832	A18297807	L1487085	S7364917	AUI	22045-9	SOS	Text area for information that is given only in coded form elsewhere or for which the abstract provides no other place. Overflow data can also be placed here. Problematic coding issues can also be discussed in this section... NAACCR Data Standards and Data Dictionary Version 11	Remarks recorded:Find:Pt:Cancer.XXX:Nar

LEA

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0551741	A18098805	L1473335	S7435868	AUI	11621-0	LEA	Not observed, normal, abnormal &/or more specific code	Activity:Find:Pt:Trunk^fetus:Nom:US
C0798654	A18216655	L1468235	S7346184	AUI	15485-6	LEA	Titer group 1	Mycoplasma gallisepticum Ab:ACnc:Pt:Ser:Ord:EIA
C0941450	A18298874	L3157173	S7374660	AUI	25277-5	LEA	Greater than 4	Streptococcus pneumoniae 8 Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn
C0945202	A18260060	L3157167	S7374390	AUI	25278-3	LEA	Greater than 4	Streptococcus pneumoniae 51 Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn
C0941456	A18260798	L3157085	S7374018	AUI	25284-1	LEA	Greater than 4	Streptococcus pneumoniae 19 Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn
C0942049	A18183959	L1836184	S7419920	AUI	26019-0	LEA	%	Creatine kinase.macromolecular.type 1/Creatine kinase.total:CFr:Pt:Ser/Plas:Qn
C0943688	A18262292	L1847353	S7375393	AUI	28026-3	LEA	Minimal Standard Terminology (MST);SNOMED;ICD-9	Study observation:Find:Stdy:Rectum+Colon:Nar:Flexible sigmoidoscopy
C0944969	A18340443	L1841041	S7430508	AUI	29529-5	LEA	Detect/Nondetect	Acetaminophen:ACnc:Pt:XXX:Ord
C0945073	A18301836	L2419939	S7425885	AUI	29652-5	LEA	Dothiepin 30 ug/L	Dothiepin:MCnc:Pt:Ser/Plas:Qn
C0945074	A18301920	L2419941	S7425887	AUI	29653-3	LEA	Dothiepin 500 nmol/L	Dothiepin:SCnc:Pt:Ser/Plas:Qn
C0945784	A18263157	L1840283	S7366206	AUI	29668-1	LEA	R.australis antibody titre 2	Rickettsia australis Ab:Titr:Pt:Ser:Qn
C0945140	A18301964	L1839474	S7455335	AUI	29735-8	LEA	Leptospira Medanensis (MAT) Negative	Leptospira interrogans serovar Medanensis Ab:ACnc:Pt:Ser:Ord:Aggl
C1113783	A18108889	L5516447	S7350847	AUI	29856-2	LEA	Positive	Anaplasma phagocytophilum Ab.IgG:ACnc:Pt:Ser:Ord
C1148143	A18187686	L2420929	S7357566	AUI	32459-0	LEA	Cataract	Physical findings:Find:Pt:Optic lens:Nom:Observed
C1114064	A18263474	L2270624	S7360127	AUI	30179-6	LEA	Titer 8	Powassan virus Ab.IgM:Titr:Pt:XXX:Qn:IF
C1114103	A18224658	L2268527	S7419699	AUI	30223-2	LEA	T	Coxsackievirus B4 Ab:ACnc:Pt:Ser:Ord
C1114324	A18302456	L6418413	S7351453	AUI	30480-8	LEA	Normal	Orotate:ACnc:Pt:Urine:Ord
C1114695	A18186797	L2271187	S7416774	AUI	30900-5	LEA	Adult cell titre @4celcius: 16 RR <64	Cold agglutinin:Titr:Pt:Ser/Plas:Qn:Aggl.adult RBC
C1114382	A18302489	L2267605	S7359292	AUI	30547-4	LEA	Negative;Positive	Polio virus 2 Ab:ACnc:Pt:Ser:Ord

LQT

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2734014	A18200566	L9076937	S11326507	AUI	56079-7	LQT	How much did you weigh before your most recent pregnancy?	Body weight^pre most recent pregnancy:Mass:Pt:^Patient:Qn
C2926066	A18240209	L9456000	S11747576	AUI	58263-5	LQT	If yes: For the above condition have you ever had Angiography (dye in the arteries of the legs)?	Ever had angiography for claudication or peripheral arterial disease:Find:Pt:^Patient:Ord
C2926607	A20090096	L10343734	S12897528	AUI	58287-4	LQT	Has a doctor ever said you had rheumatic fever (inflammatory rheumatism)?	Ever told by doctor that you had rheumatic fever:Find:Pt:^Patient:Nom
C2973026	A18816530	L9581030	S12033093	AUI	61448-7	LQT	Each time you eat Mexican foods, how much do you usually eat?	Each time you ate mexican foods, how much did you usually eat in the past 30D:Find:Pt:^Patient:Ord:PhenX
C2973104	A20848808	L10830555	S13449719	AUI	61527-8	LQT	HOW MANY YEARS did you take Regular One-a-Day type, Centrum® or Thera-type MULTIPLE VITAMINS?	How many Y did you take regular one a day type, centrum or thera type multiple vitamins:Time:Pt:^Patient:Qn:PhenX
C2973129	A18883283	L9583366	S12035958	AUI	61552-6	LQT	During the past month, how often did you eat a green leafy or lettuce SALAD, with or without other vegetables?	How often did you eat a green leafy or lettuce salad, with or without other vegetables in past 30D:Find:Pt:^Patient:Ord:PhenX
C3171831	A19504182	L10079357	S12597368	AUI	63741-3	LQT	For whom did {you/SP} work at {your/his/her} main job or business? (what is the name of the company, business, organization or employer?)	For whom did you work at you main job or business:Find:Pt:^Patient:Nom:PhenX
C3173940	A19505044	L10097532	S12598395	AUI	64407-0	LQT	Has your child ever had an itchy rash that was coming and going for at least 6 months?	Has your child ever had an itchy rash that was coming and going for at least 6Mo:Find:Pt:^Patient:Ord:PhenX
C3173056	A19513419	L10082080	S12594514	AUI	63823-9	LQT	Did you ever get a blistering sunburn?	Did you ever get a blistering sunburn:Find:Pt:^Patient:Ord:PhenX
C3173376	A20086557	L10332017	S12915176	AUI	63977-3	LQT	What type of container does your child most often use for beverages?	What type of container does your child most often use for beverages:Type:Pt:^Patient:Nom:PhenX
C3173379	A20093817	L10338710	S12915399	AUI	63980-7	LQT	Which statement best describes your child's nighttime feedings?	Which statement best describes your child's nighttime feedings:Find:Pt:^Patient:Nom:PhenX
C3173407	A20082897	L10332914	S12900993	AUI	63995-5	LQT	How many natural teeth do you have?	How many natural teeth do you have:Num:Pt:^Patient:Ord:PhenX
C3173673	A20852596	L10810643	S13453454	AUI	64176-1	LQT	In the last 3 years, how many such illnesses, with (increased) phlegm, did you have which lasted a week or more?	In the last 3 Ys, how many such illnesses, with increased phlegm, did you have which lasted a W or more:NRat:Pt:^Patient:Qn:PhenX
C3173488	A19531269	L10097602	S12598926	AUI	64205-8	LQT	Have you ever had treatment for heart trouble in the past 10 years?	Have you ever had treatment for heart trouble in the past 10Y:Find:Pt:^Patient:Ord:PhenX
C3173213	A19517827	L10099812	S12592530	AUI	64237-1	LQT	Please specify chest operations you had.	Chest operations you had:Find:Pt:^Patient:Nom:PhenX
C3173246	A19509102	L10093515	S12590666	AUI	65120-8	LQT	Are people important to him/her?	Are people important to your child:Find:Pt:^Patient:Ord:PhenX
C3173988	A19509388	L10098466	S12606103	AUI	64442-7	LQT	Over the past 3 months, I have had attacks of wheezing:	Over the past 3Mo, I have had attacks of wheezing:Find:Pt:^Patient:Ord:PhenX
C3174032	A19518130	L10088882	S12601610	AUI	64464-1	LQT	I get embarrassed using my medication in public.	I get embarrassed using my medication in public:Find:Pt:^Patient:Ord:PhenX
C3174064	A19505079	L10085856	S12601294	AUI	64480-7	LQT	I cannot move far from my bed or chair.	I cannot move far from my bed or chair:Find:Pt:^Patient:Ord:PhenX

LMM

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0551215	A18253526	L1036395	S7402190	AUI	12426-3	LMM	523.42	Brodifacoum:MCnc:Pt:Ser/Plas:Qn
C0551220	A18176379	L1036116	S7421223	AUI	12312-5	LMM	42.080	Cyclopropane:MCnc:Pt:Bld:Qn
C0551253	A18137900	L1459733	S10031062	AUI	13006-2	LMM	147.00	1,4-Dichlorobenzene:MCnc:Pt:Ser/Plas:Qn
C0363510	A18331569	L0462523	S7404793	AUI	1374-8	LMM	3425	Calcitonin^3H post 15 mg/kg calcium gluconate IV:MCnc:Pt:Ser/Plas:Qn
C0482513	A18370791	L3157936	S7418816	AUI	1447-2	LMM	362.47	Cortisol^pre 40 ug corticotropin IM 3 day:MCnc:Pt:Ser/Plas:Qn
C0482481	A18370527	L6410158	S7418467	AUI	1394-6	LMM	362.47	Cortisol.free^pre 50 ug corticotropin IM 3 day:MCnc:24H:Urine:Qn
C0482494	A18254562	L1835930	S7418655	AUI	1415-9	LMM	362.47	Cortisol^30M post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn
C0363574	A18177647	L1835986	S7418769	AUI	1440-7	LMM	362.47	Cortisol^9H post 1 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn
C0482511	A18100505	L3156463	S7418800	AUI	1445-6	LMM	362.47	Cortisol^pre 1 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn
C0363604	A18254824	L1836309	S7433597	AUI	1470-4	LMM	33000	Follitropin^1H post 100 ug lutenizing releasing hormone IV:MCnc:Pt:Ser/Plas:Qn
C0363610	A18177801	L1836341	S7433673	AUI	1476-1	LMM	33000	Follitropin^75M post 100 ug lutenizing releasing hormone IV:MCnc:Pt:Ser/Plas:Qn
C0700436	A18216376	L1460503	S7437722	AUI	1544-6	LMM	180.2	Glucose^6H post 100 g glucose PO:MCnc:Pt:Ser/Plas:Qn
C0363677	A18255295	L6410666	S7437724	AUI	1546-1	LMM	180.2	Glucose^6H post 100 g glucose PO:MCnc:Pt:Urine:Qn
C0363688	A18100839	L0527669	S7437847	AUI	1557-8	LMM	180.2	Glucose^post CFst:MCnc:Pt:BldV:Qn
C0363696	A18255409	L1838096	S7450021	AUI	1564-4	LMM	5807.65	Insulin^2H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn
C0799902	A18372095	L2419421	S7424756	AUI	16758-5	LMM	221.04	Dicamba:MCnc:Pt:Ser/Plas:Qn
C0800682	A18217923	L2424736	S7369241	AUI	17567-9	LMM	258.23	Sasapyrine:MCnc:Pt:Ser/Plas:Qn
C0363753	A18178815	L0480395	S7364994	AUI	1622-0	LMM	42270	Renin^5H post 600 ug furosemide PO:CCnc:Pt:Plas:Qn
C0799576	A18371935	L1495250	S7368592	AUI	16424-4	LMM	398.39	Salicylazosulfapyridine:MCnc:Pt:Ser:Qn

STATUS_REASON

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0485021	A18098263	L1486924	S7405111	AUI	10559-3	STATUS_REASON	Duplicate	Calcium:SCnc:Pt:Smpls:Qn
C0485028	A18136721	L0782518	S7413932	AUI	10566-8	STATUS_REASON	Duplicate	Choriogonadotropin:SCnc:Pt:Smpls:Qn
C1764761	A18213722	L1471127	S7404024	AUI	10440-6	STATUS_REASON	Duplicate	CD30 Ag:ACnc:Pt:Tiss:Ord:Immune stain
C2713229	A18291790	L1493225	S7357542	AUI	11439-7	STATUS_REASON	Duplicate	Physical findings:Find:Pt:Mouth & Throat & Teeth:Nom:Observed
C2607952	A18136905	L2268459	S7367458	AUI	10962-9	STATUS_REASON	Duplicate	Artemisia tridentata Ab.IgE:ACnc:Pt:Ser:Qn
C0550962	A20855321	L1471184	S7420615	AUI	11472-8	STATUS_REASON	Erroneous	Cryptococcus neoformans Ag:ACnc:Pt:XXX:Ord
C0551723	A20858906	L6885657	S8029905	AUI	11538-6	STATUS_REASON	Duplicate	Study.total:Find:Pt:Chest:Doc:CT
C0551801	A18136705	L1486191	S7399504	AUI	11682-2	STATUS_REASON	Duplicate	Blood flow.mean:Vel:Pt:Heart.ventricle.right.outflow tract:Qn:US.doppler
C0550548	A18253429	L6887551	S8045590	AUI	12264-8	STATUS_REASON	Duplicate	Epstein Barr virus early restricted Ab:MCnc:Pt:Body fld:Qn
C0482406	A18253709	L1470935	S7350337	AUI	1274-0	STATUS_REASON	Duplicate	O NOS Ag:ACnc:Pt:RBC^BPU:Ord:Aggl RBC
C0551364	A18370015	L1840115	S7376102	AUI	13098-9	STATUS_REASON	Erroneous	Sulfatide Ab.IgG:ACnc:Pt:Ser:OrdQn
C2718226	A18370052	L1836831	S7374024	AUI	13165-6	STATUS_REASON	Duplicate	Streptococcus pneumoniae 19 Ab:ACnc:Pt:Ser:Qn
C2718196	A18293699	L6421988	S7356824	AUI	14880-9	STATUS_REASON	Duplicate	Phosphate:SCnc:Pt:Urine:Qn
C0549873	A18138318	L1729758	S7410237	AUI	13492-4	STATUS_REASON	Duplicate	Cells.CD4+HLA-DR+:NFr:Pt:Bld:Qn
C0549876	A18331474	L1729748	S7410718	AUI	13493-2	STATUS_REASON	Duplicate	Cells.CD8+CD25+:NFr:Pt:Bld:Qn
C2718150	A18331522	L1471624	S7448191	AUI	13630-9	STATUS_REASON	Duplicate	Immune complex:ACnc:Pt:Ser/Plas:Qn:Conglutinin assay
C0797320	A18177275	L0575839	S8050241	AUI	14134-1	STATUS_REASON	Duplicate	Hemoglobin.free:MCnc:Pt:Ser:Qn
C0798540	A18139412	L6421624	S7463219	AUI	15371-8	STATUS_REASON	Erroneous	Morphine:MCnc:Pt:Meconium:Ord
C2713217	A18138795	L6420274	S7418135	AUI	14289-3	STATUS_REASON	Duplicate	Coproporphyrin:ACnc:24H:Urine:Ord

LMP

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0482254	A18175437	L1471375	S7447602	AUI	1057-9	LMP	14985-6	I (int) subtype:ACnc:Pt:RBC^patient:Ord:Aggl RBC
C1764823	A18175568	L1486332	S7462293	AUI	10816-7	LMP	6678-7	Microscopic observation:Prid:Pt:Tiss:Nom:Toluidine blue O stain
C0551720	A20862728	L6910517	S8029907	AUI	11528-7	LMP	18748-4	Study.total:Find:Pt:XXX:Doc:Radiology.XXX
C0551640	A18291792	L1491803	S7365724	AUI	11456-1	LMP	8687-6	Review of symptoms and diseases:Find:Pt:^Patient:Nom:Reported
C0482350	A18330398	L1462288	S7395277	AUI	1182-5	LMP	14990-6	little i -2 Ag:ACnc:Pt:RBC^donor:Ord:Aggl RBC
C0550992	A18253436	L6413815	S7429698	AUI	12276-2	LMP	10851-4	Escherichia coli O157:H7:ACnc:Pt:Stool:Ord:Organism specific culture
C0550654	A18176430	L1037524	S7423944	AUI	12385-1	LMP	3862-0	Desmethyldoxepin:MCnc:Pt:Ser/Plas:Qn
C1764779	A18137740	L6413520	S7420037	AUI	12571-6	LMP	12190-5	Creatinine:MCnc:Pt:Body fld:Qn
C2718244	A18215345	L1837413	S7374138	AUI	13166-4	LMP	13138-3	Streptococcus pneumoniae 23 Ab:ACnc:Pt:Ser:Qn
C1764785	A18292828	L6417149	S7428215	AUI	13353-8	LMP	12209-3	Eosinophils/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0549869	A18254192	L1729745	S7410127	AUI	13491-6	LMP	13332-2	Cells.CD4+CD25+:NFr:Pt:Bld:Qn
C0796881	A18138401	L6409161	S7384670	AUI	13690-3	LMP	3124-5	Vanillylmandelate/Creatinine:MCrto:Pt:Urine:Qn
C2713141	A18177483	L0464608	S7418580	AUI	1405-0	LMP	1404-3	Cortisol^1H post dose U/kg insulin IV:MCnc:Pt:Plas:Qn
C2718216	A18254540	L1473584	S7361853	AUI	14120-0	LMP	12841-3	Prostate specific Ag.free/Prostate specific Ag.total:MFr:Pt:Ser/Plas:Qn
C2713103	A18139247	L6418822	S7367160	AUI	15116-7	LMP	15115-9	Arsenic:SCnc:Pt:Urine:Qn
C0363642	A18255083	L0464602	S7437141	AUI	1508-1	LMP	1507-3	Glucose^1H post 75 g glucose PO:MCnc:Pt:Ser:Qn
C2718183	A18333419	L1472963	S7349282	AUI	16743-7	LMP	13572-3	Nordiazepam:ACnc:Pt:Ser/Plas:Ord
C2718159	A18372264	L1485763	S7456069	AUI	17077-9	LMP	16965-6	Lindane:MCnc:Pt:Bld:Qn
C2713158	A18140705	L1459709	S7373818	AUI	17613-1	LMP	13140-9	Streptococcus pneumoniae 1 Ab^2nd specimen:ACnc:Pt:Ser:Qn

LCD

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0549853	A18369520	L6420573	S7428640	AUI	12248-1	LCD	Y	Epithelial cells.renal:ACnc:Pt:Urine sed:Ord:Microscopy.light
C0551085	A18099150	L6418130	S7462306	AUI	12235-8	LCD	Y	Microscopic observation:Prid:Pt:Urine sed:Nom:Microscopy.light
C0549977	A18099363	L1461949	S7437143	AUI	12646-6	LCD	Y	Glucose^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0797848	A18293577	L1490323	S7418299	AUI	14674-6	LCD	Y	Corticotropin:SCnc:Pt:Plas:Qn
C0796820	A18292975	L1460275	S7450287	AUI	13629-1	LCD	Y	Interleukin 1 beta:MCnc:Pt:Ser/Plas:Qn
C0796849	A18138392	L6402361	S7383870	AUI	13658-0	LCD	Y	Urobilinogen:ACnc:Pt:Urine:Ord
C0797155	A18293239	L6405346	S7370259	AUI	13967-5	LCD	Y	Sex hormone binding globulin:SCnc:Pt:Ser/Plas:Qn
C0797166	A18215839	L1460058	S7453123	AUI	13978-2	LCD	Y	Alpha 1 globulin/Protein.total:MFr:Pt:Ser/Plas:Qn:Electrophoresis
C0797178	A18138641	L6414386	S7453143	AUI	13990-7	LCD	Y	Alpha 1 globulin/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis
C0797183	A18370556	L6403795	S7435146	AUI	13995-6	LCD	Y	Gamma globulin/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis
C0797471	A18177599	L6413796	S7429410	AUI	14290-1	LCD	Y	Erythrocytes:ACnc:Pt:Urine sed:Qn:Manual count
C0797762	A18215425	L1842279	S7448661	AUI	14586-2	LCD	Y	Aldosterone:SCnc:Pt:Ser/Plas:Qn
C0797893	A18100621	L1849306	S7430227	AUI	14719-9	LCD	Y	Ethanol:SCnc:Pt:Ser/Plas:Qn
C0798040	A18371034	L2423583	S7354313	AUI	14866-8	LCD	Y	Parathyrin.intact:SCnc:Pt:Ser/Plas:Qn
C0798101	A18332265	L1850373	S7381602	AUI	14928-6	LCD	Y	Triiodothyronine.free:SCnc:Pt:Ser/Plas:Qn
C0798111	A18216307	L6402349	S7383614	AUI	14938-5	LCD	Y	Urea nitrogen:SCnc:Pt:Urine:Qn
C0798184	A18371100	L1474735	S7449148	AUI	15011-0	LCD	Y	Aldosterone^supine:SCnc:Pt:Ser/Plas:Qn
C0482544	A18178008	L0779743	S7437848	AUI	1558-6	LCD	Y	Glucose^post CFst:MCnc:Pt:Ser/Plas:Qn
C0799525	A18294638	L1475633	S7463614	AUI	16362-6	LCD	Y	Ammonia:SCnc:Pt:Plas:Qn

MTH_LSU

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C1952938	A18273065	L6697623	S7792896	AUI	47700-0	MTH_LSU	![MICRO SIGN]!mol/L	Methionine:SCnc:Pt:Bld.dot:Qn
C1953528	A18234558	L6694688	S11747312	AUI	48139-0	MTH_LSU	![MICRO SIGN]!mol/mmol de creatinine	Erythro-4,5-Dihydroxyhexanoate/Creatinine:SCrto:Pt:Urine:Qn
C1952748	A18195872	L6697356	S11748514	AUI	47542-6	MTH_LSU	![MICRO SIGN]!mol/mmol de creatinine	Gamma hydroxybutyrate/Creatinine:SCrto:Pt:Urine:Qn
C1952934	A18389115	L6695077	S11752624	AUI	47697-8	MTH_LSU	![MICRO SIGN]!mol/mmol de creatinine	Mandelate/Creatinine:SCrto:Pt:Urine:Qn
C1952948	A18234319	L6700174	S11752899	AUI	47708-3	MTH_LSU	mmol/mmol d'uree	Methylmalonate/Urea:SCrto:Pt:Ser/Plas:Qn
C1953083	A18311866	L6700257	S11754900	AUI	47779-4	MTH_LSU	![MICRO SIGN]!mol/mmol de creatinine	Octadecanoate/Creatinine:SCrto:Pt:Urine:Qn
C1953086	A18118612	L6694177	S7797143	AUI	47781-0	MTH_LSU	![MICRO SIGN]!mol/L	Sulfocysteine:SCnc:Pt:Amnio fld:Qn
C1953120	A18350589	L6698182	S11739368	AUI	47809-9	MTH_LSU	![MICRO SIGN]!mol/mmol de creatinine	2-Hydroxysebacate/Creatinine:SCrto:Pt:Urine:Qn
C1953122	A18196047	L6699483	S10024989	AUI	47810-7	MTH_LSU	![MICRO SIGN]!mol/L	2-Methyl,3-Hydroxyvalerate:SCnc:Pt:Plas:Qn
C1953125	A18196050	L6700761	S11739397	AUI	47812-3	MTH_LSU	![MICRO SIGN]!mol/mmol de creatinine	2-Methylglutaconate/Creatinine:SCrto:Pt:Urine:Qn
C1953141	A18118629	L6697003	S10026357	AUI	47820-6	MTH_LSU	![MICRO SIGN]!mol/L	3-Hydroxyvalerate:SCnc:Pt:Plas:Qn
C1953144	A18196056	L6693156	S11739568	AUI	47822-2	MTH_LSU	![MICRO SIGN]!mol/mmol de creatinine	3-Methyladipate/Creatinine:SCrto:Pt:Urine:Qn
C1953148	A18273146	L6693215	S11739648	AUI	47824-8	MTH_LSU	![MICRO SIGN]!mol/mmol de creatinine	5-Hydroxycaproate/Creatinine:SCrto:Pt:Urine:Qn
C1953157	A18350604	L6696641	S7795929	AUI	47830-5	MTH_LSU	nmol/min/mg de proteines	Argininosuccinate synthase:CCnt:Pt:CVS:Qn
C1952646	A18117948	L6698308	S7801219	AUI	47839-6	MTH_LSU	nmol/min/mg de proteines	Carnitine acyltransferase II:CCnt:Pt:WBC:Qn
C1953166	A18196064	L6695904	S7802119	AUI	47846-1	MTH_LSU	![MICRO SIGN]!g/dL	Cortisol^post 2 mg dexamethasone PO 2.5 day high dose q6h:MCnc:Pt:Ser/Plas:Qn
C1953171	A18311897	L6698404	S7802127	AUI	47851-1	MTH_LSU	![MICRO SIGN]!g/dL	Cortisol^post dose dexamethasone:MCnc:Pt:Ser/Plas:Qn
C1953195	A18157457	L6696556	S7795052	AUI	47873-5	MTH_LSU	nmol/min/mg de proteines	Propionyl CO-A carboxylase:CCnt:Pt:Amnio fld cells:Qn
C1978081	A18197420	L6889674	S10021331	AUI	50246-8	MTH_LSU	![MICRO SIGN]!g/24h	17-Hydroxycorticosteroids^2D post high dose dexamethasone:MRat:24H:Urine:Qn

STATUS_TEXT

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0550047	A18369747	L1461723	S7457160	AUI	12674-8	STATUS_TEXT	All lutropin sources that we could reach report concentrations in international units (IU) per volume. The drug lutropin is prescribed in terms of international units per volume. Avoid mapping to this term. If you find counter examples please send us the package insert and/or a contact point for a laboratory director who is reporting mass or molar units.	Lutropin^15M pre XXX challenge:SCnc:Pt:Ser/Plas:Qn
C0550048	A18330978	L1462840	S7457182	AUI	12675-5	STATUS_TEXT	All lutropin sources that we could reach report concentrations in international units (IU) per volume. The drug lutropin is prescribed in terms of international units per volume. Avoid mapping to this term. If you find counter examples please send us the package insert and/or a contact point for a laboratory director who is reporting mass or molar units.	Lutropin^20M post XXX challenge:SCnc:Pt:Ser/Plas:Qn
C0550057	A18292402	L1465767	S7457261	AUI	12683-9	STATUS_TEXT	All lutropin sources that we could reach report concentrations in international units (IU) per volume. The drug lutropin is prescribed in terms of international units per volume. Avoid mapping to this term. If you find counter examples please send us the package insert and/or a contact point for a laboratory director who is reporting mass or molar units.	Lutropin^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
C0550815	A18292460	L1495163	S7381716	AUI	12800-9	STATUS_TEXT	Scale and property discrepency.	Trimeprazine:MCnc:Pt:Ser/Plas:Ord
C0482419	A18369939	L2403017	S7353067	AUI	1293-0	STATUS_TEXT	Test reported non-existent	P2 Ab:ACnc:Pt:Ser/Plas^donor:Ord:Aggl RBC
C0551312	A18138087	L1839549	S7346561	AUI	13096-3	STATUS_TEXT	Invalid scale	Myelin associated glycoprotein Ab.IgM:ACnc:Pt:Ser:OrdQn
C0551367	A18215311	L1840010	S7378186	AUI	13105-2	STATUS_TEXT	Invalid scale	Tetrasialylganglioside GQ1b Ab.IgG:ACnc:Pt:Ser:OrdQn
C0551277	A18099722	L1839620	S7398300	AUI	13110-2	STATUS_TEXT	Invalid scale	Beta tubulin Ab.IgM:ACnc:Pt:Ser:OrdQn
C1704287	A18370018	L1467059	S7346559	AUI	13113-6	STATUS_TEXT	Invalid scale	Myelin associated glycoprotein Ab.IgM:ACnc:Pt:Ser/Plas:OrdQn
C0551317	A18370019	L1837088	S7348301	AUI	13114-4	STATUS_TEXT	Invalid scale	Neuronal nuclear type 2 Ab:ACnc:Pt:Ser:OrdQn
C0551316	A18292683	L1836009	S7348278	AUI	13115-1	STATUS_TEXT	Invalid scale	Neuronal nuclear type 1 Ab:ACnc:Pt:Ser:OrdQn
C1704284	A18098993	L1463978	S10021972	AUI	13124-3	STATUS_TEXT	Invalid scale	Sulfate-3-Glucuronyl paragloboside Ab:ACnc:Pt:Ser/Plas:OrdQn
C0798300	A18370406	L1491083	S7432162	AUI	15129-0	STATUS_TEXT	This test is reported in mg FEU and mg DDU- with DVT decision thresholds that differ by a factor of 2.. It is very important to report the results more specifically to one of the map to options..	Fibrin D-dimer:MCnc:Pt:PPP:Qn:EIA
C0798318	A20858955	L6407111	S7431389	AUI	15147-2	STATUS_TEXT	Property of ARat must have scale = Qn	Acetone:ARat:24H:Urine:Ord
C0798534	A18101061	L6406657	S7416617	AUI	15365-0	STATUS_TEXT	Property & scale do not match	Codeine:MCnc:Pt:Meconium:Ord
C0363724	A18178620	L1836892	S7457165	AUI	1592-5	STATUS_TEXT	All lutropin sources that we could reach report concentrations in international units (IU) per volume. The drug lutropin is prescribed in terms of international units per volume. Avoid mapping to this term. If you find counter examples please send us the package insert and/or a contact point for a laboratory director who is reporting mass or molar units.	Lutropin^1H post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn
C0482562	A18371735	L3166800	S7457274	AUI	1600-6	STATUS_TEXT	All lutropin sources that we could reach report concentrations in international units (IU) per volume. The drug lutropin is prescribed in terms of international units per volume. Avoid mapping to this term. If you find counter examples please send us the package insert and/or a contact point for a laboratory director who is reporting mass or molar units.	Lutropin^pre dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn
C0799451	A18178837	L1840199	S7376121	AUI	16287-5	STATUS_TEXT	Invalid scale	Sulfatide Ab:ACnc:Pt:Ser:OrdQn
C0799453	A18255853	L1840003	S7463093	AUI	16289-1	STATUS_TEXT	Invalid scale	Monosialoganglioside GM1 Ab:ACnc:Pt:Ser:OrdQn

CHANGE_REASON_PUBLIC

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0549835	A20874034	L10811091	S13457013	AUI	11104-7	CHANGE_REASON_PUBLIC	Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation.	Normoblasts.basophilic/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0549791	A20866517	L10817959	S13442268	AUI	11105-4	CHANGE_REASON_PUBLIC	Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation.	Basophils/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0549817	A20862715	L10813721	S13454987	AUI	11108-8	CHANGE_REASON_PUBLIC	Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation.	Lymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0549821	A20847797	L10810899	S13455437	AUI	11110-4	CHANGE_REASON_PUBLIC	Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation.	Megakaryocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0549827	A20847798	L10825461	S13456589	AUI	11113-8	CHANGE_REASON_PUBLIC	Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation.	Myeloblasts/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0549849	A20866522	L10811341	S13459301	AUI	11121-1	CHANGE_REASON_PUBLIC	Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation.	Prolymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0551559	A18098748	L3165821	S7417843	AUI	11488-4	CHANGE_REASON_PUBLIC	Changed class from ATTACH.CLINRPT to DOC.CLINRPT. Edit made because this term is conformant to the Document Ontology axis values and therefore are being placed in this class.	Consultation note:Find:Pt:{Setting}:Doc:{Provider}
C0551637	A20870357	L10811337	S13459263	AUI	11510-5	CHANGE_REASON_PUBLIC	Based on Clinical LOINC Committee approval on 8/16/2011, the Component was changed from Subsequent evaluation note to Progress note. The term "Subsequent evaluation" seems to be used infrequently and is more commonly referred to as a Progress note. Also changed class from ATTACH.CLINRPT to DOC.CLINRPT since this term is conformant to the Document Ontology axis values and therefore being placed in this class.	Progress note:Find:Pt:{Setting}:Doc:Psychology
C0550515	A20858940	L10812911	S13448230	AUI	12284-6	CHANGE_REASON_PUBLIC	Component was changed from Somatotropin releasing hormone to reflect correct nomenclature	Growth hormone-releasing hormone:ACnc:Pt:Ser/Plas:Qn
C0797662	A20855363	L10822556	S13456566	AUI	14486-5	CHANGE_REASON_PUBLIC	Component changed from "Mycoplasma sp+Ureaplasma sp", property from "ACnc" and scale from "Ord" based on the fact that the two can be distinguished by culture.	Mycoplasma sp & Ureaplasma sp:Prid:Pt:Penis:Nom:Organism specific culture
C0801778	A20081895	L4853921	S7375739	AUI	18764-1	CHANGE_REASON_PUBLIC	Deprecated term based on Clinical LOINC Committee approval on 8/16/2011. Term is a duplicate of 28575-9.	Subsequent evaluation note:Find:Pt:{Setting}:Doc:Nurse practitioner
C0800560	A20874077	L6411811	S13458605	AUI	17441-7	CHANGE_REASON_PUBLIC	Changed component name from "Phenothiazine" (singular) to "Phenothiazines" (pleural) to better reflect its long term intended meaning and current conventions. . Phenothiazine is a distinct chemical but has never been used in human medicine. (It was used for parasitic diseases in animals decades ago but not now). The word phenothiazine has always been used to mean the class of drugs that are derived from phenothiazine and laboratories that use phenothiazine and phenothiazines to mean the measure of any drug of phenothiazine class contained in the specimen.	Phenothiazines:ACnc:Pt:Urine:Qn
C0800931	A18809015	L9580834	S12031269	AUI	17824-4	CHANGE_REASON_PUBLIC	In order to confirm CD8 T-cells, CD3 is required to identify the fact these are T-cells.	Cells.CD3+CD8+/100 cells:NFr:Pt:Body fld:Qn
C0802384	A18820198	L9579736	S12039442	AUI	19503-2	CHANGE_REASON_PUBLIC	Changed component from Levomepromazine to to Methotrimeprazine to reflect the current International Nonproprietary Name (INN) which is also listed as the USAN and the BAN name at the present. There may be some countries that still use Levomeprazine which we made a synonym.	Methotrimeprazine:ACnc:Pt:Urine:Ord:Confirm
C0802386	A18831399	L9577709	S12039436	AUI	19505-7	CHANGE_REASON_PUBLIC	Changed component from Levomepromazine to to Methotrimeprazine to reflect the current International Nonproprietary Name (INN) which is also listed as the USAN and the BAN name at the present. There may be some countries that still use Levomeprazine which we made a synonymn.	Methotrimeprazine cutoff:MCnc:Pt:Urine:Qn:Confirm
C0802532	A20858977	L6401636	S13458595	AUI	19672-5	CHANGE_REASON_PUBLIC	Changed component name from "Phenothiazine" (singular) to "Phenothiazines" (pleural) to better reflect its long term intended meaning and current conventions. . Phenothiazine is a distinct chemical but has never been used in human medicine. (It was used for parasitic diseases in animals decades ago but not now). The word phenothiazine has always been used to mean the class of drugs that are derived from phenothiazine and laboratories that use phenothiazine and phenothiazines to mean the measure of any drug of phenothiazine class contained in the specimen.	Phenothiazines cutoff:MCnc:Pt:Urine:Qn:Screen
C0804225	A20859009	L10828541	S13457388	AUI	21431-2	CHANGE_REASON_PUBLIC	Property changed from ACnc to reflect the fact that interpretation is based on a cut-off value (threshold)	Opiates:Threshold:Pt:Urine:Ord:Screen>2000 ng/mL
C0804503	A20851604	L10819489	S13455096	AUI	21713-3	CHANGE_REASON_PUBLIC	Changed Component part from c.A8344G to m.8344A>G since variant is located on a mitochondrial sequence and to harmonize with HGVS nomenclature guidelines.	MT-TK gene.m.8344A>G:Arb:Pt:Bld/Tiss:Ord:Molgen
C0804564	A20866618	L10826900	S13443656	AUI	21775-2	CHANGE_REASON_PUBLIC	Updated Component part to harmonize with ISCN guidelines and current LOINC nomenclature. Changed gene name FKHR to FOXO1, the recommended gene name by the HUGO Gene Nomenclature Committee (HGNC).	Cells.t(1;13)(p36.13;q14.1)(PAX7,FOXO1)/Cells.total:NFr:Pt:Bld/Tiss:Qn:Molgen

LNC

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0804828	A18181981	L1487026	S7411738	AUI	22041-8	LNC	2640	Chemotherapy Rx:Find:Pt:Cancer.XXX:Nar
C0804622	A18297687	L1474987	S7416674	AUI	21834-7	LNC	140	Coding system:Type:Pt:Census tract at cancer XXX Dx.alternate:Nom
C0804623	A18336210	L1488635	S7416656	AUI	21835-4	LNC	170	Coding system.current:Type:Pt:Race:Nom
C0804629	A18181883	L1473970	S7442976	AUI	21841-2	LNC	230	Age at cancer Dx:Num:Pt:Cancer.XXX:Qn
C0804630	A18220190	L1485519	S7398947	AUI	21842-0	LNC	250	Birthplace:ID:Pt:^Patient:Nom
C0804637	A18258894	L3165516	S7416675	AUI	21849-5	LNC	330	Coding system:Type:Pt:Occupation & Industry Hx:Nom
C0804641	A18104656	L1481843	S7369893	AUI	21853-7	LNC	380	Sequence number central.patient:Arb:Pt:Cancer.XXX:Ord
C0804644	A18258901	L2399573	S7445247	AUI	21856-0	LNC	420	Histology ICD-O-2:Prid:Pt:Cancer.XXX:Nom
C0804645	A18143093	L2399554	S7397441	AUI	21857-8	LNC	430	Behavior ICD-O-2:Prid:Pt:Cancer.XXX:Nom
C0804650	A18258114	L1470169	S7371916	AUI	21862-8	LNC	500	Source of document used to abstract:Type:Pt:Cancer.XXX:Nom
C0804653	A18103904	L1487100	S7446347	AUI	21865-1	LNC	540	Hospital.reporting:ID:Pt:Cancer.XXX:Nom
C0804668	A18297708	L8583023	S10646050	AUI	21880-0	LNC	690	Radiation Rx therapy:Type:Pt:Cancer.XXX:Nom
C0804681	A18220214	L1487109	S7364801	AUI	21893-3	LNC	820	Regional lymph nodes positive:Num:Pt:Cancer.XXX:Qn
C0804686	A18374985	L1488639	S7385338	AUI	21898-2	LNC	870	Version used:Type:Pt:Extent of disease coding system:Nom
C0804688	A18258917	L1487040	S7364812	AUI	21900-6	LNC	890	Regional lymph nodes.pathology:Class:Pt:Cancer.XXX:Nom
C0804690	A18104676	L1487038	S7373317	AUI	21902-2	LNC	910	Stage group.pathology:Class:Pt:Cancer.XXX:Nom
C0804694	A18104677	L1487033	S7364805	AUI	21906-3	LNC	950	Regional lymph nodes.clinical:Class:Pt:Cancer.XXX:Nom
C0804697	A18258922	L1487042	S7423904	AUI	21909-7	LNC	980	Descriptor.clinical:Find:Pt:Cancer.XXX:Nar
C0804701	A18220225	L1487035	S7425588	AUI	21913-9	LNC	1020	Distant metastases.other:Class:Pt:Cancer.XXX:Nom

MTH_COPYRIGHT

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C1508133	A18113452	L6700467	S7796235	AUI	38222-6	MTH_COPYRIGHT	![COPYRIGHT SIGN]! Barbara Braden and Nancy Bergstrom 1988. All rights reserved.	Sensory perception:Find:Pt:Skin:Ord:Observed.Braden scale
C1508135	A18229168	L5313479	S7357845	AUI	38224-2	MTH_COPYRIGHT	![COPYRIGHT SIGN]! Barbara Braden and Nancy Bergstrom 1988. All rights reserved.	Physical mobility:Find:Pt:^Patient:Ord:Observed.Braden scale
C1507670	A18229170	L6702310	S7804471	AUI	38226-7	MTH_COPYRIGHT	![COPYRIGHT SIGN]! Barbara Braden and Nancy Bergstrom 1988. All rights reserved.	Friction & sheer:Find:Pt:Skin:Ord:Observed.Braden scale
C1507673	A18383879	L6700193	S7793088	AUI	38229-1	MTH_COPYRIGHT	![COPYRIGHT SIGN]! Barbara Braden and Nancy Bergstrom 1988. All rights reserved.	Moisture exposure:Find:Pt:Skin:Ord:Observed.Braden scale
C1715507	A20859768	L10819787	S13457812	AUI	44249-1	MTH_COPYRIGHT	Copyright ![COPYRIGHT SIGN]! Pfizer Inc. All rights reserved. Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc. No permission required to reproduce, translate, display or distribute.	PHQ-9 quick depression assessment panel:-:Pt:^Patient:-:Reported.PHQ
C1715511	A20867322	L10813804	S13455716	AUI	44253-3	MTH_COPYRIGHT	Copyright ![COPYRIGHT SIGN]! Pfizer Inc. All rights reserved. Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc. No permission required to reproduce, translate, display or distribute.	Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W:Find:Pt:^Patient:Ord:Reported.PHQ
C1715514	A20856097	L10819848	S13458387	AUI	44256-6	MTH_COPYRIGHT	Copyright ![COPYRIGHT SIGN]! Pfizer Inc. All rights reserved. Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc. No permission required to reproduce, translate, display or distribute.	Perceived difficulty in last 2W:Find:Pt:^Patient:Ord:Reported.PHQ
C1715518	A20871175	L10823239	S13462352	AUI	44260-8	MTH_COPYRIGHT	Copyright ![COPYRIGHT SIGN]! Pfizer Inc. All rights reserved. Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc. No permission required to reproduce, translate, display or distribute.	Thoughts that you would be better off dead, or of hurting yourself in some way in last 2W:Find:Pt:^Patient:Ord:Reported.PHQ
C1717324	A20867332	L10811192	S13457808	AUI	44262-4	MTH_COPYRIGHT	Copyright ![COPYRIGHT SIGN]! Pfizer Inc. All rights reserved. Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc. No permission required to reproduce, translate, display or distribute.	PHQ-9 interpretation:Imp:Pt:^Patient:Ord:Reported.PHQ
C1976614	A18194657	L6077864	S8044084	AUI	45235-9	MTH_COPYRIGHT	![COPYRIGHT SIGN]! World Health Organization 2006![COPYRIGHT SIGN]! World Health Organization 2006. All rights reserved. Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int).The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.	Date original clinic HIV Rx start:TmStp:Pt:^Patient:Qn:Reported
C1976618	A18349241	L6079451	S8044066	AUI	45237-5	MTH_COPYRIGHT	![COPYRIGHT SIGN]! World Health Organization 2006![COPYRIGHT SIGN]! World Health Organization 2006. All rights reserved. Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int).The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.	Date lost to HIV Rx follow-up:TmStp:Pt:^Patient:Qn:Reported
C1976637	A18349243	L6074141	S8026936	AUI	45243-3	MTH_COPYRIGHT	![COPYRIGHT SIGN]! World Health Organization 2006![COPYRIGHT SIGN]! World Health Organization 2006. All rights reserved. Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int).The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.	Reason for discontinuation of anti-infective phrophylaxis medication:Type:Pt:^Patient:Nom:Reported
C1976641	A18117307	L6072339	S8044145	AUI	45245-8	MTH_COPYRIGHT	![COPYRIGHT SIGN]! World Health Organization 2006![COPYRIGHT SIGN]! World Health Organization 2006. All rights reserved. Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int).The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.	Degree of adherence to cotrimoxzole:Find:Pt:^Patient:Ord:Reported
C1976598	A18233031	L6080169	S8017237	AUI	45252-4	MTH_COPYRIGHT	![COPYRIGHT SIGN]! World Health Organization 2006![COPYRIGHT SIGN]! World Health Organization 2006. All rights reserved. Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int).The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.	Institutional entry point HIV Rx:Type:Pt:Facility:Nom:Reported
C1976647	A18233033	L6072303	S8048962	AUI	45255-7	MTH_COPYRIGHT	![COPYRIGHT SIGN]! World Health Organization 2006![COPYRIGHT SIGN]! World Health Organization 2006. All rights reserved. Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int).The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.	HIV Rx clinic transferred to:Addr:Pt:Facility:Nom:Reported
C1976649	A18310566	L6077871	S8048963	AUI	45256-5	MTH_COPYRIGHT	![COPYRIGHT SIGN]! World Health Organization 2006![COPYRIGHT SIGN]! World Health Organization 2006. All rights reserved. Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int).The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.	HIV Rx clinic transferred to:ID:Pt:Facility:Nom:Reported
C1976661	A20874867	L10832353	S13465870	AUI	45263-1	MTH_COPYRIGHT	![COPYRIGHT SIGN]! World Health Organization 2006![COPYRIGHT SIGN]! World Health Organization 2006. All rights reserved. Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int).The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.	{HIV ART medication} doses missed 3D ago:Num:Pt:^Patient:Qn:Reported.ACTG
C1830376	A18195283	L6424374	S7444983	AUI	46467-7	MTH_COPYRIGHT	The Outcome and Assessment Information Set (OASIS)![TRADE MARK SIGN]! Copyright ![COPYRIGHT SIGN]! 2002 Center for Health Services Research, UCHSC, Denver, CO. All Rights Reserved.	High risk factors:Find:Pt:^Patient:Nom:OASIS
C1830386	A18116937	L6410318	S7423730	AUI	46472-7	MTH_COPYRIGHT	The Outcome and Assessment Information Set (OASIS)![TRADE MARK SIGN]! Copyright ![COPYRIGHT SIGN]! 2002 Center for Health Services Research, UCHSC, Denver, CO. All Rights Reserved.	Depressive feelings:Find:Pt:^Patient:Nom:OASIS

LFO

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0552115	A18253290	L9092611	S11342123	AUI	11998-2	LFO	Pulsatility index = (blood flow.systolic.max - blood flow.diastolic.min) / blood flow.mean	Pulsatility index:VelRto:Pt:Cerebral artery anterior:Qn:US.doppler
C0552118	A18098855	L9081507	S11342127	AUI	12001-4	LFO	Pulsatility index = (blood flow.systolic.max - blood flow.diastolic.min) / blood flow.mean	Pulsatility index:VelRto:Pt:Ovarian artery.left:Qn:US.doppler
C0551852	A18291923	L8891398	S11022130	AUI	11733-3	LFO	log 10 (BODY WEIGHT [g]) = 1.6758 + 0.01707 * (abdominal circumference [cm]) + 0.042478 * (biparietal diameter [cm]) + 0.05216 * (femur length [cm]) + 0.01604 * (head circumference [cm])	Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&BPD&FL&HC.Roberts 1985
C0551854	A18137343	L8868779	S11022132	AUI	11735-8	LFO	log 10 (BODY WEIGHT [g]) = 1.335 + 0.0316 * (biparietal diameter [cm]) + 0.0457 * (abdominal circumference [cm]) + 0.1623 * (femur length [cm]) - 0.0034 * (abdominal circumference [cm]) * (femur length [cm])	Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&BPD&FL.Hadlock 1985
C0551856	A18098532	L8868780	S11022134	AUI	11737-4	LFO	log 10 (BODY WEIGHT [g]) = - 2.84421 + 1.85628 * log 10 (biparietal diameter [mm]) + 1.34008 * log 10 (abdominal diameter [mm])	Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&BPD.Eik-Nes 1982
C0551868	A18253126	L8868782	S11022144	AUI	11749-9	LFO	log 10 (BODY WEIGHT [g]) = 1.6961 + 0.02253 * (head circumference [cm]) + 0.01645 * (abdominal circumference [cm]) + 0.06439 * (femur length [cm])	Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&FL&HC.Weiner 1985
C0551869	A18291931	L8887612	S11022145	AUI	11750-7	LFO	log 10 (BODY WEIGHT [g]) = 1.3598 + 0.051 * (abdominal circumference [cm]) + 0.1844 * (femur length [cm]) - 0.0037 * (abdominal circumference [cm]) * (femur length [cm])	Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&FL.Hadlock 1984
C0551873	A18253129	L8883800	S11022148	AUI	11754-9	LFO	log 10 (BODY WEIGHT [g]) = 1.182 + 0.0273 * (head circumference [cm]) + 0.07057 * (abdominal circumference [cm]) - 0.00063 * (abdominal circumference [cm]) ^ 2 - 0.0002184 * (head circumference [cm]) * (abdominal circumference [cm])	Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&HC.Hadlock 1984
C0552008	A18369347	L8892552	S11031851	AUI	11891-9	LFO	GESTATIONAL AGE [wk] = 7.607 + 0.7645 * (abdominal circumference [cm]) + 0.00393 * (abdominal circumference [cm]) ^ 2	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from AC.Hadlock 1982
C0552256	A18214752	L9087314	S11343937	AUI	12142-6	LFO	SD ratio = blood flow.systolic.max / blood flow.diastolic.min	Systolic flow/Diastolic flow:VelRto:Pt:Uterine artery.left:Qn:US.doppler
C0552257	A18214753	L9092811	S11343938	AUI	12143-4	LFO	SD ratio = blood flow.systolic.max / blood flow.diastolic.min	Systolic flow/Diastolic flow:VelRto:Pt:Uterine artery.right:Qn:US.doppler
C0552246	A18099110	L9095518	S11343939	AUI	12144-2	LFO	SD ratio = blood flow.systolic.max / blood flow.diastolic.min	Systolic flow/Diastolic flow:VelRto:Pt:^Patient:Qn:US.doppler
C0551890	A18214311	L1031663	S7400135	AUI	11771-3	LFO	Lookup table	Body weight.25th:Prctl:Pt:^Population distribution:Qn:Estimated.pop birth wgt gestational age corr.ref
C0551891	A18176074	L1032094	S7400139	AUI	11772-1	LFO	Lookup table	Body weight.50th:Prctl:Pt:^Population distribution:Qn:Estimated.pop birth wgt gestational age corr.ref
C0551892	A18137355	L1032296	S7400142	AUI	11773-9	LFO	Lookup table	Body weight.75th:Prctl:Pt:^Population distribution:Qn:Estimated.pop birth wgt gestational age corr.ref
C0551961	A18136575	L1033306	S7424415	AUI	11844-8	LFO	liver length (mm) = 6.32 + 1.34 * abdominal circumference (cm)	Diameter.long.mean:Len:Pt:Liver^fetus:Qn:Estimated from abdominal circumference
C0551966	A18176113	L1033260	S7424449	AUI	11849-7	LFO	ABDOMINAL DIAMETER [mm] = -29.525 + 0.6043653 * (gestational age [days]) - 0.000418794 * (gestational age [days]) ^ 2 + 0.000000214518 * (gestational age [days]) ^ 3	Diameter.mean:Len:Pt:Abdomen^fetus:Qn:Estimated from gestational age
C0552019	A18369354	L8896449	S11031867	AUI	11902-4	LFO	GESTATIONAL AGE [wk] = 9.54 + 1.482 * (biparietal diameter [cm]) + 0.1676 * (biparietal diameter [cm]) ^ 2	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from BPD.Hadlock 1984
C0552020	A18292017	L8869950	S11031868	AUI	11903-2	LFO	Lookup table	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from BPD.Hansmann 1985

LSP

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0798602	A18371355	L1466771	S7350534	AUI	15433-6	LSP	MA	Anaplasma marginale Ab:ACnc:Pt:Ser:Ord:Aggl
C0798605	A18332620	L1467072	S7379424	AUI	15436-9	LSP	CH;TU	Avian encephalomyelitis virus Ab:ACnc:Pt:Ser:Ord:EIA
C0798610	A18101099	L2401312	S7448655	AUI	15441-9	LSP	CH	Infectious bronchitis virus Conn-42 Ab:Titr:Pt:Ser:Qn:HAI
C0798613	A18139443	L6068481	S7448780	AUI	15444-3	LSP	AV	Influenza virus A Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0798615	A18255047	L4851942	S7379954	AUI	15446-8	LSP	CH	Avian leukosis virus Ag:Titr:Pt:Eggylk:Qn:EIA
C0798618	A18255049	L1462228	S7380507	AUI	15449-2	LSP	AV	Avian paramyxovirus 2 Ab:Titr:Pt:Ser:Qn:HAI
C0798620	A18332630	L4851418	S7381302	AUI	15451-8	LSP	AV	Avian pox virus Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0798621	A18139446	L4851419	S7381508	AUI	15452-6	LSP	AV	Avian reovirus Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0798623	A18178281	L1724824	S7365633	AUI	15454-2	LSP	CH;TU	Reticuloendotheliosis virus Ab:ACnc:Pt:Ser:Ord:EIA
C0798624	A18216631	L4851429	S7399897	AUI	15455-9	LSP	MA	Bluetongue virus Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0798626	A18178283	L1468608	S7400514	AUI	15457-5	LSP	AV	Bordetella avium Ab:Titr:Pt:Ser:Qn:Aggl
C0798628	A18101106	L1459871	S7401610	AUI	15459-1	LSP	MA	Bovine herpesvirus 1 Ab:Titr:Pt:Ser:Qn:Neut
C0798630	A18371366	L4851430	S7401689	AUI	15461-7	LSP	BO	Bovine leukemia virus Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0798636	A18139450	L1459881	S7429058	AUI	15467-4	LSP	MA	Equine herpesvirus 1 Ab:Titr:Pt:Ser:Qn:Neut
C0798639	A18101111	L1466584	S7429185	AUI	15470-8	LSP	MA	Equine influenza virus A2 Ab:ACnc:Pt:Ser:Ord
C0798640	A18178296	L1466586	S7429188	AUI	15471-6	LSP	MA	Equine influenza virus A2 Ab:Titr:Pt:Ser:Qn:HAI
C0798642	A18216641	L1468694	S7429018	AUI	15473-2	LSP	EQ	Equine arteritis virus Ab:Titr:Pt:Ser:Qn:Neut
C0798649	A18216648	L1725045	S7455307	AUI	15480-7	LSP	MA	Leptospira interrogans serovar Icterohaemorrhagiae Ab:Titr:Pt:Ser:Qn:Aggl
C0798653	A18216653	L1466908	S7346183	AUI	15484-9	LSP	AV	Mycoplasma gallisepticum Ab:ACnc:Pt:Ser:Ord:Aggl

CONSUMER_NAME

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0549806	A18098586	L9454904	S11752020	AUI	11156-7	CONSUMER_NAME	WBC morphology	Leukocyte morphology finding:Prid:Pt:Bld:Nom
C0551274	A18291009	L1032593	S7432124	AUI	11561-8	CONSUMER_NAME	Acetylcholine receptor blocking Ab	Acetylcholine receptor blocking Ab:ACnc:Pt:Ser:Qn
C0551275	A18097986	L1032594	S7432306	AUI	11562-6	CONSUMER_NAME	Acetylcholine receptor modulation Ab	Acetylcholine receptor modulation Ab:ACnc:Pt:Ser:Qn
C0550486	A18175601	L1033972	S7361859	AUI	10886-0	CONSUMER_NAME	Free PSA serum/plasma	Prostate specific Ag.free:MCnc:Pt:Ser/Plas:Qn
C0550178	A18098509	L1032595	S7432025	AUI	11034-6	CONSUMER_NAME	Acetylcholine receptor binding Ab	Acetylcholine receptor binding Ab:SCnc:Pt:Ser:Qn
C0550440	A18098779	L1036157	S7352555	AUI	11556-8	CONSUMER_NAME	Oxygen (O2) pressure in blood	Oxygen:PPres:Pt:Bld:Qn
C0550246	A18097983	L1036097	S7406644	AUI	11557-6	CONSUMER_NAME	Carbon dioxide pressure in blood	Carbon dioxide:PPres:Pt:Bld:Qn
C0550447	A18368330	L7982948	S10024330	AUI	11558-4	CONSUMER_NAME	pH (acidity) in blood	pH:LsCnc:Pt:Bld:Qn
C0797306	A18137324	L1473584	S7361853	AUI	12841-3	CONSUMER_NAME	Free/Total PSA serum/plasme	Prostate specific Ag.free/Prostate specific Ag.total:MFr:Pt:Ser/Plas:Qn
C0798130	A18139141	L6421071	S11324486	AUI	14957-5	CONSUMER_NAME	Microalbumin urine	Albumin:MCnc:Pt:Urine:Qn:Detection limit <= 20 mg/L
C0800968	A18295534	L1486911	S7405060	AUI	17861-6	CONSUMER_NAME	Calcium serum/plasma serum/plasma	Calcium:MCnc:Pt:Ser/Plas:Qn
C0799300	A18333098	L1459589	S7397926	AUI	16135-6	CONSUMER_NAME	Beta 2 glycoprotein 1 Ab.IgG	Beta 2 glycoprotein 1 Ab.IgG:ACnc:Pt:Ser:Qn
C0363876	A18179501	L1842213	S7444642	AUI	1742-6	CONSUMER_NAME	Alanine aminotransferase serum/plasma	Alanine aminotransferase:CCnc:Pt:Ser/Plas:Qn
C0363885	A18293666	L2271407	S7446614	AUI	1751-7	CONSUMER_NAME	Albumin serum/plasma	Albumin:MCnc:Pt:Ser/Plas:Qn
C0802169	A18334713	L6419581	S7396635	AUI	19270-8	CONSUMER_NAME	Barbiturates screen in urine	Barbiturates:ACnc:Pt:Urine:Ord:Screen
C0803372	A18180413	L2274800	S7406882	AUI	20563-3	CONSUMER_NAME	Carboxyhemoglobin % in blood	Carboxyhemoglobin/Hemoglobin.total:MFr:Pt:Bld:Qn
C0802272	A18180520	L6426638	S7406851	AUI	19381-3	CONSUMER_NAME	Marijuana (THC) screen in urine	Carboxy tetrahydrocannabinol:ACnc:Pt:Urine:Ord:Screen
C0802428	A18218918	L6411306	S7460762	AUI	19554-5	CONSUMER_NAME	Methamphetamine (Meth) screen in urine	Methamphetamine:ACnc:Pt:Urine:Ord:Screen
C0802442	A18180389	L6428267	S7461363	AUI	19568-5	CONSUMER_NAME	Methylenedioxymethamphetamine Ecstasy (MDMA) screen in urine	Methylenedioxymethamphetamine:ACnc:Pt:Urine:Ord:Screen

CURATED_RANGE_AND_UNITS

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0551274	A18291009	L1032593	S7432124	AUI	11561-8	CURATED_RANGE_AND_UNITS	<15;% inhibition	Acetylcholine receptor blocking Ab:ACnc:Pt:Ser:Qn
C0551275	A18097986	L1032594	S7432306	AUI	11562-6	CURATED_RANGE_AND_UNITS	0-20;% modulation	Acetylcholine receptor modulation Ab:ACnc:Pt:Ser:Qn
C0488728	A18329524	L7984692	S10029495	AUI	10230-1	CURATED_RANGE_AND_UNITS	50-75;%	Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn
C0550178	A18098509	L1032595	S7432025	AUI	11034-6	CURATED_RANGE_AND_UNITS	<0.4;nmol/L	Acetylcholine receptor binding Ab:SCnc:Pt:Ser:Qn
C0550221	A18291826	L1035966	S7396969	AUI	11555-0	CURATED_RANGE_AND_UNITS	-2 to +3;mEq/L\|-2 to +3;mmol/L	Base excess:SCnc:Pt:Bld:Qn
C0797306	A18137324	L1473584	S7361853	AUI	12841-3	CURATED_RANGE_AND_UNITS	>25;%	Prostate specific Ag.free/Prostate specific Ag.total:MFr:Pt:Ser/Plas:Qn
C0798130	A18139141	L6421071	S11324486	AUI	14957-5	CURATED_RANGE_AND_UNITS	<20;mg/L	Albumin:MCnc:Pt:Urine:Qn:Detection limit <= 20 mg/L
C0797497	A18331128	L6426370	S7397637	AUI	14316-4	CURATED_RANGE_AND_UNITS	neg	Benzodiazepines:ACnc:Pt:Urine:Ord:Screen
C0797802	A18216111	L1485374	S7398560	AUI	14627-4	CURATED_RANGE_AND_UNITS	24-28:mmol/L	Bicarbonate:SCnc:Pt:BldV:Qn
C0800968	A18295534	L1486911	S7405060	AUI	17861-6	CURATED_RANGE_AND_UNITS	9-10.5;mg/mL	Calcium:MCnc:Pt:Ser/Plas:Qn
C0363876	A18179501	L1842213	S7444642	AUI	1742-6	CURATED_RANGE_AND_UNITS	0-25;U/L	Alanine aminotransferase:CCnc:Pt:Ser/Plas:Qn
C0363885	A18293666	L2271407	S7446614	AUI	1751-7	CURATED_RANGE_AND_UNITS	3.5-5.5;g/dL	Albumin:MCnc:Pt:Ser/Plas:Qn
C0802209	A18218769	L6409052	S7381430	AUI	19312-8	CURATED_RANGE_AND_UNITS	neg	Tricyclic antidepressants:ACnc:Pt:Urine:Ord:Screen
C0364060	A18180387	L0521379	S7396970	AUI	1925-7	CURATED_RANGE_AND_UNITS	-2 to +2:mmol.L	Base excess:SCnc:Pt:BldA:Qn
C0364061	A18334709	L0521381	S7396971	AUI	1926-5	CURATED_RANGE_AND_UNITS	-2 to +2:mmol.L	Base excess:SCnc:Pt:BldC:Qn
C0802237	A18141611	L6421660	S7344866	AUI	19343-3	CURATED_RANGE_AND_UNITS	neg	Amphetamine:ACnc:Pt:Urine:Ord:Screen
C0802272	A18180520	L6426638	S7406851	AUI	19381-3	CURATED_RANGE_AND_UNITS	neg	Carboxy tetrahydrocannabinol:ACnc:Pt:Urine:Ord:Screen
C0802425	A18373675	L6421513	S7460695	AUI	19550-3	CURATED_RANGE_AND_UNITS	neg	Methadone:ACnc:Pt:Urine:Ord:Screen
C0802442	A18180389	L6428267	S7461363	AUI	19568-5	CURATED_RANGE_AND_UNITS	neg	Methylenedioxymethamphetamine:ACnc:Pt:Urine:Ord:Screen

DOCUMENT_SECTION

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0488486	A18368266	L0781260	S7411970	AUI	10154-3	DOCUMENT_SECTION	SECTION	Chief complaint:Find:Pt:^Patient:Nar:Reported
C0488491	A18290941	L0693178	S7445593	AUI	10155-0	DOCUMENT_SECTION	SECTION	History of allergies:Find:Pt:^Patient:Nar:Reported
C0488495	A18252174	L0814379	S7445612	AUI	10157-6	DOCUMENT_SECTION	SECTION	History of family member diseases:Find:Pt:Family:Nar:Reported
C0488501	A18097909	L0838059	S7445660	AUI	10160-0	DOCUMENT_SECTION	SECTION	History of medication use:Find:Pt:^Patient:Nar:Reported
C0488505	A18368271	L0838067	S7445704	AUI	10162-6	DOCUMENT_SECTION	SECTION	History of pregnancies:Find:Pt:Reproductive system:Nar:Reported
C0488507	A18175096	L0838055	S7445713	AUI	10164-2	DOCUMENT_SECTION	SECTION	History of present illness:Find:Pt:^Patient:Nar:Reported
C0488555	A18097923	L0813876	S7446304	AUI	10183-2	DOCUMENT_SECTION	SECTION	Hospital discharge medications:Find:Pt:^Patient:Nar
C0488557	A18213626	L0813870	S7446309	AUI	10184-0	DOCUMENT_SECTION	SECTION	Hospital discharge physical findings:Find:Pt:^Patient:Nar
C0488564	A18097925	L0838113	S7365734	AUI	10187-3	DOCUMENT_SECTION	SECTION	Review of systems:Find:Pt:^Patient:Nar:Reported
C2713002	A18252645	L7984081	S10022039	AUI	10830-8	DOCUMENT_SECTION	SECTION	Surgical operation note complications:Imp:Pt:^Patient:Nar
C0488608	A18252194	L1849697	S7357491	AUI	10210-3	DOCUMENT_SECTION	SECTION	Physical findings:Find:Pt:General status:Nar:Observed
C0488615	A18290963	L7981391	S10022034	AUI	10213-7	DOCUMENT_SECTION	SECTION	Surgical operation note anesthesia:Find:Pt:^Patient:Nar
C0488623	A18290966	L7982745	S10022053	AUI	10215-2	DOCUMENT_SECTION	SECTION	Surgical operation note findings:Find:Pt:^Patient:Nar
C0488625	A18290968	L7977468	S10022060	AUI	10216-0	DOCUMENT_SECTION	SECTION	Surgical operation note fluids:Type:Pt:^Patient:Nar
C0488627	A18097931	L7976156	S10022063	AUI	10217-8	DOCUMENT_SECTION	SECTION	Surgical operation note indications:Imp:Pt:^Patient:Nar
C0488632	A18097932	L7974849	S10022076	AUI	10219-4	DOCUMENT_SECTION	SECTION	Surgical operation note preoperative Dx:Imp:Pt:^Patient:Nar
C0488636	A18329521	L7974852	S10022088	AUI	10221-0	DOCUMENT_SECTION	SECTION	Surgical operation note specimens taken:Find:Pt:^Patient:Nar
C0551729	A18291660	L4854115	S7376446	AUI	11537-8	DOCUMENT_SECTION	SECTION	Surgical drains:Find:Pt:Surgical procedure:Nar
C0551512	A18291721	L6072253	S7436072	AUI	11283-9	DOCUMENT_SECTION	SECTION	Acuity assessment:Fcn:Enctr^frst:^Patient:Nom

LNE

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0804618	A18143075	L1495342	S7385341	AUI	21830-5	LNE	CR0050	Version:Type:Pt:NAACCR message:Nom
C0804625	A18374956	L1485275	S7445102	AUI	21837-0	LNE	CR0190	Hispanic origin:Type:Pt:^Patient:Nom:Best estimate
C0804626	A18374959	L1488854	S7430351	AUI	21838-8	LNE	CR0200	Ethnicity:Type:Pt:^Patient:Nom:Computed
C0804627	A18258883	L1488851	S7423749	AUI	21839-6	LNE	CR0210	Derivation method:Type:Pt:Ethnicity computation:Nom:*
C0804628	A20074742	L10328264	S12898590	AUI	21840-4	LNE	CR0220	Gender:Type:Pt:^Patient:Nom:NAACCR v.11
C0804630	A18220190	L1485519	S7398947	AUI	21842-0	LNE	CR0250	Birthplace:ID:Pt:^Patient:Nom
C0804633	A18181886	L3167533	S7449387	AUI	21845-3	LNE	CR0290	Information source:Type:Pt:Usual occupation Hx:Nom:*
C0804634	A18258890	L3167531	S7449386	AUI	21846-1	LNE	CR0300	Information source:Type:Pt:Usual industry Hx:Nom:*
C0804637	A18258894	L3165516	S7416675	AUI	21849-5	LNE	CR0330	Coding system:Type:Pt:Occupation & Industry Hx:Nom
C0804640	A18336215	L5805862	S7411165	AUI	21852-9	LNE	CR0364	Census tract certainty 1970&80&90:Type:Pt:Census tract:Nom:*
C0804641	A18104656	L1481843	S7369893	AUI	21853-7	LNE	CR0380	Sequence number central.patient:Arb:Pt:Cancer.XXX:Ord
C0804645	A18143093	L2399554	S7397441	AUI	21857-8	LNE	CR430	Behavior ICD-O-2:Prid:Pt:Cancer.XXX:Nom
C0804646	A18374246	L1487096	S7438567	AUI	21858-6	LNE	CR440	Grade:Prid:Pt:Cancer.XXX:Nom
C0804647	A18374248	L1476370	S7416668	AUI	21859-4	LNE	CR0460	Coding system.original:Type:Pt:Cancer.XXX.anatomic site:Nom
C0804648	A18335465	L1487054	S7416669	AUI	21860-2	LNE	CR0480	Coding system.original:Type:Pt:Cancer.XXX.morphology:Nom
C0804649	A18142308	L1487057	S7426235	AUI	21861-0	LNE	CR0490	Dx confirmed by:Type:Pt:Cancer.XXX:Nom
C0804650	A18258114	L1470169	S7371916	AUI	21862-8	LNE	CR0500	Source of document used to abstract:Type:Pt:Cancer.XXX:Nom
C0804652	A18142310	L1487113	S7463275	AUI	21864-4	LNE	CR0520	Most recent screening result for:Type:Pt:Cancer.XXX:Nom
C0804660	A18336219	L1485365	S7364899	AUI	21872-7	LNE	CR0610	Relationship between this hospital and cancer Dx:Type:Episode:Cancer.XXX:Nom

MTH_LEA

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C1651674	A18269997	L5814537	S7384982	AUI	41897-0	MTH_LEA	ONETOUCH![REGISTERED SIGN]! II, ONETOUCH![REGISTERED SIGN]! PROFILE![REGISTERED SIGN]!, ONETOUCH![REGISTERED SIGN]! SURESTEP![REGISTERED SIGN]!, ONETOUCH![REGISTERED SIGN]! FASTTAKE![REGISTERED SIGN]!, ONETOUCH![REGISTERED SIGN]! BASIC![REGISTERED SIGN]!, ONETOUCH![REGISTERED SIGN]! ULTRA![REGISTERED SIGN]!, ONETOUCH![REGISTERED SIGN]! ULTRASMART![REGISTERED SIGN]!, INDUO![REGISTERED SIGN]!, GLUCOMETER ELITE XL DIABETES CARE SYSTEM, ASCENSIA![REGISTERED SIGN]! CONTOURTM, ASCENSIA![TRADE MARK SIGN]! BREEZE![TRADE MARK SIGN]!, ACCU-CHEK![REGISTERED SIGN]! ACTIVE METER, ACCU-CHEK![REGISTERED SIGN]! ADVANTAGE SYSTEM, ACCU-CHEK![REGISTERED SIGN]! COMPACT METER, ACCU-CHEK![REGISTERED SIGN]! COMPLETE METER, ACCU-CHEK![REGISTERED SIGN]! VOICEMATE SYSTEM, PMP SELFCHECK![TRADE MARK SIGN]! GLUCO	Vendor device name:ID:Pt:Glucose meter device:Nom
C1633474	A18153971	L5813632	S7414894	AUI	41960-6	MTH_LEA	Bayer DCA 2000+ analyzer, A1C home test![TRADE MARK SIGN]! , Nycocard![REGISTERED SIGN]! HBA1C	Class:Type:Pt:HbA1c measurement device:Nom
C1645325	A18346652	L5814543	S7384986	AUI	41966-3	MTH_LEA	BODYGEM![REGISTERED SIGN]!	Vendor device name:ID:Pt:Metabolism measurement device:Nom
C1978289	A18274624	L6912031	S8043114	AUI	50415-9	MTH_LEA	2mg Dexamethason-Shorttest: Basal Cortisol concentration was 5 ![MICRO SIGN]!g/dl.	Cortisol^pre 2 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn
C1978290	A18197563	L6899661	S8043110	AUI	50416-7	MTH_LEA	2 mg Dexamethason-Shorttest: Cortisol concentration post 2 mg Dexa was 1 ![MICRO SIGN]!g/dl.	Cortisol^post 2 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn
C1978295	A18390708	L6895533	S8043111	AUI	50421-7	MTH_LEA	CRH-Test: basal cortisol concentration 30 ![MICRO SIGN]!g/dl.	Cortisol^pre 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn
C1978296	A18352137	L6903789	S8043073	AUI	50422-5	MTH_LEA	CRH-Test: 20 minute cortisol concentration 50 ![MICRO SIGN]!g/dl.	Cortisol^20M post 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn
C1953571	A18234578	L6696012	S7803428	AUI	48164-8	MTH_LEA	"NSE in the body fluid was 123 ![MICRO SIGN]!g/L"	Enolase.neuron specific:MCnc:Pt:Body fld:Qn
C1953572	A18195377	L6695481	S7796939	AUI	48165-5	MTH_LEA	"The SCCA in the body fluid was 30![MICRO SIGN]!g/L"	Squamous cell carcinoma Ag:MCnc:Pt:Body fld:Qn
C1953922	A18389273	L6892463	S8016781	AUI	48419-6	MTH_LEA	The C1q binding circulating immune complexes (IgG) is 23 ![MICRO SIGN]!g/ml.	Immune complex.IgG:MCnc:Pt:Ser/Plas:Qn:C1q binding assay
C1953928	A18118945	L6701835	S7797775	AUI	48425-3	MTH_LEA	The troponin T in was 2 ![MICRO SIGN]!G/L.	Troponin T.cardiac:MCnc:Pt:Bld:Qn
C1954000	A18312212	L6692698	S10020240	AUI	48497-2	MTH_LEA	Pro-Hepcidin in serum is 234 ![MICRO SIGN]!g/L.	Pro-hepcidin:MCnc:Pt:Ser/Plas:Qn
C1954705	A18235076	L6904819	S8016780	AUI	48997-1	MTH_LEA	The C1q binding IgG IC in the body fluid are 13 ![MICRO SIGN]!g/ml.	Immune complex.IgG:MCnc:Pt:Body fld:Qn:C1q binding assay
C1954710	A18273811	L6697488	S7806122	AUI	49002-9	MTH_LEA	The albumin excretiion in urine is 30 ![MICRO SIGN]!g/minute.	Albumin:MRat:XXX:Urine:Qn
C1978040	A18274451	L6888416	S8017571	AUI	50201-3	MTH_LEA	190 ![MICRO SIGN]!g/dl.	Iron^4th specimen:MCnc:Pt:Ser/Plas:Qn
C1977690	A18313114	L6884224	S8017573	AUI	50202-1	MTH_LEA	160 ![MICRO SIGN]!g/dl.	Iron^5th specimen:MCnc:Pt:Ser/Plas:Qn
C1977691	A18313115	L6896652	S8017575	AUI	50203-9	MTH_LEA	170 ![MICRO SIGN]!g/dl.	Iron^6th specimen:MCnc:Pt:Ser/Plas:Qn
C1977692	A18235721	L6892557	S8017577	AUI	50204-7	MTH_LEA	190 ![MICRO SIGN]!g/dl.	Iron^7th specimen:MCnc:Pt:Ser/Plas:Qn
C1977693	A18313119	L6896653	S8017579	AUI	50205-4	MTH_LEA	196 ![MICRO SIGN]!g/dl.	Iron^8th specimen:MCnc:Pt:Ser/Plas:Qn

MTH_SOS

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0881628	A18259977	L9459588	S11759933	AUI	24357-6	MTH_SOS	Depending upon the dipstick the results for Glucose, bilirubin, ketones and protein may be reported as an ordinal (present, absent or None, 1+, 2+, 3+,) or as a quantitative value (e.g. 25 mg/dL ). The panel includes both versions to accommodate these two variations. However, one of each of these four pairs 1) Glucose [Mass/volume] , Glucose [Presence] 2) Bilirubin [Mass/volume], Bilirubin [Presence] 3) Ketones [Mass/volume], Ketones [Presence] 4) Protein [Mass/volume], Protein [Presence]must be included in the panel, and the required status is marked as Conditional ![COPYRIGHT SIGN]! to remind users that if one item in the pair is not included in the panel the other must be.	Urinalysis macro (dipstick) panel:-:Pt:Urine:-
C1717121	A18117712	L6082802	S7392199	AUI	46075-8	MTH_SOS	Complete item 2 if ADL self-performance score for TRANSFER (G.1.b.A) is 0,1,2, or 3 AND at least one of the following are present:![BULLET]! Resident received physical therapy involving gait training (P.1.b.c)![BULLET]! Physical therapy was ordered for the resident involving gait training (T.1.b)![BULLET]! Resident received nursing rehabilitation for walking (P.3.f)![BULLET]! Physical therapy involving walking has been discontinued within the past 180 daysSkip to item 3 if resident did not walk in last 7 days(FOR FOLLOWING FIVE ITEMS,BASE CODING ONTHE EPISODE WHENTHE RESIDENT WALKEDTHE FARTHEST WITHOUT SITTING DOWN. INCLUDEWALKING DURING REHABILITATION SESSIONS.)	Walking when most self sufficient:-:Pt:^Patient:Set
C1830060	A18350261	L6410873	S7445930	AUI	47214-2	MTH_SOS	Used to quantify insulin resistance. Formulat is Glucose (mg/dL)) x Insulin (mU/mL) / 405 or Glucose (mmol/L)x Insulin (![MICRO SIGN]!U/mL) / 22.5	Homeostasis model assessment:ACnc:Pt:Ser/Plas:Qn
C1954718	A18351343	L6692682	S7794736	AUI	49010-2	MTH_SOS	Assay is used to measure platelet P2Y12 receptor blockade known to occur with some drugs including the thienopyridine class of drugs, including clopidogrel (Plavix![REGISTERED SIGN]!). VerifyNow P2Y12 Assay from Accumetrics uses adenosine-5-diphosphate(ADP/PGE1) to induce platelet activation. Activated platelets bind fibrinogen in proportion to the number of expressed platelet GPIIb/IIIa receptors. Light transmittance increases as activated platelets bind and aggregate the fibrinogen-coated beads. A turbidimetric based optical detection system measures change in optical signal caused by aggregation and reports results in P2Y12 Reaction Units(PRU). Information from VerifyNow P2Y12 Assay package insert from Accumetrics dated 2006 09 01	Platelet aggregation.adenosine diphosphate induced:ACnc:Pt:PRP:Qn
C1954719	A18273819	L6692683	S7794739	AUI	49011-0	MTH_SOS	A whole blood assay for detecting platelet inhibition or dysfunction due to aspirin therapy. This in vitro assay uses citrated whole blood in the point of care or laboratory setting. Not for use in patients with underlying congenital platelet abnormalities, patients with non-aspirin induced acquired platelet abnormalities or in patients receiving non-aspirin platelet agents (may be used in patients treated with COX-2 inhibitors, e.g., (Celebrex![REGISTERED SIGN]!)).The VerifyNow assay incorporates the agonist arachidonic acid to activate platelets, and measures platelet function based upon the ability of activated platelets to bind fibrinogen. Fibrinogen-coated microparticles aggregate in whole blood in proportion to the number of unblocked platelets GP IIb/IIIa receptors. Light transmittance increases in as activated platelets bind and aggregate fibrinogen-coated beads. The instrument measures this change in optical signal caused by aggregation.Information from VerifyNow Aspirin Assay package insert from www.Accumetrics.com accessed 2090618.	Platelet aggregation.arachidonate induced:ACnc:Pt:PRP:Qn
C1977246	A18390122	L6905092	S8018916	AUI	49498-9	MTH_SOS	In the Hematology world estimated cell counts have existed for many moons and they are reported either qualitatively or quantitatively and done strictly by blood smear review.Smear Estimated WBC and Platelet counts that aren't just reported as reduced/adequate/many that are actually estimated as a numeric result like an estimate of 4 K/cumm for WBC or 400 K/cumm for platelets. Like doing a retic count by counting so many fields on the smear type of estimate.This WBC estimate count is a manual quantitative count. We report a number. See laboratory procedure:A.WBC Count Smear Estimate:1.Use the 50X oil immersion objective.2.Count the number of both intact and disrupted WBCs in each of 10 microscopic fields in different areas of the slide where RBCs slightly overlap. Divide the total number by 10 to establish the mean number of WBCs/field and multiply this mean by 3,000 to get the estimated WBC count/mm3. Do not round off the mean, e.g., if the mean is 5.7 do not round off to 6 but leave the figure at one place past the decimal point for greater accuracy.3.If the quantitative WBC count is <25,000, the estimated smear count should be within 1,500 cells of this figure. Estimate counts are less reliable at >25,000 cells/mm3.III.REFERENCES:A.A Color Atlas and Instruction Manual of Peripheral Blood Cells Morphology, by Barbara H. O'Connor, 1984, p. 20.B.Principles and Procedures, Barbara A. Brown, 6th Edition, 1993, p. 104.	Leukocytes:NCnc:Pt:Bld:Qn:Estimate
C3169358	A19525769	L10086616	S12607770	AUI	62637-4	MTH_SOS	The Pediatric Sleep Questionnaire (PSQ) protocol is a parent questionnaire for children from 2 through 18 years, and rated on a simple three-point scale ("yes," "no," or "don't know") for all items except the inattention/hyperactivity items that are rated on a four-point Likert scale. This protocol provides an overall total score and five sleep scales: (1) Sleep-Related Breathing Disorders (SRBD), (2) Snoring, (3) Sleepiness, (4) Behavior, and (5) Periodic Limb Movement Disorder (PLMD). The PSQ can be licensed and obtained at: http://techtransferstore.umich.edu/ProductDetails.asp?ProductCode=PSQ-3766, ![COPYRIGHT SIGN]! 2007 The Regents of the University of Michigan	PhenX - respiratory - sleep apnea - child protocol:-:Pt:^Patient:-:PhenX
C3169724	A19534745	L10089528	S12606969	AUI	62651-5	MTH_SOS	Male participants are also asked about contraception use in the last 12 months. The NSFG provides a card of response categories to the respondent. For example, in question 1 for males, an investigator would provide the respondent with a card listing the categories: "Condom or rubber; Withdrawal or pulling out; Vasectomy or male sterilization; Pill; Tubal ligation ("tubes tied") or female sterilization; Injection (Depo-Provera![REGISTERED SIGN]! or Lunelle); Spermicidal foam/jelly/cream/film/suppository; Hormonal implant (Norplant![REGISTERED SIGN]!); Rhythm or safe period; Something else."	PhenX - contraceptive methods - male protocol:-:Pt:^Patient:-:PhenX
C3169733	A19521615	L10092561	S12607316	AUI	62660-6	MTH_SOS	Female participants are asked whether they have ever used Evista![REGISTERED SIGN]! or Nolvadex![REGISTERED SIGN]! and then asked length of time they used it as well as whether they are currently using it. They are asked whether they are using any over-the-counter preparations for hormone replacement or post-menopause symptoms. Lastly, they are asked about their use of prescription female hormones (number of months taken, types, dosage). Note: PhenX staff removed embedded dates of original study for clarity of Toolkit users.	PhenX - hormonal therapy protocol:-:Pt:^Patient:-:PhenX
C3169735	A19512695	L10101531	S12607329	AUI	62662-2	MTH_SOS	The interviewer asks the female participant whether she has ever received a human papillomavirus (HPV) vaccination. If she answers yes, the interviewer asks her age and how many shots she received. If the participant answers "yes" to question 1, the interviewer should complete the rest of the protocol. If the participant answers "no" then the protocol is deemed complete. The PhenX Working Group notes that GARDASIL![REGISTERED SIGN]! is also known as Silgard. European Medicines Agency. (September 25, 2009). Silgard European Public Assessment Report. Retrieved from http://www.emea.europa.eu/humandocs/Humans/EPAR/silgard/silgard.htm. Waknine, Yael. (October 2, 2006). International Approvals: Singulair and Gardasil/Silgard. Medscape Today. Retrieved from http://www.medscape.com/viewarticle/545374.	PhenX - human papillomavirus vaccine use protocol:-:Pt:^Patient:-:PhenX
C3169763	A19517131	L10083820	S12608604	AUI	62690-3	MTH_SOS	Procedure for the measurement of intraocular pressure (IOP) using the TONO-PEN![REGISTERED SIGN]! XL Applanation Tonometer. TONO-PEN![REGISTERED SIGN]! is a registered trademark Reichert, Inc. This procedure is used to measure intraocular pressure (IOP). An elevated IOP can be dangerous because people with varying degrees of IOP elevation may develop damage to the optic nerve.	PhenX measure - intraocular pressure:-:Pt:^Patient:-:PhenX
C3169764	A19521630	L10092569	S12607365	AUI	62691-1	MTH_SOS	Intraocular pressure (IOP) is measured using the TONO-PEN![REGISTERED SIGN]! XL instrument. The cornea is prepared by introducing one drop of anesthetic onto the surface of the eye and the TONO-PEN![REGISTERED SIGN]! is used to obtain four valid IOP measurements. The instrument calculates an average and the examiner records the average. The instrument also provides the reliability level of the measurement. Only those readings that have a 5% variability level are recorded as they are considered to be accurate. This protocol uses TONO-PEN![REGISTERED SIGN]! to measure intraocular pressure. This instrument has the advantages of portability and is relatively easy to use. Other hand-held instruments can be used to measure intraocular pressure. If other instruments are used, the reproducibility of the measurements should be comparable to those acquired with this protocol. In addition, when other instruments are used to collect these measurements, the manufacturer and model of equipment should be recorded. These other devices may require some different steps than are described in this protocol. Investigators should follow the equipment manufacturer's instructions to ensure quality control.	PhenX - intraocular pressure protocol:-:Pt:^Patient:-:PhenX
C3171737	A19526014	L10092553	S12607234	AUI	62769-5	MTH_SOS	The Montreal Cognitive Assessment (MoCA![COPYRIGHT SIGN]!) is a screening instrument for mild cognitive impairment and more severe cognitive deficits. It is an interviewer-administered questionnaire in which the respondent performs certain tasks, such as drawing and counting, to assess various cognitive domains, such as attention, memory, orientation, language, conceptual thinking and planning. Please consult www.mocatest.org for permission and requirements to use the MoCA test.	PhenX - global mental status - adult protocol:-:Pt:^Patient:-:PhenX
C3171738	A19512765	L10089557	S12607238	AUI	62770-3	MTH_SOS	The Ages & Stages Questionnaires![REGISTERED SIGN]!, Third Edition (ASQ-3) screens infants and young children from 1 month to 66 months for developmental delays in five areas. The ASQ-3 is completed by a parent (or child's caregiver) or by an examiner asking a parent (or child's caregiver) questions about the child. The protocol includes scoring instructions. Additionally, the Brookes Publishing Company offers an optional online management system for ASQ-3 called ASQ Online. The Ages & Stages Questionnaires![REGISTERED SIGN]!, Third Edition (ASQ-3) is a proprietary, fee-based instrument that is available for purchase from Brookes Publishing Company.	PhenX - global mental status - child protocol:-:Pt:^Patient:-:PhenX
C3171740	A19517171	L10101609	S12607996	AUI	62772-9	MTH_SOS	Logical Memory is an interviewer-administered test that is a part of the Wechsler Memory Scale![REGISTERED SIGN]!, Fourth Edition (WMS![REGISTERED SIGN]!-IV). The interviewer reads the respondent a story and asks the respondent to repeat details of the story from memory. The test can be performed as both an immediate and delayed recall. The protocol includes scoring instructions that accounts for specific versus paraphrased details. Logical Memory is a subtest of the Wechsler Memory Scale![REGISTERED SIGN]!, Fourth Edition (WMS![REGISTERED SIGN]!-IV). Each WMS-III or WMS-IV subtest is a part of a complete WMS-III/IV assessment and is not sold separately. To administer a subtest requires a licensing agreement from Pearson. Researchers should complete and return an application to pas.licensing@pearson.com. The current fee for each subtest use is $1.25 each - subject to a minimum license fee.	PhenX - verbal memory protocol:-:Pt:^Patient:-:PhenX
C3171742	A19521668	L10089652	S12608012	AUI	62774-5	MTH_SOS	Visual Reproductions is an interviewer-administered test that is a part of the Wechsler Memory Scale![REGISTERED SIGN]! Fourth Edition (WMS![REGISTERED SIGN]!-IV). The interviewer shows the respondent a series of simple images and asks the respondent to draw them from memory. The test can be performed as both an immediate and delayed recall. The protocol includes scoring instructions that account for accuracy and speed. Visual Reproductions is a component of The Wechsler Memory Scale![REGISTERED SIGN]!, Fourth Edition. Each WMS-III or WMS-IV subtest is a part of a complete WMS-III/IV assessment and is not sold separately. To administer a subtest requires a licensing agreement from Pearson. Researchers should complete and return an application to pas.licensing@pearson.com. The current fee for each subtest use is $1.25 each - subject to a minimum license fee.	PhenX - visual memory protocol:-:Pt:^Patient:-:PhenX
C3171743	A19508442	L10083893	S12609114	AUI	62775-2	MTH_SOS	Digit span is an interviewer-administered test that is part of the Wechsler Adult Intelligence Scale![REGISTERED SIGN]!, Fourth Edition (WAIS![REGISTERED SIGN]!-IV). The examiner reads the respondent a series of number sequences and then asks the respondent to repeat the numbers back in forward and reverse order. The protocol also includes detailed scoring instructions. Digit Span is a subtest of the Wechsler Adult Intelligence Scale![REGISTERED SIGN]!, Fourth Edition (WAIS![REGISTERED SIGN]!-IV). Each WAIS-IV subtest is a part of a complete WAIS-IV assessment and is not sold separately. To administer a subtest requires a licensing agreement from Pearson. Researchers should complete and return an application to pas.licensing@pearson.com. The current fee for each subtest use is $1.25 each - subject to a minimum license fee.	PhenX measure - working memory:-:Pt:^Patient:-:PhenX
C3171782	A19508462	L10089515	S12606889	AUI	62814-9	MTH_SOS	The participant is asked to complete a one-mile walk test as quickly as possible on a track. A technician utilizes a stopwatch to time the walk. The participant wears a heart rate monitor that records h/her heart rate continuously through the test. After the test is completed the technician records the heart rate from the last 10 seconds of the test. In addition, the participant's age, sex, and body weight are needed to complete an equation to determine maximal oxygen consumption (VO2max). Polar![REGISTERED SIGN]! is a trademark of Polar Electro Oy	PhenX - cardiorespiratory fitness - 1 mile walk protocol:-:Pt:^Patient:-:PhenX
C3171783	A19504160	L10101486	S12606897	AUI	62815-6	MTH_SOS	The participant is asked to walk on a treadmill at a 5% grade for 4 minutes. A technician utilizes a stopwatch to time the walk. The participant wears a heart rate monitor that records h/her heart rate continuously through the test. After the test is completed the technician records the heart rate from the last 15 seconds of the test. In addition, the participant's age and gender are needed to complete an equation to determine maximal oxygen consumption (VO2max). Polar![REGISTERED SIGN]! is a trademark of Polar Electro Oy	PhenX - cardiorespiratory fitness - treadmill protocol:-:Pt:^Patient:-:PhenX

HL7_FIELD_SUBFIELD_ID

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0551623	A18098696	L1035467	S7459245	AUI	11380-3	HL7_FIELD_SUBFIELD_ID	PID-16	Marital status and living arrangements:Find:Pt:^Patient:Nar:Reported
C0551624	A18252926	L1483838	S7459246	AUI	11381-1	HL7_FIELD_SUBFIELD_ID	PID-16	Marital status and living arrangements:Find:Pt:^Patient:Nom:Reported
C0802049	A18295881	L1494191	S7446323	AUI	19111-4	HL7_FIELD_SUBFIELD_ID	PID-21	Hospital number:ID:Pt:^Mother:Nom
C0803906	A18297287	L1485516	S7398943	AUI	21112-8	HL7_FIELD_SUBFIELD_ID	PID-7.1	Birth date:TmStp:Pt:^Patient:Qn
C0804623	A18336210	L1488635	S7416656	AUI	21835-4	HL7_FIELD_SUBFIELD_ID	PID-10.3	Coding system.current:Type:Pt:Race:Nom
C0804624	A18374955	L1488647	S7416670	AUI	21836-2	HL7_FIELD_SUBFIELD_ID	PID-10.3	Coding system.original:Type:Pt:Race:Nom
C0804626	A18374959	L1488854	S7430351	AUI	21838-8	HL7_FIELD_SUBFIELD_ID	PID-22	Ethnicity:Type:Pt:^Patient:Nom:Computed
C0804630	A18220190	L1485519	S7398947	AUI	21842-0	HL7_FIELD_SUBFIELD_ID	PID-23	Birthplace:ID:Pt:^Patient:Nom
C0804805	A18104733	L1494285	S7462431	AUI	22018-6	HL7_FIELD_SUBFIELD_ID	PID-27	Military patient number:ID:Pt:^Patient:Nom
C1146896	A18340607	L2419239	S7422498	AUI	31211-6	HL7_FIELD_SUBFIELD_ID	PID-29	Date of death:TmStp:Pt:^Patient:Qn
C1315098	A18264804	L3168147	S7364179	AUI	32624-9	HL7_FIELD_SUBFIELD_ID	PID-10	Race:Type:Pt:^Patient:Nom
C1624675	A18308808	L5812826	S7419034	AUI	42062-0	HL7_FIELD_SUBFIELD_ID	PID-11.9;PID-12	County--current:Prid:Pt:Cancer.XXX:Nom
C1626258	A18270066	L9076276	S11344139	AUI	42077-8	HL7_FIELD_SUBFIELD_ID	PID-13	Telephone:Tele:Pt:^Patient:Nom
C2598118	A18237009	L8566311	S10634589	AUI	52461-1	HL7_FIELD_SUBFIELD_ID	PID-5.3	Middle name:Pn:Pt:^Patient:Nom
C2599456	A18392642	L8574230	S10636831	AUI	54125-0	HL7_FIELD_SUBFIELD_ID	PID-5	Name:Pn:Pt:^Patient:Nom
C2599464	A18315223	L8533789	S10619641	AUI	54131-8	HL7_FIELD_SUBFIELD_ID	PID-8	Gender:Type:Pt:^Patient:Nom:USSG-FHT
C2599465	A18392646	L8561320	S10655787	AUI	54132-6	HL7_FIELD_SUBFIELD_ID	PID-24	Twin:Arb:Pt:^Patient:Ord
C2599466	A18354028	L8564118	S10679437	AUI	54133-4	HL7_FIELD_SUBFIELD_ID	PID-22	Ethnicity:Type:Pt:^Patient:Nom:USSG-FHT
C2598508	A18315225	L8560151	S10646044	AUI	54134-2	HL7_FIELD_SUBFIELD_ID	PID-10	Race:Type:Pt:^Patient:Nom:USSG-FHT

LCB

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0484575	A18213782	L3157795	S7418808	AUI	10332-5	LCB	HYDROCORTISONE	Cortisol^pre 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn
C0484996	A18252334	L2424741	S7376002	AUI	10342-4	LCB	SULFAMETHOXAZOLE	Sulfamethoxazole:MCnc:Pt:Ser/Plas:Qn
C0485000	A18136532	L0869625	S7377691	AUI	10343-2	LCB	TEMAZEPAM	Temazepam:MCnc:Pt:Ser/Plas:Qn
C0485012	A18175255	L6422616	S7381580	AUI	10345-7	LCB	TRIHEXYPHENIDYL HYDROCHLORIDE	Trihexyphenidyl:MCnc:Pt:Urine:Qn
C0486101	A18329662	L6423654	S7418947	AUI	10364-8	LCB	(S)-1-METHYL-5-(3-PYRIDINYL)-2-PYRROLIDINONE	Cotinine:MCnt:Pt:Hair:Qn
C0486102	A18213800	L0800182	S7418944	AUI	10365-5	LCB	(S)-1-METHYL-5-(3-PYRIDINYL)-2-PYRROLIDINONE	Cotinine:MCnc:Pt:Ser/Plas:Qn
C0486103	A18368442	L6403313	S7418945	AUI	10366-3	LCB	(S)-1-METHYL-5-(3-PYRIDINYL)-2-PYRROLIDINONE	Cotinine:MCnc:Pt:Urine:Qn
C0486106	A18252349	L6417235	S7430198	AUI	10367-1	LCB	ETHYL ALCOHOL	Ethanol:MCnc:Pt:Gast fld:Qn
C0486122	A18252350	L0749151	S7454069	AUI	10368-9	LCB	LEAD	Lead:MCnc:Pt:BldC:Qn
C0486167	A18175265	L6401626	S7356029	AUI	10370-5	LCB	PHENCYCLIDINE	Phencyclidine:MCnt:Pt:Hair:Qn
C0484581	A18175208	L0629012	S7437158	AUI	10449-7	LCB	D-GLUCOSE	Glucose^1H post meal:MCnc:Pt:Ser/Plas:Qn
C0484599	A18252272	L0623749	S7437831	AUI	10450-5	LCB	D-GLUCOSE	Glucose^post 10H CFst:MCnc:Pt:Ser/Plas:Qn
C0484606	A18098030	L0628943	S7393056	AUI	10452-1	LCB	ALPHA-D-XYLOSE	Xylose^1H post 25 g xylose PO:MCnc:Pt:Ser/Plas:Qn
C0484607	A18329600	L0628985	S7393064	AUI	10453-9	LCB	ALPHA-D-XYLOSE	Xylose^1H post dose xylose PO:MCnc:Pt:Ser/Plas:Qn
C0484608	A18098176	L0634918	S7393085	AUI	10454-7	LCB	ALPHA-D-XYLOSE	Xylose^2H post 25 g xylose PO:MCnc:Pt:Ser/Plas:Qn
C0484609	A18252434	L0634927	S7393106	AUI	10455-4	LCB	ALPHA-D-XYLOSE	Xylose^30M post 25 g xylose PO:MCnc:Pt:Ser/Plas:Qn
C0484610	A18213884	L0646967	S7393165	AUI	10456-2	LCB	ALPHA-D-XYLOSE	Xylose^post 6H CFst:MCnc:Pt:Ser/Plas:Qn
C0484672	A18252444	L1471099	S7404759	AUI	10468-7	LCB	CALCITONIN	Calcitonin Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0484691	A18175355	L1471171	S7414175	AUI	10473-7	LCB	CYMOTRYPSIN	Chymotrypsin Ag:ACnc:Pt:Tiss:Ord:Immune stain

MTH_LQT

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2973103	A18850058	L9571227	S12036224	AUI	61526-0	MTH_LQT	HOW OFTEN did you take Regular One-a-Day type, Centrum![REGISTERED SIGN]! or Thera-type MULTIPLE VITAMINS?	How often did you take regular one a day type, centrum or thera type multiple vitamins:Find:Pt:^Patient:Ord:PhenX
C2973104	A20848808	L10830555	S13449719	AUI	61527-8	MTH_LQT	HOW MANY YEARS did you take Regular One-a-Day type, Centrum![REGISTERED SIGN]! or Thera-type MULTIPLE VITAMINS?	How many Y did you take regular one a day type, centrum or thera type multiple vitamins:Time:Pt:^Patient:Qn:PhenX
C2973127	A18861191	L9575278	S12035880	AUI	61550-0	MTH_LQT	How often did you drink FRUIT-FLAVORED DRINKS with sugar (such as Kool-Aid![REGISTERED SIGN]!, Hi-C![REGISTERED SIGN]!, lemonade, or cranberry cocktail)?	How often did you drink fruit flavored drinks with sugar (such as kool aid, hi C, lemonade, or cranberry cocktail) in past 30D:Find:Pt:^Patient:Ord:PhenX
C2973055	A18872095	L9575270	S12035832	AUI	61478-4	MTH_LQT	HOW OFTEN DID YOU DRINK Black tea such as Lipton![REGISTERED SIGN]!, or Earl Grey (Not decaffeinated-instant, bottled, and brewed)?	How often did you drink black tea such as lipton, or earl grey:Find:Pt:^Patient:Ord:PhenX
C2973056	A18850020	L9582404	S12045308	AUI	61479-2	MTH_LQT	What is your serving size for Black tea such as Lipton![REGISTERED SIGN]!, or Earl Grey (Not decaffeinated-instant, bottled, and brewed)?	What is your serving size for black tea such as lipton, or earl grey:Find:Pt:^Patient:Ord:PhenX
C2973073	A18850030	L9571189	S12035903	AUI	61496-6	MTH_LQT	HOW OFTEN DID YOU DRINK Jolt![REGISTERED SIGN]!, Surge![REGISTERED SIGN]!, Mountain Dew![REGISTERED SIGN]!, Red Bull![REGISTERED SIGN]! and other highly caffeinated sodas?	How often did you drink jolt, surge, mountain dew, red bull and other highly caffeinated sodas:Find:Pt:^Patient:Ord:PhenX
C2973074	A18883246	L9572279	S12045367	AUI	61497-4	MTH_LQT	What is your serving size for Jolt![REGISTERED SIGN]!, Surge![REGISTERED SIGN]!, Mountain Dew![REGISTERED SIGN]!, Red Bull![REGISTERED SIGN]! and other highly caffeinated sodas?	What is your serving size for jolt, surge, mountain dew, red bull and other highly caffeinated sodas:Find:Pt:^Patient:Ord:PhenX
C2973131	A18883286	L9575288	S12036003	AUI	61554-2	MTH_LQT	During the past month, how often did you eat DOUGHNUTS, sweet rolls, Danish, muffins, or Pop-Tarts![REGISTERED SIGN]!?	How often did you eat doughnuts, sweet rolls, danish, muffins, or pop-tarts in past 30D:Find:Pt:^Patient:Ord:PhenX
C3173334	A19509135	L10086038	S12602695	AUI	63951-8	MTH_LQT	In the past 3 years, please indicate if you have taken either of the following types of medications.Statin medications such as lovastatin (Mevacor![REGISTERED SIGN]!), atorvastatin (Lipitor![REGISTERED SIGN]!), rosuvastain (Crestor![REGISTERED SIGN]!), pravastatin (Pravachol![REGISTERED SIGN]!), simvastatin (Zocor![REGISTERED SIGN]!), fluvastatin (Lescol![REGISTERED SIGN]!)	In the past 3Y have you taken statins, lovastatin - mevacor, atorvastatin - lipitor, rosuvastain - crestor, pravastatin - pravachol, simvastatin - zocor, fluvastatin - lescol:Find:Pt:^Patient:Ord:PhenX
C3173130	A19522274	L10097621	S12599062	AUI	63874-2	MTH_LQT	The most frequently used estrogen is oral Premarin![REGISTERED SIGN]!. Have you ever taken Premarin![REGISTERED SIGN]! by mouth (as pills)?	Have you ever taken premarin by mouth as pills:Find:Pt:^Patient:Ord:PhenX
C3173132	A19535447	L10084676	S12591062	AUI	63875-9	MTH_LQT	At what age did you first take Premarin![REGISTERED SIGN]!?	At what age did you first take premarin:Time:Pt:^Patient:Qn:PhenX
C3173134	A19517805	L10078583	S12591077	AUI	63876-7	MTH_LQT	At what age did you last take Premarin![REGISTERED SIGN]!?	At what age did you last take premarin:Time:Pt:^Patient:Qn:PhenX
C3173136	A19513457	L10097742	S12600071	AUI	63877-5	MTH_LQT	How many years in total did you take Premarin![REGISTERED SIGN]! (exclude those periods when you temporarily stopped)?	How many Y in total did you take premarin - exclude those periods when you temporarily stopped:Time:Pt:^Patient:Qn:PhenX
C3173138	A20090213	L10343087	S12915391	AUI	63878-3	MTH_LQT	Five commonly used doses of Premarin![REGISTERED SIGN]! can be distinguished by the color of the pill. Please indicate any you have ever used and the one you used for the longest period.	Which premarin pill did you use the longest:Find:Pt:^Patient:Nom:PhenX
C3173139	A19517809	L10081655	S12591072	AUI	63879-1	MTH_LQT	At what age did you first use estrogens other than Premarin![REGISTERED SIGN]! pills?	At what age did you first use estrogens other than premarin pills:Time:Pt:^Patient:Qn:PhenX
C3173141	A19531136	L10096637	S12591087	AUI	63880-9	MTH_LQT	At what age did you last use estrogens other than Premarin![REGISTERED SIGN]! pills?	At what age did you last use estrogens other than premarin pills:Time:Pt:^Patient:Qn:PhenX
C3173143	A19531137	L10091693	S12600066	AUI	63881-7	MTH_LQT	How many years in total did you take estrogens other than Premarin![REGISTERED SIGN]! pills (exclude any time when you temporarily stopped)?	How many Y in total did you take estrogens other than premarin pills - exclude any time when you temporarily stopped:Time:Pt:^Patient:Qn:PhenX
C3173145	A20075607	L10332847	S12899977	AUI	63882-5	MTH_LQT	Sometimes another type of female hormone, progesterone (or progestin), is given for symptoms of menopause, either alone or in combination with estrogen. The most frequently used progestin is Provera![REGISTERED SIGN]! (medroxyprogestoerone acetate). Have you ever used progesterone or a progestin?	Have you ever used progesterone or a progestin:Find:Pt:^Patient:Nom:PhenX
C3173153	A19526674	L10094979	S12602428	AUI	63886-6	MTH_LQT	If you used Provera![REGISTERED SIGN]!, what was your usual dose?	If you used provera, what was your usual dose:Find:Pt:^Patient:Nom:PhenX

MTH_LRN2

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C0796873	A18368356	L6416368	S10025717	AUI	13682-0	MTH_LRN2	; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Creat; Crea; CR; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; mRto; Mass concentration ratio; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY; UCr	3-Hydroxy,3-Methylglutarate/Creatinine:MCrto:Pt:Urine:Qn
C0796820	A18292975	L1460275	S7450287	AUI	13629-1	MTH_LRN2	; Il1Beta; IL-1![LATIN SMALL LETTER SHARP S]!; IL-1B; IL-1; Lymphocyte-Activating Factor; CG Antigen-Specific Helper Factor; ETAF; Epidermal Cell Derived Thymocyte-Activating Factor; Lymphocyte-Stimulating Hormone; Macrophage Cell Factor; T Helper Factor; IL1; Mass concentration; Level; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; IL; B; I; Chemistry	Interleukin 1 beta:MCnc:Pt:Ser/Plas:Qn
C0797232	A18177479	L6427043	S7418846	AUI	14044-2	MTH_LRN2	11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; mRate; Mass rate; 1 day; 24 hours; 24HR; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Chemistry	Cortisone:MRat:24H:Urine:Qn
C0797344	A18254563	L1490331	S7418845	AUI	14159-8	MTH_LRN2	11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Mass concentration; Level; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; Chemistry	Cortisone:MCnc:Pt:Ser/Plas:Qn
C0945215	A18106114	L1848404	S7418850	AUI	25382-3	MTH_LRN2	11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Substance concentration; Level; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; Chemistry	Cortisone:SCnc:Pt:Ser/Plas:Qn
C0942531	A18338875	L6419739	S11739456	AUI	26583-5	MTH_LRN2	; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Creat; Crea; CR; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; sRto; Substance concentration ratio; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY; UCr	3-Hydroxy,3-Methylglutarate/Creatinine:SCrto:Pt:Urine:Qn
C1113793	A18263269	L6423097	S10025725	AUI	29867-9	MTH_LRN2	; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Arbitrary concentration; Point in time; Random; Ur; UR; Urn; UA; Ql; Ordinal; QL; Qualitative; Qual; Screen; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY	3-Hydroxy,3-Methylglutarate:ACnc:Pt:Urine:Ord
C1113972	A18263362	L6416889	S7418844	AUI	30072-3	MTH_LRN2	11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Mass concentration; Level; 1 day; 24 hours; 24HR; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; High pressure liquid chromatography; High performance liquid chromatography; Chemistry	Cortisone:MCnc:24H:Urine:Qn:HPLC
C1114354	A18109347	L6413483	S7418841	AUI	30511-0	MTH_LRN2	11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Creat; Crea; CR; mRto; Mass concentration ratio; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Chemistry; UCr	Cortisone/Creatinine:MCrto:Pt:Urine:Qn
C1830843	A18233773	L6401988	S7370575	AUI	46765-4	MTH_LRN2	HBSS; HbS![LATIN SMALL LETTER SHARP S]!o Thalassemia; SS; Hb S/S; Falciform anemia; Interpretation; Interp; Impression; Impressions; Point in time; Random; DBS; Filter paper; FP; Dried blood spot; Blood; WB; Whole blood; Ql; Ordinal; QL; Qualitative; Qual; Screen; Chemistry	Sickle cell anemia:Imp:Pt:Bld.dot:Ord
C1830845	A18350006	L6414139	S7442920	AUI	46767-0	MTH_LRN2	; Hb S/bTh; HbS![LATIN SMALL LETTER SHARP S]!+; Hb S/A; Hgb S; Sickle cell; Sickle cells; HbS; Haemoglobin; Interpretation; Interp; Impression; Impressions; Point in time; Random; DBS; Filter paper; FP; Dried blood spot; Blood; WB; Whole blood; Ql; Ordinal; QL; Qualitative; Qual; Screen; S prime; B; Chemistry; Sickle cell screen; Sicklequik; Sickledex	Hemoglobin S beta thalassemia:Imp:Pt:Bld.dot:Ord
C1977101	A18274188	L6884205	S8017368	AUI	49717-2	MTH_LRN2	; Il1Beta; IL-1![LATIN SMALL LETTER SHARP S]!; IL-1B; IL-1; Lymphocyte-Activating Factor; CG Antigen-Specific Helper Factor; ETAF; Epidermal Cell Derived Thymocyte-Activating Factor; Lymphocyte-Stimulating Hormone; Macrophage Cell Factor; T Helper Factor; IL1; Mass concentration; Level; Point in time; Random; BF; Fluid; Body fluid; B/F; FLU; Fl; Quantitative; QNT; Quant; Quan; IL; B; I; Chemistry	Interleukin 1 beta:MCnc:Pt:Body fld:Qn
C1954752	A18389890	L6694573	S7802084	AUI	49029-2	MTH_LRN2	; Cortis F; 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Coritsol; Cort; hydrocortisone; Compound F; 17-Hydroxycorticosterone; mRto; Mass concentration ratio; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; FR; Non-protein bound; Chemistry	Cortisol.free/Cortisone.free:MCrto:Pt:Urine:Qn
C1977635	A18158617	L6886484	S11739455	AUI	49819-6	MTH_LRN2	; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Creat; Crea; CR; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; sRto; Substance concentration ratio; 1 day; 24 hours; 24HR; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY; UCr	3-Hydroxy,3-Methylglutarate/Creatinine:SCrto:24H:Urine:Qn
C2598770	A18121963	L8548058	S10673316	AUI	53777-9	MTH_LRN2	11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Mass concentration; Level; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; FR; Non-protein bound; Chemistry	Cortisone.free:MCnc:Pt:Urine:Qn
C3259230	A20068664	L10330541	S12899660	AUI	66388-0	MTH_LRN2	; Txs; Tx; Deltasone; Cortan; Meticorten; Prednicen-M; Orasone; Liquid Pred; Panasol-S; Child steroids anti-CA drugs; Drug; 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Finding; Findings; Point in time; Random; Ql; Ordinal; QL; Qualitative; Qual; Screen; Ste; Steriods; Steroid; Othr	Has the child take cortisone, prednisone, other steroids, or anticancer drugs or had x-ray treatments in the past 3Mo:Find:Pt:^Patient:Ord:PhenX
C3259220	A20075957	L10334790	S12896578	AUI	66378-1	MTH_LRN2	; Txs; Tx; Deltasone; Cortan; Meticorten; Prednicen-M; Orasone; Liquid Pred; Panasol-S; Drug; Steroids anti-CA drugs radiation; 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Finding; Findings; Point in time; Random; Ql; Ordinal; QL; Qualitative; Qual; Screen; Ste; Steriods; Steroid; Othr	Do you take cortisone, prednisone, other steroids, or anticancer drugs, or have you had radiation treatments:Find:Pt:^Patient:Ord:PhenX
C3481886	A20867953	L10814866	S13440720	AUI	69832-4	MTH_LRN2	; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Substance concentration; Level; Point in time; Random; Cerebral spinal fluid; Spinal Fluid; Cerebrospinal Fl; Spinal Flu; Spinal Fld; Quantitative; QNT; Quant; Quan; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY	3-Hydroxy,3-Methylglutarate:SCnc:Pt:CSF:Qn
C3481887	A20864229	L10817785	S13440719	AUI	69833-2	MTH_LRN2	; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Substance concentration; Level; Point in time; Random; Amn; Amniotic fluid; Amn fl; Amniotic flu; AF; Quantitative; QNT; Quant; Quan; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY	3-Hydroxy,3-Methylglutarate:SCnc:Pt:Amnio fld:Qn

MTH_LFO

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C1315557	A18226363	L8896462	S11031936	AUI	33086-0	MTH_LFO	Gestational age from Biparietal Diameter: GA = EXP (0.04557BPD-0.0061838BPD * ln(BPD) + 1.985); SD: ![PLUS-MINUS SIGN]! 0.0002531* BPD+0.02988; Derived output: 12-39 week; Published input: BPD 21-89 mm	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from O-I BPD.Chitty 1997
C1315558	A18226364	L8869958	S11031937	AUI	33087-8	MTH_LFO	Gestational age from Biparietal Diameter: GA = EXP (0.044653BPD-0.0060089BPD * ln (BPD) +1.961)SD: ![PLUS-MINUS SIGN]! 0.0002577* BPD+0.03061Derived output: 12-39 weeks Published input: BPD 22-91 mm	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from O-O BPD.Chitty 1997
C1315569	A18381116	L8881079	S11031896	AUI	33098-5	MTH_LFO	Gestational age from Femur Length: GA = Exp (0.034375FL-0.0037254Flloge (Fl)+2.306); SD: ![PLUS-MINUS SIGN]! 0.00025215Fl+0.03165; Derived output: 12-39 weeks; Published input: 10-67 mm	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from FL.Chitty 1997
C1315581	A18342548	L8896460	S11031919	AUI	33110-8	MTH_LFO	Gestational age from Head Circumference: GA = Exp (0.010451HC - 0.000029919HC2 + 0.4315610-7HC3 + 1.854); SD: ![PLUS-MINUS SIGN]! 0.000059454*HC+0.024261; Derived output: 12-39 weeks; Published input: 85-325 mm	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from HC measured.Chitty 1997
C1315582	A18110735	L8877427	S11031918	AUI	33111-6	MTH_LFO	Gestational age from Head Circumference: GA = Exp (0.010611HC-0.00003032HC2+0.4349810-7HC3+0.08024); SD: ![PLUS-MINUS SIGN]! 0.0005263HC + 0.000014204HC2 + 0.08024; Derived output: 12-39 weeks; Published input: 80-320 mm	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from HC derived.Chitty 1997
C1315603	A18265011	L8892569	S11031949	AUI	33132-2	MTH_LFO	Gestational age from Transverse Cerebella Diameter: GA = Exp (0.79107* loge (TCD)+0.6439)SD: ![PLUS-MINUS SIGN]! 0.0078877*TCD2+0.1225Derived output: 12-39 weeks Published input: 13-36 mm	Gestational age:Time:Pt:^Fetus:Qn:US.estimated from TCD.Chitty 1994
C3172439	A19517533	L10093763	S12592800	AUI	63369-3	MTH_LFO	CUI = (a/![LATIN SMALL LETTER SHARP S]!)*10, where a represents the amount of histamine released by the donor basophils and associated leukocytes in response to the patient serum; and ![LATIN SMALL LETTER SHARP S]! represents the normalized baseline of histamine release.	Chronic urticaria index:ACnc:Pt:Ser:Qn

MTH_SOS

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2971984	A19511818	L8882611	S11044703	CODE	LP90326-7	MTH_SOS	MULTI-AXIAL:Resident mood interview (PHQ-9![COPYRIGHT SIGN]!) \| patient	Resident mood interview (PHQ-9©) \| patient
C2972165	A19511858	L8871556	S11046619	CODE	LP90310-1	MTH_SOS	MULTI-AXIAL:Signs and symptoms of delirium (from CAM![COPYRIGHT SIGN]!) \| patient	Signs and symptoms of delirium (from CAM©) \| patient
C2972261	A19516299	L8879113	S11047672	CODE	LP90366-3	MTH_SOS	MULTI-AXIAL:Staff assessment of resident mood (PHQ-9-OV![COPYRIGHT SIGN]!) \| patient	Staff assessment of resident mood (PHQ-9-OV©) \| patient
C2971984	A18896503	L8882611	S11044703	CODE	LP110193-2	MTH_SOS	SUPERSYSTEMMULTI-AXIAL:Resident mood interview (PHQ-9![COPYRIGHT SIGN]!) \| patient	Resident mood interview (PHQ-9©) \| patient
C2972165	A18862947	L8871556	S11046619	CODE	LP110185-8	MTH_SOS	SUPERSYSTEMMULTI-AXIAL:Signs and symptoms of delirium (from CAM![COPYRIGHT SIGN]!) \| patient	Signs and symptoms of delirium (from CAM©) \| patient
C2972261	A18873925	L8879113	S11047672	CODE	LP110212-0	MTH_SOS	SUPERSYSTEMMULTI-AXIAL:Staff assessment of resident mood (PHQ-9-OV![COPYRIGHT SIGN]!) \| patient	Staff assessment of resident mood (PHQ-9-OV©) \| patient

COPYRIGHT

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2736105	A18239863	L9086874	S11340224	AUI	57696-7	COPYRIGHT	Copyright 2011 International Association for the Study of Pain (IASP). Used with permission. Before translating text into a language other than found on the Pediatric Pain Sourcebook (www.painsourcebook.ca), please contact IASP to gain permission.	Pain severity:Find:Pt:^Patient:Ord:Reported.FPS-R
C3483309	A20849807	L10828253	S13455008	AUI	71891-6	COPYRIGHT	Used with permission	M3 Checklist - follow-up:-:Pt:^Patient:-:M3

FROMRSAB

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	FROMRSAB	LNC	LNC215 to CPT2005 Mappings

FROMVSAB

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	FROMVSAB	LNC215	LNC215 to CPT2005 Mappings

MAPSETRSAB

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	MAPSETRSAB	LNC	LNC215 to CPT2005 Mappings

MAPSETTYPE

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	MAPSETTYPE	LOINC has associated CPT code	LNC215 to CPT2005 Mappings

MAPSETVERSION

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	MAPSETVERSION	200707	LNC215 to CPT2005 Mappings

MAPSETVSAB

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	MAPSETVSAB	LNC224	LNC215 to CPT2005 Mappings

MTH_MAPFROMCOMPLEXITY

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	MTH_MAPTOEXHAUSTIVE	SINGLE CODE	LNC215 to CPT2005 Mappings

MTH_MAPFROMEXHAUSTIVE

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	MTH_MAPFROMEXHAUSTIVE	N	LNC215 to CPT2005 Mappings

MTH_MAPSETCOMPLEXITY

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	MTH_MAPSETCOMPLEXITY	N_TO_ONE	LNC215 to CPT2005 Mappings

MTH_MAPTOCOMPLEXITY

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	MTH_MAPTOEXHAUSTIVE	SINGLE CODE, MULTIPLE CODE	LNC215 to CPT2005 Mappings

MTH_MAPTOEXHAUSTIVE

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	MTH_MAPTOEXHAUSTIVE	N	LNC215 to CPT2005 Mappings

TORSAB

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	TORSAB	CPT	LNC215 to CPT2005 Mappings

TOVSAB

(return to top)

CUI	METAUI	LUI	SUI	STYPE	CODE	ATN	ATV	STR
C2706621	A16924870	L6107611	S7015223	CODE	MTHU031471	TOVSAB	CPT2005	LNC215 to CPT2005 Mappings

Unified Medical Language System® (UMLS®)

2012AB LOINC Source Information

Counts

Notes

Sample Data

COMMON_ORDER_RANK

COMMON_SI_TEST_RANK

COMMON_TEST_RANK

LCL

LCN

LCS

LOINC_COMPONENT

LRN2

LOINC_TIME_ASPECT

LOINC_SYSTEM

LOINC_PROPERTY

LOINC_SCALE_TYP

LLR

LCT

LOR

LUR

LCA

LOINC_METHOD_TYP

EXAMPLE_UCUM_UNITS

EXAMPLE_UNITS

HL7_V2_DATATYPE

LSU

HL7_V3_DATATYPE

LQS

SOS

LEA

LQT

LMM

STATUS_REASON

LMP

LCD

MTH_LSU

STATUS_TEXT

CHANGE_REASON_PUBLIC

LNC

MTH_COPYRIGHT

LFO

LSP

CONSUMER_NAME

CURATED_RANGE_AND_UNITS

DOCUMENT_SECTION

LNE

MTH_LEA

MTH_SOS

HL7_FIELD_SUBFIELD_ID

LCB

MTH_LQT

MTH_LRN2

MTH_LFO

MTH_SOS

COPYRIGHT

FROMRSAB

FROMVSAB

MAPSETRSAB

MAPSETTYPE

MAPSETVERSION

MAPSETVSAB

MTH_MAPFROMCOMPLEXITY

MTH_MAPFROMEXHAUSTIVE

MTH_MAPSETCOMPLEXITY

MTH_MAPTOCOMPLEXITY

MTH_MAPTOEXHAUSTIVE

TORSAB

TOVSAB

Unified Medical Language System^® (UMLS^®)